UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

☒  ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended September 30, 2015

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE EXCHANGE ACT

 

For the transition period from _________ to ________

 

Commission File No. 000-55127

 

 

 

Blue Sphere Corporation
(Exact name of registrant as specified in its charter)
 
Nevada 98-0550257
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
 
301 McCullough Drive, 4th Floor, Charlotte, North Carolina 28262
(Address of principal executive offices) (zip code)
 
704-909-2806
(Registrant’s telephone number, including area code)
 
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Exchange Act of 1934: None.

Securities registered pursuant to Section 12(g) of the Exchange Act of 1934: Common Stock, $0.001 per share.

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act of 1933.

Yes ☐   No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act of 1934.

Yes ☐   No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒    No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☒    No ☐

 
 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer     Accelerated filer  
Non-accelerated filer (Do not check if a smaller reporting company) Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐   No ☒

The aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was approximately $4,802,337, based on the closing sales price of the registrant’s common stock as of the last business day of its most recently completed second fiscal quarter. For purposes of the foregoing calculation only, the registrant has assumed that all officers and directors of the registrant are affiliates.

State the number of shares outstanding of each of the issuer’s classes of common equity as of the latest practicable date:

 

As of December 31, 2015, there were 181,317,675 shares of common stock, par value $0.001 per share, issued and outstanding.

 
 

 

TABLE OF CONTENTS

 

PART I 2
  Item 1. Business 2
  Item 1A. Risk Factors 10
  Item 1B. Unresolved Staff Comments 17
  Item 2. Properties 18
  Item 3. Legal Proceedings 18
  Item 4. Mine Safety Disclosures 18
PART II 18
  Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters  and Issuer Purchases of Equity Securities 18
  Item 6. Selected Financial Data 19
  Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 19
  Item 7A. Quantitative and Qualitative Disclosures about Market Risk 21
  Item 8. Financial Statements and Supplementary Data 21
  Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 21
  Item 9A. Controls and Procedures 22
  Item 9B. Other Information 23
PART III 23
  Item 10. Directors, Executive Officers and Corporate Governance 23
  Item 11. Executive Compensation 26
  Item 12. Security Ownership of Certain Beneficial Owners and Management 30
  Item 13. Certain Relationships, Related Transactions and Director Independence 31
  Item 14. Principal Accounting Fees and Services 32
  Item 15. Exhibits and Financial Statement Schedules 33

APPENDIX A – FINANCIAL STATEMENTS

F-1

  

Our audited financial statements are stated in United States dollars (“U.S. $”, “$” or “USD”) and are prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”). In this annual report, unless otherwise specified, all dollar amounts are expressed in United States dollars.

As used in this report, the terms “we”, “us”, “our”, “Blue Sphere” or the “Company” mean Blue Sphere Corp. and its wholly-owned subsidiaries, unless the context clearly requires otherwise.

i
 

 

Note Regarding Forward-Looking Statements

This report contains forward-looking statements. Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks set out below, any of which may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These risks include, without limitation, (i) uncertainties regarding our ability to obtain adequate financing on a timely basis including financing for specific projects, (ii) the financial and operating performance of our projects, (iii) uncertainties regarding the market for and value of carbon credits, renewable energy credits and other environmental attributes, (iv) political and governmental risks associated with the countries in which we may operate, (v) unanticipated delays associated with project implementation including designing, constructing and equipping projects, as well as delays in obtaining required government permits and approvals, (vi) the development stage of our business and (vii) our lack of operating history.

This list is not an exhaustive list of the factors that may affect an of our forward-looking statements. These and other factors should be considered carefully and readers should not place undue reliance on our forward-looking statements.

Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and we undertake no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

PART I

Item 1. Business

Company Overview

We are an international Build, Own & Operate company (BOO) active around the world in the clean energy production and organics to energy markets. We aspire to become a key player in these global markets, working with enterprises with clean energy, organics to energy and related by-product potential to generate clean energy, soil amendments, compost and other by-products. We believe that these markets have tremendous potential insofar as there is a virtually endless supply of waste and organic material that can be used to generate power and valuable by-products. Not only is there a virtually endless supply of waste and organic material, but in most, if not all, cases, disposing of such waste and material in most parts of the world today is a costly problem with an environmentally-damaging solution, such as landfilling. We seek to offer a cost-effective, environmentally-safe alternative.

We are currently focusing on (i) 10 projects related to the construction, acquisition or development of biogas facilities, for which we have signed definitive agreements, letters of intent or memoranda of understanding to own and implement such projects, as well as pipeline of similar projects in a less mature phase, and (ii) our fast charging battery technology. We elected to prioritize our projects in the United States and Italy over projects we were previously pursuing in Africa based on our view of these projects’ greater potential.

Projects

United States

Charlotte, NC Waste to Energy Anaerobic Digester 5.2 MW Plant

 

Johnston, RI Waste to Energy Anaerobic Digester 3.2 MW Plant

Italy

Soc. agr. AGRICERERE srl – Tromello (Pavia) 999 KW Plant

 

Soc. agr. AGRIELEKTRA srl – Alagna (Pavia) 999 KW Plant

 

Soc. agr. AGRISORSE srl - Garlasco (Pavia) 999 KW Plant

 

Soc. agr. GEFA srl – Dorno (Pavia) 999 KW Plant

 

Soc. agr. SAMMARTEIN srl – San Martino in Rio (Reggio Emilia) 999 KW Plant

 

Soc. agr. ER srl – Aprilia (Latina) 999 KW Plant

 

Soc. agr. BIOENERGIE SRL – Aprilia (Latina) 999 KW Plant

Israel

Ramat Chovav Waste to Energy Anaerobic Digester 5.0 MW Plant

2
 

United States Projects

On October 19, 2012, we signed definitive project agreements in respect of both the North Carolina and Rhode Island sites with Orbit Energy, Inc. (“Orbit”), pursuant to which we would be entitled to full ownership of each of the entities that owns the rights to implement the respective projects (Orbit Energy Charlotte, LLC in the case of the North Carolina project (“OEC”) and Orbit Energy Rhode Island, LLC in the case of the Rhode Island project (“OERI”)), subject to the satisfaction of certain conditions.

North Carolina Project

On November 19, 2014, we signed an amended and restated purchase agreement with Orbit for the North Carolina project (the “Amended OEC Purchase Agreement”). Subject to the terms of the Amended OEC Purchase Agreement, Orbit transferred ownership of OEC to us in exchange for a development fee of $900,000, reimbursement of $17,764 and an amount equal to 30% of the distributable cash flow from the North Carolina project after the project achieves a post-recoupment 30% internal rate of return computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature. We also agreed to use high solid anaerobic digester units designed by Orbit (the “HSAD Units”) and to retain Orbit to implement and operate the HSAD Units for an annual management fee of $187,500 (the “OEC Management Fee”), subject to certain conditions. The Amended OEC Purchase Agreement provided that we had until December 15, 2014 to pay Orbit the development fee and reimbursement amount, which was extended to January 15, 2015 upon payment of $75,000. We did not pay Orbit the development fee and reimbursement amount and, pursuant to the terms of the Amended OEC Purchase Agreement, ownership of OEC reverted back to Orbit on January 15, 2015.

On January 30, 2015, we entered into the Orbit Energy Charlotte, LLC Membership Interest Purchase Agreement by and among the Company, Orbit, Concord Energy Partners, LLC, a Delaware limited liability company (“Concord”), and OEC (the “New OEC Purchase Agreement”), pursuant to which (i) Concord purchased all of Orbit’s right, title and interest in and to the membership interests of OEC (the “OEC Interests”), (ii) Orbit abandoned all economic and ownership interest in the OEC Interests in favor of Concord, (iii) Orbit ceased to be a member of OEC and (iv) Concord was admitted as the sole member of OEC.

Subject to the satisfaction of certain conditions by Orbit, we agreed to be responsible for all costs of evaluating and incorporating into the North Carolina project (i) Orbit’s high solids anaerobic digestion technology, consisting of a proprietary process that uses an anaerobic digester design developed by the U.S. Department of Energy and subsequently modified by Orbit in combination with the proprietary bacteria supplied by Orbit (the “Orbit Technology”), and (ii) two HSAD Units designed by Orbit with up to a total maximum capacity of 100 tons per day. We are responsible for both direct and indirect costs, all payments to be made to Orbit and all increased costs, expenses and any damages incurred in connection with the design, installation, integration, operation and maintenance of the Orbit Technology incorporated into the project. We also agreed to enter into an operations agreement with Orbit in respect of the HSAD Units to be integrated into the North Carolina project, and to pay Orbit the OEC Management Fee.

In a letter agreement executed in connection with the New OEC Purchase Agreement, we agreed to pay Orbit an amount equal to thirty percent (30%) of the North Carolina project’s distributable cash flow after we and the other equity investors in the North Carolina project fully recoup their respective investments in the North Carolina project (such investments to be calculated solely as amounts expended in and for the construction of the North Carolina project) and the North Carolina project achieves a thirty percent (30%) internal rate of return. The calculation of the project’s internal rate of return would take into account and be computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature, as well as the OEC Management Fee.

On the same date as the New OEC Purchase Agreement, (i) the Company, Concord and York Renewable Energy Partners LLC (“York”) entered into a development and indemnification agreement (the “Concord Development and Indemnification Agreement”), pursuant to which Concord paid us $1,250,000, issued us 250 Series B units of Concord (“Concord Series B Units”) and issued 750 Series A units of Concord (“Concord Series A Units”) to York, and (ii) we and York entered into an amended and restated limited liability company operating agreement (the “Concord LLC Agreement”) to establish the Concord Series A Units and Concord Series B Units and admit us and York as 25% and 75% members of Concord, respectively. Purs uant to the foregoing agreements, York also agreed to pay us two equal installments of $587,500 upon (a) mechanical completion of the North Carolina project and (b) commercial operation of the North Carolina project. Our right to receive distributions from Concord are subject to certain priorities in favor of York.

3
 

Pursuant to the Concord LLC Agreement, Concord is managed by a board of managers initially consisting of three managers (the “Concord Board”). So long as York owns more than 50% of the membership interests of Concord, York is entitled to appoint two of the Concord Board’s three managers. So long as we own no less than 12.5% of the membership interests of Concord, we are entitled to appoint one manager of the Concord Board. In the event that the Concord Board determines in good faith that additional equity capital is needed by Concord and is in the best interests of the North Carolina project, the Concord Board may determine the amount of additional capital needed and issue new units to raise the necessary funds. In this case, our percentage interest in Concord would be reduced accordingly. The Concord LLC Agreement also contains certain restrictions on our right to transfer our membership interests in Concord to third parties.

In connection with the foregoing, on January 30, 2015, we terminated our amended and restated construction finance agreement, dated June 6, 2014, with Caterpillar Financial Services Corporation. In February 2015, we received $1,586,000 for development fees and reimbursements in connection with the North Carolina project and credited these amounts against project expenses.

OEC and Duke Energy Carolinas, LLC (“Duke Energy”) are parties to an Amended and Restated Renewable Energy Purchase Agreement, dated October 12, 2012 and amended on April 25, 2013, January 31, 2014 and January 20, 2015 (as amended, the “Duke PPA”), pursuant to which OEC has agreed to sell, and Duke has agreed to purchase, the energy output of OEC’s facility, subject to the terms and conditions of the Duke PPA. Among other things, the Duke PPA requires OEC to commence commercial operations by December 31, 2015 or, if not operational within 60 days of such date, pay Duke Energy $500,000 of liquidated damages, which would extend the deadline for commercial operation to March 30, 2016. The Duke PPA is effective until December 31, 2029. The loss of Duke Energy as a customer of OEC could have a material adverse effect on the Company.

OEC and ARC Development are parties to an Organic Waste Delivery Agreement, dated February 4, 2014, in respect of the North Carolina project, which upon commencement of operations will provide 100 tons a day of organic feedstock to OEC’s facility. The Organic Waste Delivery Agreement has a ten year term beginning on the date of the first supply of organic feedstock. In addition, OEC is party to a Substrates Supply and Transportation Agreement with CP Bio Energy LLC, which upon commencement of operations will provide approximately 220 tons a day of substrate to OEC’s facility, increasing to 320 tons a day of substrate by the second year of commercial operation. The Substrates Supply and Transportation Agreement has a ten year term (with an automatic five year renewal) beginning on the date OEC’s facility commences commercial operations. OEC is projected to require about 432 tons of organic feedstock on a daily basis and is working with other organic waste suppliers to arrange for additional supplies of feedstock.

Although no assurances can be given, we expect the North Carolina project to commence commercial operations in the first quarter of 2016. If commercial operations are not commenced within 60 days of December 31, 2015, OEC will be required to pay $500,000 of liquidated damages to Duke Energy pursuant to the Duke PPA. If applicable, York will be responsible for contributing these funds to OEC.

Rhode Island Project

On January 7, 2015, we signed an amended and restated purchase agreement with Orbit for the Rhode Island project (the “Amended OERI Purchase Agreement”). Subject to the terms of the Amended OERI Purchase Agreement, Orbit transferred full ownership of OERI to us in exchange for a development fee of $300,000, reimbursement of $86,432 and an amount equal to 30% of the distributable cash flow from the Rhode Island project after the project achieves a post-recoupment 30% internal rate of return computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature. We also agreed to use HSAD Units designed by Orbit and to retain Orbit to implement and operate the HSAD Units for an annual management fee of $187,500 (the “OERI Management Fee”), subject to certain conditions. The Amended OERI Purchase Agreement provided that we had until January 22, 2015 to pay Orbit the development fee and reimbursement amount, which was extended to February 28, 2015 upon payment of $31,000. We did not pay the development fee and reimbursement amount and, pursuant to the terms of the Amended OERI Purchase Agreement, ownership of OERI reverted back to Orbit.

On April 8, 2015, we entered into the Orbit Energy Rhode Island, LLC Membership Interest Purchase Agreement by and among the Company, Orbit, Rhode Island Energy Partners, LLC, a Delaware limited liability company (“Rhode Island”) and OERI (the “New OERI Purchase Agreement”), pursuant to which (i) Rhode Island purchased all of Orbit’s right, title and interest in and to the membership interests of OERI (the “OERI Interests”), (ii) Orbit abandoned all economic and ownership interest in the OERI Interests in favor of Rhode Island, (iii) Orbit ceased to me a member of OERI and (iv) Rhode Island was admitted as the sole member of OERI.

Subject to the satisfaction of certain conditions by Orbit, we agreed to be responsible for all costs of evaluating and incorporating into the Rhode Island project (i) the Orbit Technology and (ii) two HSAD Units designed by Orbit with up to a total maximum capacity of 75 tons per day. We are responsible for both direct and indirect costs, all payments to be made to Orbit and all increased costs, expenses and any damages incurred in connection with the design, installation, integration, operation and maintenance of the Orbit Technology incorporated into the project. We also agreed to enter into an operations agreement with Orbit in respect of the HSAD Units to be integrated into the Rhode Island project and to pay Orbit the OERI Management Fee.

4
 

We also acknowledged in the New OERI Purchase Agreement our continuing responsibility to pay Orbit an amount equal to thirty percent (30%) of the Rhode Island project’s distributable cash flow after we and the other equity investors in the Rhode Island project fully recoup our respective investments in the Rhode Island project (such investments to be calculated solely as amounts expended in and for the construction of the Rhode Island project) and the Rhode Island project achieves a thirty percent (30%) internal rate of return. The calculation of the project’s internal rate of return would take into account and be computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature, as well as the OERI Management Fee.

On the same date as the New OERI Purchase Agreement, (i) the Company, Rhode Island and York entered into a development and indemnification agreement (the “Rhode Island Development and Indemnification Agreement”), pursuant to which Rhode Island agreed to pay us $1,481,900, issue us 2,275 Series B units of Rhode Island (“Rhode Island Series B Units), and issue 7,725 Series A units of Rhode Island (“Rhode Island Series A Units”) to York, and (ii) we and York entered into an amended and restated limited liability company operating agreement (the “Rhode Island LLC Agreement”) to establish the Rhode Island Series A Units and Rhode Island Series B Units and admit us and York as 22.75% and 77.25% members of Rhode Island, respectively. Pursuant to the foregoing agreements, York also agreed to pay us three equal installments of $562,500 upon (a) signing of the Rhode Island Development and Indemnification Agreement, (b) the later of (x) the date of mechanical completion of the Rhode Island project and (y) the date on which an executed interconnection agreement between OERI and National Grid, including receipt of any regulatory approvals from the Rhode Island Public Utility Commission, is delivered by OERI, and (c) commercial operation of the Rhode Island project.

Pursuant to the Rhode Island LLC Agreement, Rhode Island is managed by a board of managers initially consisting of three managers (the “Rhode Island Board”). So long as York owns more than 50% of the membership interests of Rhode Island, York is entitled to appoint two of the Rhode Island Board’s three managers. So long as we own no less than 11.375% of the membership interests of Rhode Island, we are entitled to appoint one manager of the Rhode Island Board. In the event that the Rhode Island Board determines in good faith that additional equity capital is needed by Rhode Island and is in the best interests of the Rhode Island project, the Rhode Island Board may determine the amount of additional capital needed and issue new units to raise the necessary funds. In this case, our percentage interest in Rhode Island would be reduced accordingly. The Rhode Island LLC Agreement also contains certain restrictions on our right to transfer our membership interests in Rhode Island to third parties.

In April 2015, we received $1,481,900 for development fees and reimbursements in connection with the Rhode Island project and credited these amounts against project expenses.

OERI and The Narragansett Electric Company d/b/a National Grid (“National Grid”) are parties to a Power Purchase Agreement, dated May 26, 2011 and amended on April 11, 2013, December 9, 2013 and January 9, 2015 (as amended, the “National Grid PPA”), pursuant to which OERI has agreed to sell, and National Grid has agreed to purchase, the energy output of OERI’s facility, subject to the terms and conditions of the National Grid PPA. Among other things, the National Grid PPA requires OERI to commence commercial operations by December 31, 2015, which may be extended up to six months by OERI upon deposit of $22,500 of collateral. The National Grid PPA is effective for 15 years from the date commercial operations are commenced, which may be extended by 6 years at the option of National Grid. The loss of National Grid as a customer of OERI could have a material adverse effect on the Company.

OERI and Organic Waste Management, LLC are parties to an Organic Waste Delivery Agreement, dated February 27, 2015, in respect of 1100 to 1400 tons a week of organic feedstock, and OERI and E.L. Harvey & Sons are parties to a feedstock supply agreement, dated August 5, 2013, in respect of 50 to 100 tons a day of organic feedstock. Both agreements have ten year terms with certain provisions for renewal. Feedstock will be supplied to the Rhode Island project upon commencement of operations. OERI is projected to require 220 tons of organic feedstock on a daily basis and is working with other organic waste suppliers to arrange for additional supplies of feedstock.

Although no assurances can be given, we expect the Rhode Island project to commence commercial operations in the second quarter of 2016. Since commercial operations were not commenced by December 31, 2015, OERI will be required to deposit additional collateral of $22,500 pursuant to the National Grid PPA. York will be responsible for contributing these funds to OERI.

Both the Rhode Island and North Carolina projects previously entered into ten year compost off-take agreements, dated May 15, 2013, with McGill Environmental Systems (“McGill”), a market leader in the compost industry. The compost to be purchased by McGill will comprise the digestate that is a by-product from the anaerobic digestion process at each plant. The agreement between OEC and McGill never became effective, as the OEC facility was not operating by May 15, 2015. The agreement between OERI and McGill will become effective once the OERI facility is steadily producing 30 tons per day of compost. In general, we are currently seeking to diversify sales of the plants’ by-products among several buyers on more attractive terms.

5
 

Italy Projects

In September 2014, we entered into a letter of intent to acquire Kinexia S.p.A.’s right, interest and title in, to and under four biogas projects in the Vigevano area in Italy. The letter of intent also provides for the purchase of three additional biogas projects in the Emillia-Romagna and Lazio regions upon the same principals set forth in the letter of intent and subject to definitive agreements.

On May 14, 2015, we entered into a Share Purchase Agreement (the “Italy Projects Agreement”) with Volteo Energie S.p.A., Agriholding S.r.l., and Overland S.r.l. (each, a “Seller” and collectively, the “Sellers”) through our indirect, wholly-owned subsidiary, Bluesphere Italy S.r.l. (we subsequently changed the name of Bluesphere Italy S.r.l to Bluesphere Pavia, which is the name we use herein). Pursuant to the Italy Projects Agreement, we agreed to purchase one hundred percent (100%) of the share capital of Agricerere S.r.l., Agrielektra S.r.l., Agrisorse S.r.l. and Gefa S.r.l (each, an “SVP” and collectively, the “SVPs”) from the Sellers, who collectively hold all of the outstanding share capital of each SVP, Each SVP is engaged in the owning and operating of an anaerobic digestion biogas plant for the production and sale of electricity to Gestore del Servizi Energetici GSE, S.p.A., a state-owned company, pursuant to a power purchase agreement. Pursuant to the Italy Projects Agreement, we also issued a corporate guarantee to the Sellers, whereby the Company will secure the obligations of Bluesphere Pavia under the Italy Projects Agreement.

Pursuant to the Italy Projects Agreement, we agreed to pay an aggregate purchase price of five million six hundred thousand euros (€5,600,000) for all of the SVPs, consisting of a purchase price for each SVP of one million four hundred thousand euros (€1,400,000) (the “Purchase Price”). The Purchase Price for each SVP was determined based on a “Base Line EBITDA” guaranteed by the Sellers and an “Equity IRR Target” calculated on the Purchase Price of no less than twenty-five percent (25%). The Purchase Price is subject to certain adjustments prior to and after closing of the acquisitions, and any variation of EBITDA results in the 18 months following a closing will trigger an adjustment to the Purchase Price for the relevant SVP, as further set forth in the Italy Projects Agreement. Fifty-percent (50%) of the Purchase Price for each SVP will be paid at the relevant closing, and the remaining fifty percent (50%) of the Purchase Price, subject to specified adjustments, will be promised by a note from each Seller, to be paid on the third anniversary of the date of the relevant closing, along with interest on the balance due at an annual rate of five percent (5%). In addition, the Sellers granted us credit of one hundred thousand euros (€100,000) per SVP, half of which is allocable to each such payment.

The closing in relation to each SVP will occur independently of closings of the sale of the other SVPs, and any such closing is subject to certain conditions precedent including, but not limited to, obtaining consent to the proposed sale and resulting change of control from the SVPs’ lender in connection with a certain Financing Agreement, dated February 25, 2013, between the SPVs, Banca IMI S.p.A. and Intesa San Paolo S.p.A, as well as from other counterparties to certain agreements to which the SVPs are a party. We have agreed to pay fifty percent (50%) of any fees and expenses charged by the lenders in connection with obtaining these consents. On July 31, 2015, Banca IMI S.p.A. consented to the changes of control, subject to certain conditions precedent, including payment of a waiver fee equal to one hundred thousand euros (€100,000).

On July 17, 2015, we entered into a Framework EBITDA Guarantee Agreement (the “EBITDA Agreement”) with Austep S.p.A. (“Austep”), an Italian corporation. Austep specializes in the design, construction, operation and servicing of anaerobic digestion plants. The EBITDA Agreement provides a framework pursuant to which Austep will perform technical analyses of operating anaerobic digestion plants in Italy that we identify as potential acquisition targets. If and when we acquire such anaerobic digestion plants in Italy, subject to the terms of the EBITDA Agreement, we and Austep have agreed to negotiate individual agreements pursuant to which Austep will operate, maintain and supervise each plant and guarantee agreed-upon levels of EBITDA for a specified period. The EBITDA Agreement will apply to the first fifteen anaerobic digestion plants that we may acquire in Italy, including the plants subject to the Italy Projects Agreement.

On August 18, 2015, we and two of our wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern Sphere”) and BlueSphere Pavia, entered into a Long Term Mezzanine Loan Agreement (the “Helios Loan Agreement”) with Helios Italy Bio-Gas 1 L.P. (“Helios”) to finance the Italy Projects Agreement. Under the Helios Loan Agreement, Helios will make up to five million euros (€5,000,000) available to Bluesphere Pavia (the “Helios Loan”) to finance (a) ninety percent (90%) of the total required investment of the first four SVPs acquired, (b) eighty percent (80%) of the total required investment of up to three SVPs subsequently acquired, (c) certain broker fees incurred in connection with the acquisitions, and (d) any taxes associated with registration of an equity pledge agreement (as described below). Each financing of an SVP acquisition will be subject to specified conditions precedent and will constitute a separate loan under the Helios Loan Agreement. Helios may, within 90 days of a closing, require repayment of ten percent (10%) of the relevant loan and broker fees. If no such repayment is required, Helios may reduce the amount of its commitment to finance the acquisitions of the three additional SVPs to seventy to eighty percent (70-80%) of the total required investment. Helios’s commitment to provide any loan under the Helios Loan Agreement that is not utilized by June 30, 2016 will automatically cancel, unless extended in writing by Helios.

6
 

Subject to specified terms, representations and warranties, the Helios Loan Agreement provides that each loan thereunder will accrue interest at a rate of fourteen and one-half percent (14.5%) per annum, paid quarterly. Helios will also be entitled to an annual operation fee, paid quarterly. The final payment for each loan will become due no later than the earlier of (a) thirteen and one half years from the date such loan was made available to Bluesphere Pavia, and (b) the date that the Feed in Tariff license granted to the relevant SVP expires. Pursuant to the Helios Loan Agreement and an equity pledge agreement, Eastern Sphere pledged all its shares in Bluesphere Pavia to secure all loan amounts utilized under the Helios Loan Agreement.

On December 14, 2015, pursuant to the Italy Projects Agreement, we completed the acquisitions of the four SVPs. We paid an aggregate purchase price of five million two hundred thousand euros (€5,200,000), subject to certain post-closing adjustments, to acquire the share capital of the SPVs. Fifty percent (50%) of this adjusted Purchase Price was paid at closing, and the balance is due to the Sellers on the third anniversary of the closing date. The portion of the Purchase Price and closing costs paid at closing was primarily financed by a loan of two million nine hundred thousand euros (€2,900,000) pursuant to the Helios Loan Agreement. In accordance with the EBITDA Agreement, Austep will operate, maintain and supervise the biogas plants owned by the SPVs. In addition, Austep will guarantee a monthly aggregate EBITDA of one hundred eighty-eight thousand euros (€188,000) from the four SPVs for the initial six months following the acquisition, and thereafter Austep will guarantee an annual aggregate EBITDA of three million seven hundred sixty thousand euros (€3,760,000) from the four SVPs. Pursuant to the terms of the agreements with Austep, we will receive the guaranteed levels of EBITDA and Austep will receive any revenue in excess of these levels.

Israel Project

In September 2014, we signed a memorandum of understanding (the “Ramat Chovav MoU”) to develop a 5.0 MW biogas project (the “Israel Project”) together with an Israeli state-owned company in Israel. The Ramat Chovav MoU contemplates that the Israeli state-owned company will lease a suitable site and perform maintenance services for the Israel Project. The Ramat Chovav MoU further contemplates that after the Israel Project is in operation for three years, the Israeli state-owned company has the option to purchase up to a 50% ownership stake at the then fair market value. We are currently conducting development activities in respect of the Israel Project, and we also expect to enter into a long-term power purchase agreement with the Israel Electric Company. Recently, the state-owned company has informed us that it will proceed with the Israel Project through a tender, and we are planning to participate. There is no assurance that we will enter into a signed definitive agreement or consummate the purchase of the Israel Project, or that project financing will be available in a timely manner or at all.

Fast Charging Battery Technology

Last year we decided to enter the fast charging battery space. On October 30, 2014, we entered into a license agreement (the “NTU License Agreement”) with Nanyang Technological University based in Singapore (“NTU”), pursuant to which NTU granted us a perpetual, exclusive, worldwide, royalty-bearing license, with rights to sublicense, to certain of its intellectual property and know-how (the “Licensed Technology”) relating to fast-charging lithium-ion batteries. Under the NTU License Agreement, we are committed to exercise our best efforts to commercialize the Licensed Technology in the consumer electronics and electric vehicle fields within four years (which can be extended in 12 month increments upon payment of $25,000 to NTU). If we fail to meet our performance milestones, then NTU will have the right to convert the license from exclusive to non-exclusive in respect of the relevant field of use (i.e., consumer electronics and electric vehicles). We also paid NTU 10,000 Singapore dollars (“SD”) upon signing the NTU License Agreement and are obligated to pay NTU (i) SD 50,000 upon production of a non-laboratory scale prototype of the first product using the Licensed Technology, (ii) SD 50,000 upon the first commercial sale of such product, and (iii) royalties of 3.5% of net sales of any products covered by the NTU License Agreement and 15% of sublicense revenue. We are responsible for all costs and expenses of patents relating to the Licensed Technology.

On January 8, 2015, we entered into a Founders Agreement with one of the inventors of the Licensed Technology (the “Quickcharge Founders Agreement”), pursuant to which we incorporated Quickcharge PTE Ltd. (“Quickcharge”) for the purpose of developing and commercializing the Licensed Technology. Pursuant to the Quickcharge Founders Agreement, we own 70% of the issued share capital of Quickcharge and are committed to provide Quickcharge up to $500,000 in loan financing. The Quickcharge Founders Agreement also contains provisions regarding dilution, option shares, restrictions on share transfers and drag along rights.

Currently, we are in discussions with potential buyers of the Licensed Technology, but there is no assurance any transaction will be consummated.

7
 

Strategy

Our main focus is providing tailored solutions internationally to produce clean energy primarily out of waste. We are focused on waste-to-energy projects in the United States, Italy and Israel and are in the process of developing a pipeline of similar projects. We believe there is a virtually endless supply of waste suitable for such projects and the demand for energy (particularly from such projects) is growing every year.

Our model in respect of waste-to-energy is to acquire or build, own and operate. We select projects with signed, long-term agreements with waste producers or waste haulers in respect of feedstock, with national governments or electricity corporations in respect of the energy output and with private entities in respect of other project by-products (such as renewable energy credits, heat, compost and fertilizer). We are currently focused on several types of projects: (i) anaerobic digestion to electricity, (ii) landfill gas to energy, (iii) anaerobic digestion to renewable natural gas, (iv) biomass and (v) energy crop to electricity.

Another component of the clean energy and waste-to-energy business in the United States is renewable energy credits (“RECs”). An REC represents a MWh or KWh of clean energy. Many states, including North Carolina and Rhode Island, the sites of our two United States projects, require their utilities to prove that a portion of the energy they sell is produced from clean or renewable sources. An REC is used to demonstrate that the relevant unit of energy has a clean or renewable source. Consequently, utilities purchase RECs from producers of clean and renewable energy. Our agreements with Duke Energy and National Grid provide for “bundled” pricing for the sale of electricity and RECs.

We expect to generate revenue through sales of thermal and electrical energy, energy efficiency technologies and RECs, and by-products, project development services, and tipping fees from accepting waste. As of September 30, 2015, we have recorded deferred revenue in respect of our projects in the United States (which will be recorded as revenue upon successful completion of those projects), but we have not otherwise received any revenues from our projects.

Our strategy is to integrate all activities and components that make up a project, providing a turnkey, one-stop shop solution for waste-to-energy projects. We are also active in seeking to purchase already operational facilities. We work with and outsource key components of projects to engineering, procurement and construction (“EPC”) and technology providers and other project participants that provide the most economically viable solution for each individual project. We believe this provides us the flexibility and freedom to tailor the best solution for each project. We expect that we will remain involved in managing and financing all aspects of our projects for their lifetimes or until they are sold. We believe this assures all of the involved parties, including waste producers, financing parties, EPC and technology providers, and customers, that there is long-term continuity and responsibility for each project.

We aim to be distinctive and successful in the waste-to-energy market by:

providing a one-stop, turn-key/build, own and operate/transfer solution that is unique in the market today;
identifying and obtaining the rights to lucrative projects without incurring material expense;
delivering seamless and professional project implementation through a combination of our own expertise and the use of third-party experts with a track-record of success;
using mature and well-known technologies when necessary to tailor make cost-efficient and effective solutions for our projects;
leveraging our management’s more than 30 years of experience in successful implementation of large and complex projects in the developing world;
building local and international teams to support each project;
obtaining political, property, non-performance and insolvency insurance for our projects; and
receiving almost all of our revenue in United States dollars or euros, whether operating in the United States, Europe or the developing world.

8
 

Competition

There are a number of other companies operating in the clean energy and waste-to-energy space, ranging from other project developers to service or equipment providers, buyers and/or investors. Unlike the standard market approach in this space (i.e., being solely a project developer, service or equipment provider or a buyer or investor), we seek to provide a one-stop shop, turn-key solution to project owners. As described above, our business model is to acquire or initiate, finance, develop, and manage all aspects of project implementation and sales of the project’s clean energy and by-products. We believe this one-stop shop approach is attractive to project owners and will differentiate us in a positive manner from our competition. We are aware of several competitors in the United States that have a similar model to us – Harvest Power, Neo Energy, Anaergia, Quasar, CH4 and others. We value these companies, as they are helping to create awareness and credibility for the waste-to-energy space. We are not aware of competitors with a similar business model in Italy or Israel.

The clean energy and waste-to-energy space is intensely competitive and subject to rapid and significant technological change. Many of our competitors and other companies operating in this space have greater financial and other resources than we have. As a result, these companies may be more effective in developing and implementing a business model similar to ours and/or competing with us in any aspect of project implementation and clean energy sales.

Government Regulation

Permitting

Each of our projects in development requires certain government approvals. In the United States, the standard required environmental permits relate to solid waste composting and air quality. All construction and operational permits for our North Carolina project have been obtained. All construction and operational permits for our Rhode Island project have been obtained, except as follows:

OERI’s application for the construction, installation and operation of a biogas to electricity plant was reviewed and approved by the Rhode Island Department of Environmental Management (“RIDEM”) on October 27, 2015. However, OERI has requested certain adjustments to its air permit according to its approved air distribution model.
OERI has revised its solid waste permit application to address certain requirements and comments of RIDEM, which was submitted on November 12, 2015.
OERI has submitted an industrial pretreatment permit application to the Narragansett Bay Commission (“NBC”), which addresses certain comments from NBC.

In Italy, all permits for operation of the projects have been received since these projects are operational.

Effect of Existing or Probable Government Regulations on Our Business

Our business is affected by numerous laws and regulations on the international, federal, state and local levels, including energy, environmental, conservation, tax and other laws and regulations relating to our industry. Failure to comply with any laws and regulations may result in the assessment of administrative, civil and criminal penalties, the imposition of injunctive relief or both. Moreover, changes in any of these laws and regulations could have a material adverse effect on our business. In view of the many uncertainties with respect to current and future laws and regulations, including their applicability to us, we cannot predict the overall effect of such laws and regulations on our future operations.

We believe that our operations comply in all material respects with applicable laws and regulations and that the existence and enforcement of such laws and regulations have no more restrictive an effect on our operations than on other similar companies in our industry. We do not anticipate any material capital expenditures to comply with international, federal and state environmental requirements.

Employees

We have seven persons providing us services on a full-time basis – our non-executive chairman, chief executive officer, executive vice-president, chief technical officer, chief financial officer, vice president of mergers and acquisitions, and vice president of business development – and a part-time office manager. Our subsidiary, Eastern Sphere, has one full-time employee.

Segments and Geographic Information

We have one reporting segment. For information regarding revenue and other information regarding our results of operations for each of our last three fiscal years, please refer to our financial statements included in this Annual Report on Form 10-K and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in Item 7 of this Annual Report on Form 10-K.

9
 

Corporate History

We were incorporated in the state of Nevada on July 17, 2007 and were originally in the business of developing and promoting automotive internet sites. In 2010, we conducted a reverse merger, name change and forward split of our common stock, and current management took over operations, at which point we changed our business focus to become a project integrator in the clean energy production and waste to energy markets.

In 2013, we amended and restated our Articles of Incorporation to (a) authorize the issuance of 500,000,000 shares of preferred stock, $0.001 par value, in one or more series and with such rights, preferences and privileges as our Board of Directors may determine and (b) effect a 1 for 113 reverse stock split of our outstanding common stock.

Our direct and indirect wholly-owned subsidiaries are Eastern Sphere, Binosphere Inc (“Binosphere”), Johnstonsphere LLC (“Johnstonsphere”), Sustainable Energy Ltd. (“SEL”) and Bluesphere Pavia. As of September 30, 2015, Johnstonsphere had not commenced operations. We formed Bluesphere Pavia, a subsidiary of Eastern, on May 12, 2015, which acquired four biogas plants located in Italy, as described above. We also own a 70% interest in Quickcharge, a 25% interest in Concord (which owns OEC) and a 22.75% interest in Rhode Island (which owns OERI). In addition, Eastern Sphere owns 50% interests in each of Permanent Energy Ltd. and PureSphere Ltd.

Available Information

We also make our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and related amendments, available free of charge through our website at www.bluespherecorporate.com as soon as reasonably practicable after we electronically file such material with (or furnish such material to) the Securities and Exchange Commission. The information contained on our website is not incorporated by reference into this Annual Report on Form 10-K and should not be considered to be part of this Annual Report on Form 10-K.

Copies of the reports and other information we file with the Securities and Exchange Commission may also be examined by the public without charge at 100 F Street, N.E., Room 1580, Washington D.C., 20549, or on the internet at www.sec.gov. Copies of all or a portion of such materials can be obtained from the SEC upon payment of prescribed fees. Please call the SEC at 1-800-SEC-0330 for further information.

Item 1A. Risk Factors

Set forth below are risks with respect to the Company. Readers should review these risks together with the other information in this report. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known by us or that we currently deem immaterial may have a material adverse effect on our business, financial condition, results of operations and stock price. If any of the following risks actually occur, our business, financial condition, results of operations or stock price could be harmed. See “Forward-Looking Statements” at the beginning of this report for additional risks.

Risks Relating to Financial Position and Need for Additional Capital

We have a limited operating history which makes it difficult to evaluate our business and prospects.

The Company has a limited operating history upon which you can base an evaluation of its business and prospects. Currently none of our United States projects have commenced commercial operations, and we recently acquired four biogas plants in Italy pursuant to the Italy Projects Agreement. We have entered into certain agreements for the acquisition or development of other projects, but there is no assurance that we will successfully acquire or develop such projects. Accordingly, our business is subject to substantial risks, uncertainties and expenses that are difficult to evaluate. Our ability to generate revenue and become and remain profitable will depend on, among other things:

our ability to satisfy the conditions for obtaining ownership of our projects for those projects we have entered into definitive signed agreements for;
our ability to enter into definitive signed agreements for the acquisition of our projects for which we have entered into term sheets, letter of intent or memoranda of understanding;
our ability to obtain adequate financing for our projects on terms and upon timing consistent with our expectations;
our ability to develop and construct our projects at our projected cost and within our projected timetables;
our ability to effectively manage the operations at our projects;
our ability to develop and maintain an effective internal corporate organization; and
our ability to attract, hire and retain qualified and experienced management as well as technical and operations personnel.

10
 

There can be no assurance that we will generate sufficient revenue or that we will have adequate working capital to meet our obligations as they become due. Readers should consider the risks and difficulties frequently encountered by companies like Blue Sphere, particularly in rapidly evolving markets. We cannot be certain that our business strategy will be successful or that we will successfully address these risks. In the event that we do not successfully address these risks, our business, prospects, financial condition, and results of operations could be materially and adversely affected.

We have a history of losses and can provide no assurance of our future operating results.

As of September 30, 2014 and 2015, we had working capital deficit of $55,000 and $7,542,000 respectively, and shareholders’ (deficit) of $310,000 and $2,694,000, respectively. For the years ended September 30, 2014 and 2015, we incurred net losses of $7,376,000 and $7,462,000. As of September 30, 2015, we had an aggregate accumulated deficit of $43,404,000. There is a substantial change that we will incur additional substantial operating losses for the foreseeable future, and we may never achieve or maintain profitability. We anticipate that our expenses increase as we continue to implement our project development and construction plan and expand our general and administrative operations. As a result, we will need to generate significant revenues in order to achieve and maintain profitability. We may not be able to generate these revenues or achieve profitability in the future. Our failure to achieve or maintain profitability could negatively impact the value of our common stock.

Any delay in, or failure to, accomplish our acquisition, financing and development plans could adversely affect our ability to generate revenues and become profitable.

Because of the numerous uncertainties associated with the acquisition, financing, and development of our projects, we are unable to predict the timing of when we will become profitable, if ever. No assurances can be given about if and when our North Carolina and Rhode Island projects will commence commercial operations, if we will close acquisitions of additional biogas plants in Italy, or if we will be able to continue to develop a pipeline of projects. We may fail to satisfy the conditions in our acquisition, financing and development agreements, and project construction may not be completed on the schedule or within the budget that we intend, or at all. The foregoing could materially and adversely affect our ability to generate revenue and become profitable. Even if we do achieve profitability, we may be unable to sustain or increase our profitability in the future.

Our independent auditors’ report states that there is substantial doubt that we will be able to continue as a going concern.

Our independent registered public accounting firm, Brightman Almagor Zohar & Co., a member firm of Deloitte Touche Tohmatsu, state in their audit report, dated January 13, 2016, that our recurring losses from operations raise substantial doubt about our ability to continue as a going concern. There is a risk that we will continue to incur expenses without generating significant revenue into the future. Our source of funds to date has been the sale of our common stock, debt financing and certain development fees and reimbursements in connection with our North Carolina and Rhode Island projects. Because we cannot ensure that any of our projects will become operational or that we will be able to generate any significant revenue, obtaining new sources of equity or debt financing will be difficult.

We will require additional funding, and our future access to capital is uncertain. Insufficient capital may limit our ability to pursue our projects.

All of our current and future projects will require significant amounts of financing from us and/or our partners. We also may seek additional capital due to favorable market conditions or strategic considerations, even if we believe we have sufficient funds for our current or future operating plans. There can be no assurance that additional funds will be available on acceptable terms or at all. We may be required to pursue sources of additional capital through various means, including debt or equity financings. Future financings through equity financings are likely to be dilutive to existing stockholders. Newly issued securities may include preferences, voting rights, warrants or other derivative securities, which may have additional dilutive effects to existing stockholders. Further, we may incur substantial costs to obtain additional funding, including investment banking fees, legal fees, accounting fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we issue, such as convertible notes and warrants, which will adversely impact our financial condition. Our ability to obtain additional funding may be impaired by general market conditions and/or our financial condition, which could impact the availability or cost of future financings. If the amount of capital we are able to raise from financing activities, together with our future revenue from operations, if any, is not sufficient to satisfy our capital needs, we may not be able to pursue our projects and our business, financial condition and results of operations may be materially and adversely affected.

11
 

We have incurred substantial indebtedness.

As of September 30, 2015, we had indebtedness of approximately $1,425,000. Our level of indebtedness increases the possibility that we may not have sufficient cash to pay, when due, the principal, interest or other amounts due in respect of such indebtedness. Our level of indebtedness, combined with other financial obligations and contractual commitments, could:

make it difficult for us to satisfy our obligations with respect to such indebtedness, which could result in events of default under the loan agreements and instruments governing the indebtedness;
require us to dedicate a substantial portion of our cash flow from operations to payments on indebtedness, thereby reducing funds available for working capital, capital expenditures, and other corporate purposes;
increase our vulnerability to adverse economic and industry conditions, which could place us at a competitive disadvantage compared to competitors that have relatively less indebtedness;
limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate; and
limit our ability to borrow additional funds, or to dispose of assets to raise funds, if needed, for working capital, capital expenditures, and other corporate purposes.

We may incur additional indebtedness in the future, including through the issuance of convertible notes. If we incur a substantial amount of additional indebtedness, the related risks that we face could become more significant. Additionally, the terms of any future debt that we incur may impose requirements or restrictions that further affect our financial and operating flexibility.

Risks Relating to Business and Industry

Project construction and development requires significant outlays of capital and is subject to numerous risks.

The construction and development of our projects involves numerous risks. We are required to outlay significant capital for preliminary engineering, permitting, legal, and other expenses before we can determine whether a project is feasible or economically attractive. In order to successfully construct and develop our projects, we need to negotiate satisfactory engineering, procurement and construction agreements and feedstock supply and power purchase agreements, receive all required governmental permits and approvals, obtain financing, and timely implement construction and development. Successful completion of a particular project may be adversely affected by numerous factors, including: (i) failure or delay in obtaining required government permits and approvals with acceptable conditions; (ii) unavailability of financing; (iii) uncertainties relating to land costs for projects; (iv) engineering problems; (v) construction delays and contractor performance shortfalls; (vi) work stoppages; (vii) cost over-runs; (viii) failure of equipment and materials supply; (ix) adverse weather conditions; and (x) environmental and geological conditions.

Our power purchase agreements, which we expect to be the primary source of future revenue, require us to meet certain milestones and other performance criteria.

Power purchase agreements typically require us to meet certain milestones and other performance criteria, including the commencement of a project’s commercial operations by a certain date. Our failure to meet these milestones and other criteria may result in termination of these contracts, in which case we would lose any future cash flow from the relevant project and may be required to pay fees and penalties to our counterparty. We cannot assure you that we will be able to perform our obligations under such contracts or that we will have sufficient funds to pay any fees or penalties thereunder. In the past we have had to pay fees under the Duke PPA and National Grid PPA to extend certain milestones. The Duke PPA and National Grid PPA require us to commence commercial operations of the North Carolina and Rhode Island projects, respectively, by December 31, 2015, which may be further extended upon payment of additional fees or penalties. Since we do not anticipate the North Carolina and Rhode Island projects to commence operations until 2016, we expect certain fees and penalties to be due to Duke Energy and National Grid. Although York will be responsible for these amounts, we are heavily dependent on the Duke PPA and National Grid PPA as our expected primary source of future revenue.

12
 

Our business model depends on performance by third parties under contractual arrangements.

Our businesses depend on a limited number of third parties to, among other things, own and operate our projects, purchase energy produced by our projects, and supply and deliver the goods and services necessary for the construction and operation of our projects. The viability of our projects depends significantly upon the performance of these third parties in accordance with long-term contracts. If these third parties cannot or will not perform their contractual obligations, whether due to their financial condition, force majeure events, changes in laws or regulations, or otherwise, we may not be able to secure alternate arrangements on substantially the same terms or at all for the goods and services provided under such contracts. In addition, some of the owners and operators of our projects may be smaller companies that are more likely to experience financial and operational difficulties than relatively larger, well-established companies, which could result in interruptions or delays in the operation of our projects. Any of the foregoing could have a material adverse effect on our business, financial condition and results of operations.

We may not be able to obtain feedstock or other inputs at acceptable prices, which could increase our operating costs significantly and harm our financial condition and results of operations.

Although we can obtain certain project inputs pursuant to fixed price arrangements, we are vulnerable to the availability and price fluctuations of certain raw materials and utilities, such as feedstock and electricity. Our ability to operate our projects is dependent upon the availability of feedstock and utilities at reasonable prices. Market conditions can impact the availability and price of these inputs, and our suppliers may be unable to deliver our requirements for these inputs at acceptable prices or at all. During periods when availability of these inputs decreases or their prices increase, we may incur significant increases in our operating costs without being able to increase the selling price of our projects’ energy output under fixed price power purchase agreements. This could have a material adverse effect on our financial condition and results of operations.

Our operations in foreign markets could cause us to incur additional costs and risks associated with doing business internationally.

Our operations in markets outside the United States subject us to additional costs and risks, including:

compliance with foreign requirements regulating the environment and the waste-to-energy market;
difficulties in establishing, staffing and managing international operations;
U.S. laws and regulations related to foreign operations, including tax and anti-corruption laws and regulations;
differing intellectual property laws;
differing contract laws that impact the enforceability of agreements among energy suppliers and energy consumers;
imposition of special taxes;
strong national and international competitors;
currency exchange rate fluctuations; and
political and economic instability in the countries in which we operate.

 In addition, although our principal executive office is in the United States, a substantial part of our business and management is based in Israel. Therefore, our business, financial condition and results of operations could be adversely affected by political, economic and military instability in Israel. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its Arab neighbors. Any hostilities involving Israel or the interruption or curtailment of trade within Israel or between Israel and its trading partners could adversely affect our operations and could make it more difficult for us to raise capital.

Our failure to manage the risks associated with international operations could limit the future growth of our business and adversely affect our business, financial condition and results of operations. We may be required to make a substantial financial investment and expend significant management efforts in connection with our international operations.

13
 

Our planned operations in the developing world could cause us to incur additional costs and risks associated with doing business in developing markets.

We are seeking to operate in the developing world (such as, e.g., countries in Eastern Europe), which would make us vulnerable to political, economic and social instability in such areas. Many areas of the developing world have experienced political, economic and social uncertainty in recent years, including an economic crisis characterized in some cases by increased inflation, high domestic interest rates, negative economic growth, reduced consumer purchasing power and high unemployment. Currently, many of the countries in the developing world where we have projects have been pursuing economic stabilization policies, including the encouragement of foreign trade and investment and other reforms, but there is no guarantee these policies will be successful or stay in place. Political, economic and social instability in these countries may have an adverse effect on our business, financial condition and results of operations.

Acquisition, financing, construction and development of new projects and project expansions may not commence as anticipated or at all.

Our strategy is to continue to expand in the future, including through acquisition of additional projects. The acquisition, financing, construction and development of new projects involves numerous risks, including:

difficulties in identifying, obtaining and permitting suitable sites for new projects;
assumptions with respect to the cost and schedule for completing construction;
the ability to obtain financing for a project on acceptable terms;
delays in deliveries of, or increases in the prices of, equipment;
the unavailability of sufficient quantities of waste or other fuels for startup;
permitting and other regulatory issues, license revocation and changes in legal requirements;
labor disputes and work stoppages;
unforeseen engineering and environmental problems;
cost overruns; and
weather conditions and certain force majeure events.

 In addition, new projects have no operating history and may employ recently developed technology and equipment. A new project may be unable to fund principal and interest payments under its debt service obligations or may operate at a loss. In certain situations, if a project fails to achieve commercial operation, at certain levels or at all, termination rights in the agreements governing the project financing may be triggered, rendering all of the project’s debt immediately due and payable. As a result, the project may be rendered insolvent and we may lose our interest in the project.

Changes in climate conditions could materially affect our business and prospects.

Significant changes in weather patterns and volatility could have a positive or negative influence on our existing business and our prospects for growth. Such changes may cause episodic events (such as floods or storms) that are difficult to predict or prepare for, or longer-term trends (such as droughts or sea-level rise). These or other meteorological changes could lead to increased operating costs, capital expenses, disruptions in facility operations or supply chains, changes in waste generation and interruptions in waste deliveries, and changes in energy pricing, among other effects.

We may face intense competition and may not be able to successfully compete.

There are a number of other companies operating in the renewable energy and waste-to-energy markets. These include service or equipment providers, consultants, managers, buyers and/or investors. In contrast to the standard market approach in these markets, we seek to provide a one-stop shop, turn-key solution to project owners.

We may not have the resources to compete with our existing competitors or with any new competitors. Most of our competitors have significantly greater personnel, financial and managerial resources than we have, and we may fail to maintain or expand our business. Moreover, as the demand for renewable energy increases, new companies may enter the market, and the influx of added competition will pose an increased risk to us. Increased competition could harm our business, prospects, financial condition and results of operations.

14
 

We rely on key personnel, and if we are unable to retain or hire qualified personnel, we may not be able to maintain or expand our business.

The development of our business will continue to place a significant strain on our limited personnel, management, and other resources. Our future success depends upon the continued services of our executive officers and the engagement of key employees and contractors who have critical industry experience and relationships that we will rely on to implement our business plan. The loss of the services of any of our officers or the lack of availability of other skilled personnel would negatively impact our ability to maintain or expand our business, which could adversely affect our business, prospects, financial condition and results of operations. In order to support our projected growth, we will be required to effectively recruit, hire, train and retain additional qualified management personnel. Our inability to attract and retain the necessary personnel could have a material adverse effect on us. We have no “key man” insurance on any of our key employees.

If we fail to establish and maintain a system of disclosure controls and procedures and an effective system of internal control over financial reporting, we may not be able to accurately and timely disclose information and financial results of the Company or prevent fraud. Any inability to accurately and timely disclose information and financial results could harm our business and reputation and cause the price of our common stock to decline.

A system of disclosure controls and procedures is necessary to ensure that information required to be disclosed by the Company in the reports that we file under the Exchange Act is recorded, processed, summarized and reported, within the time specified in the Securities and Exchange Commission’s rules and forms. Effective internal control over financial reporting is necessary for us to provide reliable financial reports and prevent fraud. If we cannot disclose required information or provide reliable financial reports, we may not be able to manage our business as effectively as we would if an effective control environment existed, and our business and reputation with investors may be harmed. Due to lack of segregation of duties, limited resources, and lack of a formal audit committee and financial expert on our Board, we concluded that our internal controls over financial reporting were not effective as of September 30, 2015. In addition, our management concluded that our disclosure controls and procedures were not effective as of September 30, 2015 due to our limited internal resources and lack of ability to have multiple levels of transaction review. We have taken certain steps to address these deficiencies, but we continue to determine how best to change our current system and implement a more effective system. There can be no assurance that implementation of any changes will be completed in a timely manner or that they will be adequate once implemented.

Volatility in foreign exchange currency rates could adversely affect our financial condition and results of operations.

Foreign currency exchange rate movements between the U.S. dollar and the currencies of the jurisdictions in which we operate or receive payment (including the Euro) could make doing business more expensive or revenue in foreign currencies less valuable, which could have a material adverse effect on our financial condition and results of operations.

If our strategy is unsuccessful, we will not be profitable and our stockholders could lose their investment.

We do not believe there is a track record for companies pursuing our specific strategy, and there is no guarantee that our strategy will be successful or profitable. If our strategy is unsuccessful and we do not generate revenue or profit, the value of the Company could decrease and our stockholders could lose their investments in the Company.

Risks Relating to Regulation

We may be unable to obtain, modify, or maintain the regulatory permits, approvals and consents required to construct and operate our projects.

In order to construct and operate our projects, we must obtain and modify numerous environmental and other regulatory permits and certifications from federal, state and local agencies and authorities, including air permits and wastewater discharge permits. A number of these permits and certifications must be obtained prior to the start of construction of a project, while other permits are required to be obtained at or prior to the time of first commercial operation or within prescribed time frames following commencement of commercial operations. Any failure to obtain or modify the necessary environmental and other regulatory permits and certifications on a timely basis could delay the construction or commercial operation of our projects. In addition, once a permit or certification has been issued for a project, we must take steps to comply with each permit’s or certification’s conditions, which can include conditions as to timely construction and commencement of the project. Failure to comply with these conditions could result in revocation or suspension of the permit or certification and/or the imposition of penalties or other consequences. We also may need to modify existing permits to reflect changes in project design or requirements, which could trigger a legal or regulatory review under a standard that may be more stringent than when the permits were originally granted.

Obtaining and modifying necessary permits and certifications is a time-consuming and expensive process, and we may not be able to obtain or modify them on a timely basis or at all. In the event that we fail to obtain or modify all necessary permits and certifications, we may be forced to delay construction or operation of a project or abandon the project altogether, which could have a material adverse effect on our business, financial condition and results of operations. In addition, we may be required to make capital expenditures on an ongoing basis to comply with increasingly stringent federal, state, provincial and local environmental, health and safety laws, regulations and permits.

15
 

We are subject to environmental laws and potential exposure to environmental liabilities.

Because of the nature of our projects, we are subject to various federal, state and local environmental laws and regulations that govern our operations, including the import, handling and disposal of non-hazardous and hazardous wastes, and emissions and discharges into the environment. Failure to comply with these laws and regulations could result in costs for corrective action, penalties or the imposition of other liabilities. We also are subject to laws and regulations that impose liability and clean-up responsibility for releases of hazardous substances into the environment. Under certain of these laws and regulations, a current or previous owner or operator of property may be liable for the costs of remediating the release or spill of hazardous substances or petroleum products on or from its property, without regard to whether the owner or operator knew of, or caused, the contamination, and such owner or operator may incur liability to third parties impacted by such contamination. Failure to comply with applicable environmental laws and regulations and the imposition of environmental liability could have a material adverse effect on our business, financial condition and results of operations.

Changes in applicable laws and regulations can adversely affect our business, financial condition and results of operations.

Governmental entities that regulate our operations or projects may adopt new laws, regulations or policies, or amend or change the interpretation of existing laws, regulations or policies, at any time. We have no control over these changes, which could potentially have an adverse effect on our business, prospects, financial condition and results of operations.

Our business and reputation could be adversely affected if we or third parties with whom we have a relationship fail to comply with United States or foreign anti-corruption laws or regulations.

Our business and operations may be conducted in countries where corruption has historically penetrated the economy to a greater extent than in the United States. It is our policy to comply, and to require our local partners and those with whom we do business to comply, with all applicable anti-corruption laws, such as the U.S. Foreign Corrupt Practices Act, and with applicable local laws of the foreign countries in which we operate. Our business and reputation may be adversely affected if we or our local partners fail to comply with such laws.

Risk Relating to Common Stock

Future sales of our common stock by existing stockholders could cause our stock price to decline.

If our existing stockholders sell substantial amounts of our common stock in the public market, or if there is a perception that our stockholders might sell shares of our common stock, the price of our common stock could decrease significantly. If we issue convertible notes or warrants, the conversion of these securities into our common stock could also decrease the price of our common stock. A decline in the price of our common stock might impede our ability to raise capital through the issuance of additional shares of our common stock or other securities.

There is a limited public market for our common stock.

Trading in our common stock continues to be conducted on the electronic bulletin board in the over-the-counter market. As a result, a holder of our common stock may find it difficult to dispose of or to obtain accurate quotations as to the market value of our common stock, and our common stock may be less attractive for margin loans, investment by financial institutions, as consideration in future capital raising transactions or for other purposes.

Our common stock is thinly traded, the price of our common stock may not reflect the value of the Company, and there can be no assurance that there will be an active market for our common stock either now or in the future.

Our common stock is thinly traded and the price of our common stock may not reflect the actual or perceived value of the Company. There can be no assurance that there will be an active market for our common stock either now or in the future. Consequently, holders of our common stock may not be able to liquidate their investment in the Company at an acceptable price to them or at all.

The market liquidity of our common stock depends, in part, on the perception of our business. We may take certain steps, including utilizing investor awareness campaigns and firms, press releases, road shows and conferences, to increase awareness of our business, which may require us to compensate consultants with cash and/or common stock. There can be no assurance that these steps will result in any impact on the trading volume or price of our common stock.

16
 

Holders of our common stock may incur dilution.

We may issue additional shares of common stock or securities convertible into or exchangeable for share of our common stock in order to raise additional capital, which could dilute existing stockholders’ percentage ownership of the Company.

The market price of our common stock could be highly volatile.

Because there is currently a low price for our common stock, many brokerage and clearing firms are not willing to effect transactions in our common stock or accept our shares for deposit in an account. Many lending institutions will not permit the use of low priced common stock as collateral for loans. If a more active market for our common stock develops, the price of our common stock could be highly volatile. The low and/or volatile price of our common stock may make it difficult for holders to sell our common stock at an acceptable price to them or at all.

Our common stock is a “penny stock”, as defined in the Exchange Act. Trading of our common stock may be restricted by the Securities and Exchange Commission’s “penny stock” regulations, which may limit a stockholder’s ability to buy and sell our stock.

Our common stock is subject to the regulations of the Securities and Exchange Commission promulgated under the Exchange Act that require additional disclosure for trading in penny stocks. The Securities and Exchange Commission regulations generally define penny stocks to be any equity security that is not listed on a national securities exchange and has a market price of less than $5.00 per share, subject to certain exceptions. Unless an exception is available, those regulations require broker-dealers to (i) approve the customer for the specific penny stock transaction and receive from the customer a written agreement to the transaction; (ii) furnish the customer a disclosure document describing the risks of investing in penny stocks; (iii) disclose to the customer the current market quotation, if any, for the penny stock; and (iv) disclose to the customer the amount of compensation the firm and its broker will receive for the trade. In addition, after executing the sale, a broker-dealer must send to its customer monthly account statements showing the market value of each penny stock held in the customer’s account. These disclosure requirements may have the effect of reducing the level of trading activity, if any, in the secondary market for a stock that becomes subject to the penny stock rules. Consequently, these penny stock rules may adversely affect the ability of broker-dealers and stockholders to trade our common stock.

As an issuer of “penny stock,” the safe harbor provided by the federal securities laws relating to forward-looking statements does not apply to the Company.

Although federal securities laws provide a safe harbor for forward-looking statements made by a public company that files reports under the federal securities laws, this safe harbor is not available to issuers of penny stocks. As a result, we will not have the benefit of this safe harbor in the event of a private legal action against us based on a claim that any forward-looking statement in our reports contained a material misstatement of fact or omitted a material fact necessary to make the statement not misleading. Such an action, whether successful or not, could have a material adverse effect on our business.

We have no intention to pay dividends at the present time.

We have never paid dividends or made other cash distributions on our common stock, and we do not expect to declare or pay any dividends in the foreseeable future. We intend to retain future earnings, if any, for working capital and to finance current operations and expansion of our business.

Item 1B . Unresolved Staff Comments

Not applicable.

17
 

Item 2. Properties

Our principal executive office is located in North Carolina at 301 McCullough Drive, 4th Floor, Charlotte, NC 28262. We lease office space at this site for $179 per month. We also have office space located at 35 Asuta St. Even Yehuda, Israel 40500, for which we pay the operating expenses but do not pay any rent. We intend to obtain additional working space near our projects if and when we believe this is necessary for the development and operation of the projects. Until such time, we believe that our property is adequate for the conduct of our business.

Item 3. Legal Proceedings

From time to time we and our subsidiaries may be parties to legal proceedings arising in the normal course of our business. We and our subsidiaries are currently not a party to any pending legal proceeding, nor is our property the subject of a pending legal proceeding, and to our knowledge, no such proceedings are threatened. None of our directors, officers, affiliates, or any owner of record or beneficially of more than five percent of our common stock, is involved in a material proceeding adverse to us or our subsidiaries or has a material interest adverse to us or our subsidiaries.

Item 4. Mine Safety Disclosures

Not applicable.

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Recent Sales of Unregistered Securities

The following are sales of our unregistered securities during the fiscal year ended September 30, 2015 that have not otherwise been reported in our periodic or current reports:

On July 1, 2015, we entered into a subscription agreement with a non-U.S. person pursuant to which we issued 2,000,000 shares of our common stock in exchange for $32,000.

In August 2015, we issued 3,474,405 shares of our common stock to two affiliate entities of Maxim Group LLC in respect of its financial advisor and investment banking agreement with the Company. We valued the issued shares at $34,397.

In August 2015, we issued 1,128,237 shares of our common stock to a non-U.S. person in respect of its financial advisor and investment banking settlement agreement with the Company. We estimated the fair value of such shares and recorded an expense of $13,088.
Between February and August 2015, holders of convertible promissory notes representing an aggregate principal amount of $1,480,716 converted their notes into 75,060,414 shares of our common stock.
     
Between July and September 2015, we issued 8,035,000 shares of our common stock to a consultant in respect of his investor relations and public relations services consulting agreement with the Company. We estimated the fair value of such shares and recorded an expense of $198,614.
     
On October 21, 2015, we issued 1,630,000 and 8,484,848 shares of our common stock to Dr. Borenstein Ltd. in respect of subscription agreements entered into with Dr. Borenstein Ltd. on April 15, 2015 and June 12, 2015 for an aggregate purchase price of $48,000 and $140,000, respectively.

The transactions described above were exempt from registration under the Securities Act as transactions not involving a public offering.

Market Information

Our common stock is quoted on the OTCQB under the symbol “BLSP”. The following quotations, which were obtained from nasdaq.com, reflect the high and low bids for our common stock for the periods indicated, based on inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions. The first day on which our common stock traded under BLSP was March 16, 2010. The prices set forth below for the quarter ended December 31, 2013 give retroactive effect to our 1 for 113 reverse split, which became effective on December 4, 2013.

18
 

The high and low bid prices of our common stock for the periods indicated below are as follows:

Quarter Ended   High   Low
         
September 30, 2015     $ 0.04     $ 0.01  
June 30, 2015     $ 0.07     $ 0.02  
March 31, 2015     $ 0.23     $ 0.04  
December 31, 2014     $ 0.20     $ 0.12  
                   
Quarter Ended   High     Low  
                   
September 30, 2014     $ 0.32     $ 0.17  
June 30, 2014     $ 0.37     $ 0.06  
March 31, 2014     $ 0.39     $ 0.09  
December 31, 2013     $ 0.49     $ 0.05  
                     

Holders

As of December 31, 2015, we had 281 holders of record of our common stock. This number does not include beneficial owners whose shares are held in the names of various security brokers, dealers, and registered clearing agencies.

Dividends

We have never paid any cash dividends on our common stock and do not anticipate paying any cash dividends on our common stock in the foreseeable future. We intend to retain future earnings, if any, to fund ongoing operations and the future capital requirements of our business. Any future determination to pay cash dividends will be at the discretion of the Board and will be dependent upon our financial condition, results of operations, capital requirements and such other factors as the Board deems relevant.

Issuer Purchases of Equity Securities

On June 17, 2015, our Board approved a share repurchase program (the “Share Repurchase Program”). Under the Share Repurchase Program, we are authorized to repurchase up to $500,000 worth of our common stock. We may purchase shares of our common stock on the open market or through privately negotiated transactions from time-to-time and in accordance with applicable laws, rules and regulations. We are not obligated to make any purchases, including at any specific time or in any particular situation. The Share Repurchase Program may be limited or terminated at any time without prior notice.

Our share repurchase activity during the three months ended September 30, 2015 is presented in the table below..

Period   Total Number of Shares Purchased   Average Price Paid per Share   Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs   Approximate Dollar Value of Shares that May Yet Be Purchased Under the Share Repurchase Program
July 1 to July 31       144,054       0.1966       144,054     $ 471,672  
August 1 to August 31       0             0     $ 471,672  
September 1 to September 30       0             0     $ 471,672  
Total:       0             0     $ 471,672  
                                     

Item 6. Selected Financial Data

 

As a smaller reporting company, we are not required to provide the information required by this item.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the consolidated audited financial statements and notes thereto included in Part II, Item 8 of this Form 10-K. The following discussion contains forward-looking statements. Forward-looking statements are not guarantees of future performance and our actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed under the heading “Note Regarding Forward-Looking Statements” and in Part I, Item 1A of this Form 10-K under the heading “Risk Factors.” We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.  

19
 

Company Overview

We are an international Build, Own & Operate company (BOO) active around the world in the clean energy production and organics to energy markets. We aspire to become a key player in these global markets, working with enterprises with clean energy, organics to energy and related by-product potential to generate clean energy, soil amendments, compost and other by-products. We are currently focusing on projects related to the construction, acquisition or development of biogas facilities in the United States, Italy and Israel, as well as our fast charging battery technology.

Our business model is based on two main activities: we are a Build, Own & Operate (BOO) company, and we are a strategic acquirer of already built and operational facilities. In 2015, we executed on our BOO business model by integrating the construction, financing and management of the North Carolina and Rhode Island projects. We anticipate these projects to commence commercial operations in the first and second quarters of 2016, respectively, and to have a collective capacity of 8.4 MW. Any revenue generated by these projects is recognized as deferred revenue until the facilities are commercially operational. We also executed on our acquisition strategy in 2015 by acquiring four SVPs in Italy, each of which owns an operational anaerobic digester with approximately 1 MW of capacity. The foregoing achievements have put a tremendous burden on our human and financial resources. We plan to expand our BOO and strategic acquisition activities in the coming year, which will require adding members to our team and additional capital investments.

Results of Operations

Deferred Revenue 

$1,481,900 of development fees for the Rhode Island project is recorded as deferred revenue. Upon successful completion of the project, this amount will be recorded as revenue.

We have recorded no revenue since inception of the Company.

General and Administrative Expenses

General and administrative expenses for the year ended September 30, 2015 were $5,331,000 as compared to $7,120,000 for the year ended September 30, 2014. The decrease is mainly attributable to the decrease in share-based compensation expenses to employees and service providers.

Net Loss

We incurred a net loss of $7,462,000 for the year ended September 30, 2015, as compared to a net loss of $7,376,000 for the year ended September 30, 2014. The increase in net loss is mainly attributable to an increase in financial expenses, partially offset by a decrease in share-based compensation expenses to employees and service providers.

Inflation and Seasonality

In management’s opinion, our results of operations have not been materially affected by inflation or seasonality, and management does not expect that inflation risk or seasonality would cause material impact on our operations in the future.

Critical Accounting Policies

The preparation of financial statements in conformity with GAAP in the United States requires our management to make assumptions, estimates and judgments that affect the amounts reported in the financial statements, including the notes thereto, and related disclosures of commitments and contingencies, if any. Note 3 to our consolidated audited financial statements describes the significant accounting policies and methods used in the preparation of our financial statements. We consider our critical accounting policies to be those related to share-based payments because they are both important to the portrayal of our financial condition and require management to make judgments and estimates about uncertain matters.

20
 

Liquidity and Capital Resources

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.

As of September 30, 2015, we had cash of $161,000, as compared to $298,000 as of September 30, 2014. As of September 30, 2015, we had a working capital deficit of $7,542,000, as compared to $55,000 as of September 30, 2014. The increase in our working capital deficit is mainly attributable to deferred revenues from projects and joint ventures.

Net cash used in operating activities was $818,000 for the year ended September 30, 2015, as compared to $1,802,000 for the year ended September 30, 2014. The decrease is mainly attributable to the decrease in share-based compensation expenses.

Net cash flows used in investing activities was $37,000 for the year ended September 30, 2015, as compared to $198,000 for the year ended September 30, 2014. The decrease in cash used in investing activities is due to a decrease in payments on account of projects capitalized, partially offset by payments for the acquisition of fixed assets and investments in a nonconsolidated subsidiary.

Net cash flows provided by financing activities was approximately $718,000 for the year ended September 30, 2015 as compared to approximately $2,252,000 for the prior period September 30, 2014. The decrease in cash provided by financing activities was due to the decrease in equity financing, such as convertible debentures received containing a beneficial conversion feature and other loans received, and repayments of convertible debentures and loan repayments. We have principally financed our operations through the sale of our common stock and the issuance of convertible debt. Subsequent to the year ended September 30, 2015, we closed a $3 million offering of senior debentures and warrants, as further described in our Form 8-K filed with the SEC on December 28, 2015.

The opinion of our independent registered public accounting firm on our audited financial statements as of and for the year ended September 30, 2015 contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon raising capital from financing transactions and future sales.

To date, we have principally financed our operations through the sale of our common stock, the issuance of debt and development fees received for the North Carolina and Rhode Island projects. Although management anticipates that cash resources will be available to the Company, including the Helios Loan Agreement, expected revenue from the North Carolina and Rhode Island projects, and the proceeds of its $3 million debenture offering in December 2015, it believes existing cash will not be sufficient to fund planned operations and project investment through the next 12 months.

Therefore, we are still seeking to raise additional funds for future operations and possible project investment, and any meaningful equity or convertible debt financing will likely result in significant dilution to our existing stockholders. There is no assurance that additional funds will be available on terms acceptable to us, or at all.

Off-Balance Sheet Arrangements

As of September 30, 2015, we had no off-balance sheet arrangements of any nature.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

As a smaller reporting company, we are not required to provide the information required by this item.

Item 8. Financial Statements and Supplementary Data

The financial statements required to be included in this report appear as indexed in Appendix A to this report beginning on page F-1.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

21
 

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Pursuant to Rule 13a-15(b) under the Exchange Act, the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer (“CEO”) and the Company’s Chief Financial Officer (“CFO”), of the effectiveness of the Company’s disclosure controls and procedures as of the year ended September 30, 2015. Based on that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures were not effective as of September 30, 2015 in ensuring that (i) information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Management is in the process of determining how best to change our current system and implement a more effective system to insure that information required to be disclosed has been recorded, processed, summarized and reported accurately. Our management acknowledges the existence of this issue, and intends to develop procedures to address it to the extent possible given limitations in financial and human resources. While management is working on a plan, no assurance can be made that the implementation of more effective controls and procedures will be completed in a timely manner, or that such controls and procedures will be adequate once implemented.

 

Evaluation of Internal Controls over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal controls over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our system of internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external reporting purposes in accordance with GAAP.

Because of its inherent limitations, internal control over financial reporting may not prevent all error or fraud. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. In addition, an evaluation of effectiveness of controls is subject to the risk that the controls may become inadequate because of changes in business conditions, or that the degree of compliance with policies or procedures may decrease over time.

Our internal control over financial reporting includes those policies and procedures that (a) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (b) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with GAAP, and that our receipts and expenditures are made only in accordance with authorizations of our management and directors; and (c) provide reasonable assurance regarding prevention or timely detection of unauthorized use, acquisition, or disposition of our assets that could have a material effect on the consolidated financial statements.

Pursuant to Rule 13a-15(c) under the Exchange Act, the Company carried out an evaluation, with the participation of the Company’s management, including the CEO and CFO, of the effectiveness of our internal controls over financial reporting as of the year ended September 30, 2015. In making this assessment, we utilized the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework. Based on that evaluation, the Company’s CEO and CFO concluded that the Company’s internal controls over financial reporting were not effective as of September 30, 2015. Specifically, during our assessment of the effectiveness of internal controls over financial reporting, management identified material weaknesses related to the lack of segregation of duties and the need for stronger financial reporting oversight. Due to our limited resources, we do not have multiple levels of transaction review. Additionally, during the year ended September 30, 2015, we did not have a formal audit committee and the Board did not have a financial expert, which might have contributed to a lack of Board oversight of the financial reporting process.

Our management is in the process of determining how best to change our current system and implement a more effective system of controls and procedures. For example, we recently added a financial expert to the Board and formed an audit committee to provide Board oversight of the financial reporting process. However, given limitations in financial and human resources, we may not have the resources to address fully the weaknesses in controls. No assurance can be made that the implementation of a more effective system of controls and procedures will be completed in a timely manner, or that such controls and procedures will be adequate once implemented.

22
 

Changes in Internal Controls over Financial Reporting

Our management, with the participation of our CEO and CFO, performed an evaluation to determine whether any change in our internal controls over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the year ended September 30, 2015. Based on that evaluation, our CEO and our CFO concluded that no change occurred in the Company’s internal controls over financial reporting during the year ended September 30, 2015, that has materially affected, or is reasonably likely to materially affect, the Company’s internal controls over financial reporting.

Item 9B. Other Information

Not applicable.

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Executive Officers and Directors

The following table sets forth the names and ages of the members of our Board of Directors and our executive officers and the positions held by each. There are no family relationships among any of our directors and executive officers.

Name   Age   Position
Joshua Shoham   64   Chairman of the Board
         
Shlomo Palas   54   Chief Executive Officer and Director
         
Yigal Brosh   52   Director
         
Shimon Erlichman   64   Director
         
Itai Haboucha   36   Director
         
Roy Amitzur   53   Executive Vice President
         
Shlomo Zakai   46   Chief Financial Officer (Israel)
         
Steven Paulik   49   Chief Financial Officer (U.S.)

 

Joshua Shoham – Chairman of the Board

Mr. Shoham became our Chairman on March 2, 2012. Mr. Shoham has extensive experience in senior executive management and in international business development in the United States, Europe and China. He has held several General Manager positions and is co-founder of several high-tech startups. Mr. Shoham was also a strategic market development consultant responsible for a range of transactions in the Israeli and Chinese traditional and high-tech industries. He previously served as a director on the board of Bio-Cell (TASE: BCEL), which merged its activities into Protalix Biotherapeutics (AMEX: PLX). Mr. Shoham holds an MBA and a B.A. in Economics, both from the Hebrew University of Jerusalem, and an LL. B degree from the Faculty of Law of Tel-Aviv University. The Board has determined that Mr. Shoham is qualified to serve on the Board as a result of his extensive experience in senior management and international business development.

Shlomo Palas – Chief Executive Officer and Director

Mr. Palas became our Chief Executive Officer and a director on March 3, 2010. Mr. Palas is a highly experienced entrepreneur who has held executive positions at a number of leading Israeli firms. From 2005 to 2010, he served as an entrepreneur advising companies in the biodiesel industry. Prior to that he was a senior consultant with Mitzuv, a leading management consulting firm, and has served in a variety of marketing roles. Since 2010, Mr. Palas has specialized in the renewable and clean tech industries. He has gained significant experience in renewable and clean tech manufacturing, off-take contracts with leading petrol companies, legal/financial structuring, and fundraising for these industries. He has also developed a large network in private and government sectors in many cities across China. Mr. Palas previously served as Chief Executive Officer of Becco Biofuels China Ltd., which was a company active in the biofuel industry. Mr. Palas participated in the establishment of the largest commercial algae farm in China together with one of China’s largest electrical utilities. Mr. Palas holds a B.A. in Statistics and Management from Haifa University and an M.S. from Baruch College. The Board has determined that Mr. Palas is qualified to serve on the Board as a result of his significant experience in renewable and clean tech manufacturing and his management and entrepreneurial experience.

23
 

 

Yigal Brosh – Director

Mr. Brosh is a director at Abroker Trading & Securities LTD. and Chairman of the Board at Environmental Services Company Ltd. Environmental Services Company is a government-owned national infrastructure company, established for the purpose of handling all the hazardous waste produced in Israel. The company owns the Ramat Hovav plant for the treatment of hazardous waste, which handles a wide variety of organic, inorganic and solid materials. Mr. Brosh previously served as a director at Analyst Portfolio Management Ltd. and is former CEO, director and partner of Millennium Mutual Funds. Mr. Brosh holds a B.A. in Economics and M.B.A (Hebrew University of Jerusalem) and an investment portfolio management license from the Israel Securities Authority (ISA).

 

Shimon Erlichman – Director

Mr. Erlichman previously served as CFO of two Israeli companies traded on the Israeli Stock Exchange and established his own company in 1980, which provides services to local and foreign companies in Israel. Mr. Erlichman holds a B.A. in Accounting and Economics from Bar Ilan University and is a member of the Israeli Institute of Certified Public Accountants.

 

Itai Haboucha – Director

Mr. Haboucha is a corporate finance expert and has held various roles in his diversified career. Mr. Haboucha has served as an attorney, financial advisor, strategic advisor, credit rating specialist and underwriter with various public and private corporations, totaling over 100 clients worldwide. In 2010, Mr. Haboucha joined the GSE group, the leading financial consulting firm in Israel, where he provided the firm’s clients with financial advisory, credit rating advisory, underwriting, and M&A services. Currently, Mr. Haboucha serves as Head of M&A at GSE, leads GSE’s relations with overseas clients, and serves on the board of directors of several public and private companies. Mr. Haboucha holds an LL B and MBA (specializing in finance) from TAU. 

 

Roy Amitzur – Executive Vice President

Mr. Amitzur has served as our Executive Vice President since August 2011. Since 2008, Mr. Amitzur has served as President of Clean Technologies Group Ltd, a holding and integration company specializing in investment in water technologies and water and waste water project execution. In addition, Mr. Amitzur has managed a number of start-up companies, including Bio Pure Technology Ltd., Proxy Aviation Systems, Inc., and Aquarius Technologies Inc. Mr. Amitzur has significant experience in implementing BOT and turn-key projects in water technologies and water and waste water execution around the world.

Shlomo Zakai – Chief Financial Officer (Israel)

Mr. Zakai has served as our Chief Financial Officer (Israel) since January 9, 2012. Mr. Zakai is an expert in finance with many years of experience with U.S. public companies. He established his own accounting firm in 2004, providing a range of services to publicly traded and private companies, and he has served as controller and Chief Financial Officer of a number of private companies. Mr. Zakai serves as the internal auditor of several Israeli traded companies and oversees Sarbanes-Oxley compliance in several U.S. and Israeli traded companies. He previously worked as an accountant for nine years in the hi-tech department of Kost, Forer, Gabbay & Kasierer, an independent registered public accounting firm and a member firm of Ernst & Young Global, where he last served as a senior manager and worked with companies publicly traded on NASDAQ and in Israel. Mr. Zakai is a CPA (Certified Public Accountant) and holds a B.A. in Accounting from the College of Management in Rishon Le’Zion.

Steven Paulik – Chief Financial Officer (U.S.)

Mr. Paulik has served as our Chief Financial Officer (U.S.) since August 2013. He has over 15 years of finance experience in the utility and alternative energy fields, including serving as CFO for Global Energy Holdings Group, a publicly traded alternative energy company. Mr. Paulik also served in leadership roles for an investor owned utility, serving as controller for the company’s energy marketing and alternative energy subsidiaries and as director of corporate accounting. He is a Certified Public Accountant and has a B.S. in Accounting from Lehigh University and an M.B.A. from Georgia State.

During the past ten years, none of the following events have occurred with respect to our directors and executive officers:

(1) A petition under the federal bankruptcy laws or any state insolvency law was filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing;
(2) Such person was convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses);
(3) Such person was subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities; and
(4) Such person was found by a court of competent jurisdiction (in a civil action), the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.

 

24
 

Corporate Governance

Board of Directors

We currently have five directors serving on our Board of Directors. A majority of the authorized number of directors constitutes a quorum of the Board for the transaction of business. The directors must be present at the meeting to constitute a quorum. However, any action required or permitted to be taken by the Board may be taken without a meeting if all members of the Board consent in writing to the action.

We are not a listed issuer, as such term is defined in Rule 10A-3 of the Exchange Act, and are therefore not subject to director independence standards. However, using the definition of “independent director” from Section 803 of the rules of the NYSE MKT, the following directors would be considered independent: Yigal Brosh, Shimon Erlichman and Itai Haboucha.

Our directors are elected by the vote of a majority in interest of the holders of our common stock and hold office until the earlier of his or her death, resignation, removal or expiration of the term for which he or she was elected and until a successor has been elected and qualified. The Board may also appoint directors to fill vacancies on the Board created by the death, resignation or removal of any director.

On June 17, 2015, our Board approved an amendment to the Company’s bylaws, effective as of such date, (i) to require any stockholder intending to propose business to be conducted at the annual meeting or to nominate any candidate for election to the Board to notify the Company not later than the close of business on the ninetieth (90th) day, nor earlier than the close of business on the one hundred twentieth (120th) day, in advance of the first anniversary of the preceding year’s annual meeting (provided, however, that in the event that the date of the annual meeting is more than thirty (30) days before or more than seventy (70) days after such anniversary date, notice by the stockholder must be so delivered by the tenth (10th) day following the day on which public announcement of the date of such meeting is first made by the Company) and (ii) to require any such stockholder to provide specified information and representations and, if applicable, require director nominees to provide specified information and representations in order to be eligible to be elected as a director.

Committees of the Board of Directors

 

On October 12, 2015, our Board designated the following three committees of the Board: an audit committee, a finance committee and an administration and management committee. We do not have compensation or nominating committees.

The members of the audit committee are Yigal Brosh and Shimon Erlichman CPA. The audit committee is responsible for, among other things, overseeing the financial reporting and audit process and evaluating our internal controls over financial reporting. The Board has determined that both Yigal Brosh and Shimon Erlichman would be considered “independent directors” and “audit committee financial experts” within the meaning of the NYSE MKT and Exchange Act rules.

The members of the finance committee are Shlomi Palas, Yigal Brosh and Itai Haboucha. The finance committee is responsible for, among other things, reviewing our investment policy, annual financing plan and financial structure.

The members of the administration and management committee are Shlomi Palas and Joshua Shoham. The administration and management committee is responsible for, among other things, managing and overseeing daily operations and transactions in the ordinary course of our business.

Code of Ethics

 

Due to the limited size and resources of the Company, we have not adopted a code of ethics applicable to our principal executive, financial and accounting officers. However, our Board is considering implementation a code of ethics.

 

25
 

 

Compliance under Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than 10% of a registered class of our equity securities, to file initial reports of ownership and reports of changes in ownership with the Securities and Exchange Commission. Such persons are required by the Securities and Exchange Commission to furnish us with copies of all Section 16(a) reports they file. Based solely on a review of copies of reports furnished to us, or written representations that no reports were required, we believe that Shlomi Palas, Joshua Shoham, Yigal Brosh, Shlomo Zakai, Roy Amitzur and Steven Paulik failed to file Forms 3 and/or 4 with respect to various grants and purchases of shares of our common stock and other of our securities during the year ended September 30, 2015.

Item 11. Executive Compensation

Summary Compensation

The table below sets forth, for our last two fiscal years, the compensation earned by Shlomo Palas, our Chief Executive Officer, Shlomo Zakai and Steven Paulik, our Chief Financial Officers, and Roy Amitzur, our Executive Vice President.

Name and Principal Position   Year   Salary ($)   Bonus ($)   Stock awards ($) (1)   Option awards ($) (1)   Non-equity incentive plan compensation ($)   Non-qualified deferred compensation earnings
($)
  All other compen-sation ($)   Total
($)
                                                                         
Shlomo Palas     2015       180,000             72,250       67,093                         319,843  
(CEO) (2)     2014       120,000             265,350       65,000                         450,350  
                                                                         
                                                                         
Shlomo Zakai     2015       33,820             8,562       5,673                         48,055  
(CFO)     2014       22,500                                           22,500  
                                                                         
                                                                         
Roy Amitzur     2015       180,000             67,750       50,400                         278,150  
(EVP)     2014       120,000             217,591       47,500                         385,091  
                                                                         
                                                                         
Steven Paulik     2015       122,168             10,750       5,673                         138,591  
(CFO)     2014                                                  

 

(1) For assumptions made in the valuation of stock awards and option awards, see Note 7 to our audited consolidated financial statements.

(2) Shlomo Palas is also a director of the Company. Mr. Palas receives no compensation as a director.

 

Narrative Disclosure to Summary Compensation Table

Shlomi Palas

On October 11, 2015, we entered into a service agreement with Mr. Palas to retain him as the Company’s Chief Executive Officer. The service agreement, which was intended to extend the term of a previous service agreement with Mr. Palas, will expire on October 10, 2020, subject to a five year extension at the option of the Company and Mr. Palas. As CEO, Mr. Palas, among other duties, is responsible for setting our overall corporate direction, including establishing and maintaining budgets and ensuring we have adequate capital for our operations, marketing and general corporate activities. Under the terms of his service agreement, Mr. Palas will receive $204,000 in annual base compensation during the first year of the agreement, subject to an annual increase review, as well as stock option grants each year of the agreement to purchase 950,000 shares of the Company’s common stock at an exercise price and on such other terms as provided in the grants. Mr. Palas will also be entitled to participate in any bonus, incentive compensation, savings and retirement and insurance plans of the Company. Mr. Palas’ employment may be terminated with or without cause by the Company, subject to the terms of his service agreement.

On February 24, 2015, Mr. Palas was issued 750,000 shares of common stock to under the 2010 Plan. In addition, on February 24, 2015 the Company granted under its 2014 Plan 3,600,000 shares of common stock and 900,000 options to purchase shares of common stock to Mr. Palas. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.

26
 

Roy Amitzur

On October 15, 2015, we entered into a service agreement with Roy Amitzur and JLS Advanced Investment Holdings Limited (“JLS”), a company owned by Mr. Amtizur, to retain Mr. Amitzur as the Company’s Executive Vice President. The service agreement, which was intended to extend the term of a previous service agreement with Mr. Amitzur, will expire on October 14, 2020, subject to a five year extension at the option of the Company and Mr. Palas. As Executive Vice President, Mr. Amitzur, among other duties, is responsible for developing and managing the Company’s projects and sourcing the required capital for such projects. Under the terms of his service agreement, Mr. Amitzur will receive $180,000 in annual base compensation during the first year of the agreement, subject to an annual increase review, as well as stock option grants each year of the agreement to purchase 850,000 shares of the Company’s common stock at an exercise price of $0.01 and on such other terms as provided in the grants. Mr. Amitzur will also be entitled to participate in any bonus, incentive compensation, savings and retirement and insurance plans of the Company. Mr. Amitzur’s employment may be terminated with or without cause by the Company, subject to the terms of his service agreement.

On February 24, 2015 the Company granted under its 2014 Plan 3,500,000 shares of common stock and 700,000 options to purchase shares of common stock to Mr. Amitzur. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.

Shlomo Zakai

On January 9, 2012, we entered into a service agreement with Shlomo Zakai engaging Mr. Zakai as our Chief Financial Officer (Israel). Beginning January 1, 2014, Mr. Zakai began to receive base compensation at a variable monthly rate of $1,500 to $3,500, subject to the terms of the service agreement. Both we and Mr. Zakai have the right to terminate the service agreement for any reason with prior notice of thirty days.

On February 24, 2015 the Company granted under its 2014 Plan 350,000 shares of common stock and 175,000 options to purchase shares of common stock to Mr. Zakai. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.

Steven Paulik

We entered into an agreement on or around August 1, 2013 with Steven Paulik to provide services to the Company as its Chief Financial Officer (United States) for a base salary, currently at $138,375, and other such compensation as determined by the Company in its discretion.

On February 24, 2015 the Company granted under its 2014 Plan 600,000 shares of common stock and 175,000 options to purchase shares of common stock to Mr. Paulik. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.

 

27
 

 

Outstanding Equity Awards at Fiscal Year-End

As of September 30, 2015, the following named executive officers had the following unexercised options, stock that has not vested, and equity incentive plan awards:

    Option Awards   Stock Awards
Name   Number of securities underlying unexercised options (#) exercisable   Number of securities underlying unexercised options (#) un-exercisable   Option exercise price   Option
expiration
date
  Number of shares or units of stock that have not vested   Market value of shares or units of stock that have not vested ($)   Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested (#)   Equity incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested ($)
                                 
Shlomo Palas (1) (CEO)     455,088       675,000     0.14
-0.5763
    04/30/2018
–02/24/2020
      2,700,000       81,000              
                                                             
Shlomo Zakai (2) (CFO)     43,750       131,250     0.14     02/24/2020       262,500       7,875              
                                                             
Roy Amitzur (3) (EVP)     343,142       525,000     0.14
-0.5763
    04/30/2018
–02/24/2020
      2,625,000       78,750              
                                                             
Steven Paulik (4) (CFO)     43,750       131,250     0.14     02/24/2020       450,000       13,500              

 

(1) On April 30, 2013, Mr. Palas was granted 230,089 shares of our common stock and options to purchase 230,089 shares of common stock, each of which will vest over a two-year period with 1/8 of the total amount of the shares and options vesting at the end of each quarter from the date of the grant. The options are exercisable for 5 years at an exercise price of $0.5763 per share. On February 24, 2015, Mr. Palas was issued 750,000 shares of common stock under the 2010 Plan. In addition, on February 24, 2015, Mr. Palas was issued 3,600,000 shares of common stock and 900,000 options to purchase shares of common stock under the 2014 plan. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.

 

(2) On February 24, 2015, Mr. Zakai was issued 350,000 shares of common stock and 175,000 options to purchase shares of common stock under the 2014 plan. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.
(3) On April 30, 2013, Mr. Amitzur was granted 168,142 shares of our common stock and options to purchase 168,142 shares of common stock, each of which will vest over a two-year period with 1/8 of the total amount of the shares and options vesting at the end of each quarter from the date of the grant. The options are exercisable for 5 years at an exercise price of $0.5763 per share. On February 24, 2015, Mr. Amitzur was issued 3,500,000 shares of common stock and 700,000 options to purchase shares of common stock under the 2014 plan. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.

 

(4) On February 24, 2015, Mr. Paulik was issued 600,000 shares of common stock and 175,000 options to purchase shares of common stock under the 2014 plan. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.

Equity Compensation Plan Information

On February 24, 2015, our Board approved and adopted the Global Share and Options Incentive Enhancement Plan (2014) (the “2014 Plan”), pursuant to which the Company may award shares of its common stock, options to purchase shares of its common stock and other equity-based awards to eligible participants. The 2014 Plan replaced the Company’s Global Share Incentive Plan (2010) (the “2010 Plan”). The 2010 Plan and 2014 Plan are further described in Note 7 to our audited financial statements.

28
 

The following table summarizes information as of the close of business on September 30, 2015 about the 2014 Plan and 2010 Plan:

    Number of securities to be issued upon exercise of outstanding options, warrants and rights   Weighted-average exercise price of outstanding options, warrants and rights   Securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
Plan category   (a)   (b)   (c)
Equity compensation plans approved by security holders                  
                         
Equity compensation plans not approved by security holders     4,303,761     $ 0.222       3,221,239  
 Total     4,303,761     $ 0.222     3,221,239  

 

Director Compensation

The table below sets forth, for our last fiscal year, the compensation earned by each of our directors:

 

Name   Fees earned or paid in cash
($)
  Stock awards
($)(1)
  Options awards
($)(2)
  Non-equity incentive plan compensation ($)   Nonqualified deferred compensation earnings
($)
  All other compensation
($)
  Total ($)
                             
Shlomi Palas                                          
                                                         
Joshua Shoham     180,000       30,625       56,234                         266,859  
                                                         
Yigal Brosh           3,062       5,673                         8,735  
                                                         
Shimon Erlichman                                          
                                                         
Itai Haboucha                                          

 

(1) As of September 30, 2015, the aggregate number of stock awards outstanding was 14,578,761.

(2) As of September 30, 2015, the aggregate number of option awards outstanding was 4,303,761.

Narrative Disclosure to Director Compensation Table

Currently, the Board has not determined standard, uniform compensation and expense reimbursement arrangements for individuals serving only as a director. Shimon Erlichman and Itai Haboucha did not earn compensation during our last fiscal year since they joined the Board on September 29, 2015. All of the compensation received by Shlomi Palas was attributable to his role as Chief Executive Officer of the Company, as described above under the heading “Summary Compensation.” The compensation received by our other directors was individually negotiated, as described below.

On October 15, 2015, we entered into an advisory agreement with Joshua Shoham to retain Mr. Shoham as a strategic and business advisor to the Company, in addition to his role as Chairman of the Board. The agreement, which was intended to extend the term of a previous advisory agreement with Mr. Shoham, will expire on October 14, 2020, subject to a five year extension at the option of the Company and Mr. Shoham. Under the terms of his advisory agreement, Mr. Shoham will receive $180,000 in annual base compensation during the first year of the agreement, subject to an annual increase review, as well as stock option grants each year of the agreement to purchase 850,000 shares of the Company’s common stock at an exercise price of $0.01 and on such other terms as provided in the grants. Mr. Shoham will also be entitled to participate in any bonus, incentive compensation, savings and retirement and insurance plans of the Company. Mr. Shoham’s employment may be terminated with or without cause by the Company, subject to the terms of his advisory agreement.

29
 

On February 24, 2015, the Board authorized the issuance to Mr. Shoham of 4,100,000 shares of our common stock and options to purchase 700,000 shares of common stock, and the issuance to Mr. Brosh of 450,000 shares of our common stock and options to purchase 175,000 shares of common stock. Of these grants, 600,000 shares issued to Mr. Shohan and 100,000 shares issued to Mr. Brosh vested immediately. With respect to the rest of the grants, the shares and options will vest over a two-year period with 1/8 of the total amount of the shares and options vesting at the end of each quarter from the date of the grant.

Item 12. Security Ownership of Certain Beneficial Owners and Management

Principal Stockholders

The following table sets forth certain information as of December 31, 2015 regarding the beneficial ownership of our common stock, by (i) each person or entity who, to our knowledge, owns 5% or more of our common stock, (ii) our named executive officers, (iii) each director, and (iv) our named executive officers and directors as a group. Unless otherwise indicated in the footnotes to the table, we believe each stockholder named in the table has sole voting and investment power with respect to the shares of common stock listed. Unless otherwise indicated in the footnotes to the table, the address for each named executive officer and director is 35 Asuta Street, Even Yehuda, Israel 40500. Shares of common stock subject to options, warrants, or other rights currently exercisable or exercisable within 60 days of December 31, 2015, are deemed to be beneficially owned and outstanding for computing the share ownership and percentage of the stockholder holding such options, warrants or other rights, but are not deemed outstanding for computing the percentage of any other stockholder.

    Number of Shares of Common Stock   Percent Of
Class (1)
Name and Address of Beneficial Owner 5% Stockholders        
         
Dr. Borenstein Ltd.     12,801,610       7.06 %

18 Reipes St.

Tel Aviv, Israel

               
                 
Directors and Named Executive Officers                
                 
Shlomo Palas (2)     3,898,124       2.12 %
Joshua Shoham (3)     2,805,977       1.53 %
Yigal Brosh (4)     196,875       0.11 %
Shimon Erlichman            
Itai Haboucha            
Roy Amitzur (3)     3,496,772       1.91 %
Shlomo Zakai (4)     296,875       0.16 %
Steven Paulik (5)     390,625       0.22 %
                 
All Directors and Executive Officers as a Group (8 Persons)     11,085,248       6.11 %

(1) Based on 181,317,675 shares of common stock issued and outstanding as of December 31, 2015.

  

 
(2) Includes 337,500 shares issuable upon options exercisable within 60 days of December 31, 2015 and 1,350,000 shares vested within 60 days of December 31, 2015.
(3) Includes 262,500 shares issuable upon options exercisable within 60 days of December 31, 2015 and 1,312,500 shares vested within 60 days of December 31, 2015.
(4) Includes 65,625 shares issuable upon options exercisable within 60 days of December 31, 2015 and 131,250 shares vested within 60 days of December 31, 2015.
(5) Includes 65,625 shares issuable upon options exercisable within 60 days of December 31, 2015 and 225,000 shares vested within 60 days of December 31, 2015.

30
 

Changes in Control

We are not aware of any contract or other arrangement, the operation of which may at a subsequent date result in a change of control of our Company.

Item 13. Certain Relationships, Related Transactions and Director Independence

Related Transactions

In the last two fiscal years, there has not been any transaction, and currently there is no proposed transaction, in which we were or are going to be a participant and the amount involved exceeds $120,000, in which any related person had or will have a direct or indirect material interest, except as set forth below. A related person is any person who is a director or executive officer of the Company, a holder of 5% or more of our common stock, and any immediate family member of the foregoing.

On December 18, 2015, we entered into a no-interest bearing €118,000 promissory note with R.S. Palas Management Ltd., an entity owned and controlled by Shlomi Palas. The loan under the promissory note was used to finance a portion of the acquisition of the four SPVs in Italy pursuant to the Italy Projects Agreement. We have since paid back the loan under the promissory note with proceeds from our $3 million debenture offering.

Director Independence

Please see Part III, Item 10 under the heading “Corporate Governance” for information about the independence of our directors.

Item 14. Principal Accounting Fees and Services

Brightman Almagor Zohar& Co., a member firm of Deloitte Touche Tohmatsu Limited, an independent registered public accounting firm, served as our independent public accountants for the fiscal years ended December 31, 2015 and 2014, for which audited financial statements appear in this Annual Report on Form 10-K.

 

The following table presents the aggregate fees for professional services rendered by such accountants to us during their respective term as our principal accountants in 2015 and 2014.

 

    2015   2014
    (US$ in thousands)   (US$ in thousands)
Audit Fees (1)     60       45  
Tax Fees     16        
Total     76       45  

 

 (1) Includes professional services rendered in connection with the audit of our annual financial statements and the review of our interim financial statements.

 

Audit Fees

The aggregate fees billed by our principal accountant for the audit of our annual financial statements, review of financial statements included in the quarterly reports and other fees that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for the fiscal years ended September 30, 2015 and 2014 were $60,000 and $45,000, respectively.

Audit-Related Fees

Our principal accountant did not provide assurance or related services that are reasonably related to the performance of our audit or review of our financial statements for the fiscal years ended September 30, 2015 and 2014.

Tax Fees

The aggregate fees billed for professional services rendered by our principal accountant for tax compliance, tax advice and tax planning for the fiscal year ended September 30, 2015 were $16,000. There were no such fees billed for the fiscal year ended September 30, 2014.

31
 

All Other Fees

There were no other fees billed for products or services provided by our principal accountant for the fiscal years ended September 30, 2015 and 2014.

Our Board did not have an audit committee until after the end of the fiscal year ending September 30, 2015. Therefore, the audit committee did not review or approve the engagement of the Company’s principal accountant or the fees disclosed above.

32
 

Item 15. Exhibits and Financial Statement Schedules

No.   Description
 3.1   Amended and Restated Articles of Incorporation, dated November 22, 2013 (1)
 3.2   Amended and Restated Bylaws, dated June 17, 2015 (2)
10.1   Orbit Energy Rhode Island LLC Membership Interest Purchase Agreement, dated April 8, 2015 (3)
10.2   Rhode Island Energy Partners LLC Development and Indemnification Agreement, dated April 8, 2015 (3)
10.3   Amended and Restated Rhode Island Energy Partners LLC Agreement, dated April 8, 2015 (3)
10.4   Orbit Energy Charlotte, LLC Letter Agreement dated January 29, 2015 (4)
10.5   Orbit Energy Charlotte, LLC Membership Interest Purchase Agreement, dated January 30, 2015 (5)
10.6   Concord Energy Partners, LLC Development and Indemnification Agreement, dated January 30, 2015 (4)
10.7   Amended and Restated Concord Energy Partners LLC Agreement, dated January 30, 2015 (4)
10.8   Ori Ackerman Loan Agreement, dated March 15, 2015 (6)
10.9*   Global Share and Options Incentive Enhancement Plan (2014) (6)
10.10   Share Purchase Agreement by and among Bluesphere Italy S.r.l. and Volteo Energie S.p.A., Agriholding S.r.l. and Overland S.r.l., dated May 14, 2015 (7)
10.11   Framework EBITDA Guarantee Agreement dated July 17, 2015 (5)
10.12   Long Term Mezzanine Loan Agreement by and among Blue Sphere Corp., Eastern Sphere Ltd., Bluesphere Italy S.r.l., and Helios Italy Bio-Gas 1 L.P., dated August 18, 2015 (8)
10.13*   Service Agreement between Blue Sphere Corporation and Shlomo Palas, dated October 15, 2015
10.14*   Service Agreement by and among Blue Sphere Corporation, JLS Advanced Investment Holdings Limited, and Roy Amitzur, dated October 15, 2015
10.15*   Advisory Agreement between Blue Sphere Corporation and Joshua Shoham, dated October 15, 2015
10.16   License Agreement between Blue Sphere Corporation and Nanyang Technological University, dated October 30, 2014
10.17   Founders Agreement between Blue Sphere Corporation and Prof. Chen Xiaodong, dated January 8, 2015
21.1   List of Subsidiaries
31.1   Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer
31.2   Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer
32.1   Section 1350 Certification of Chief Executive Officer
32.2   Section 1350 Certification of Chief Financial Officer
101   The following materials from Blue Sphere Inc.’s Annual Report on Form 10-K for the year ended September 30, 2015 are formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statement of Shareholders’ Equity/ (Deficit), (iv) Consolidated Statements of Cash Flow, and (iv) Notes to Consolidated Financial Statements
101.INS   XBRL Instance Document  
101.SCH   XBRL Taxonomy Extension Schema Document  
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document  
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document  
101.LAB   XBRL Taxonomy Extension Label Linkbase Document  
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document  

_________________________________

 

(1) Incorporated by reference to our current report on Form 8-K filed with the SEC on December 3, 2013.
(2) Incorporated by reference to our current report on Form 8-K filed with the SEC on June 17, 2015.
(3) Incorporated by reference to our current report on Form 8-K filed with the SEC on April 14, 2015.
(4) Incorporated by reference to our current report on Form 8-K filed with the SEC on February 5, 2015.
(5) Incorporated by reference to our quarterly report on Form 10-Q filed with the SEC on August 14, 2015.
(6) Incorporated by reference to our quarterly report on Form 10-Q filed with the SEC on May 15, 2015.
(7) Incorporated by reference to our current report on Form 8-K filed with the SEC on May 18, 2015.
(8) Incorporated by reference to our current report on Form 8-K filed with the SEC on August 24, 2015.
 
* Indicates management contract or compensatory plan or arrangement.

33
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

January 13, 2016 Blue Sphere Corporation
     
  By: /s/ Shlomo Palas
    Shlomo Palas
    President, Chief Executive Officer, Secretary and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By: /s/ Shlomo Palas   January 13, 2016
  Shlomo Palas    
  President, Chief Executive Officer, Secretary and Director    
  (Principal Executive Officer)    

By: /s/ Shlomo Zakai   January 13, 2016
  Shlomo Zakai    
  Chief Financial Officer and Treasurer    
  (Principal Accounting Officer and Principal Financial Officer)    

 

 

By: /s/ Steven Paulik   January 13, 2016
  Steven Paulik    
  Chief Financial Officer    

 

By: /s/ Joshua Shoham   January 13, 2016
  Joshua Shoham    
  Director     

 

By: /s/ Yigal Brosh   January 13, 2016
  Yigal Brosh    
  Director    

 

By: /s/ Shimon Erlichman   January 13, 2016
  Shimon Erlichman    
  Director    

 

By: /s/ Itai Haboucha   January 13, 2016
  Itai Haboucha    
  Director    

 

34
 

 

APPENDIX A - FINANCIAL STATEMENTS

  

 

 

 

 

 

 

F- 1

 

 

 

 

 

BLUE SPHERE CORP.

 

 

CONSOLIDATED FINANCIAL STATEMENTS

 

AS OF SEPTEMBER 30, 2015

 

 

 

F- 2

 

  

BLUE SPHERE CORP.

 

 

CONSOLIDATED FINANCIAL STATEMENTS

 

AS OF SEPTEMBER 30, 2015

IN U.S. DOLLARS  

 

 

TABLE OF CONTENTS

 

  Page
   
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM F-4
   
CONSOLIDATED FINANCIAL STATEMENTS:  
Balance sheets as of September 30, 2015 and 2014 F-5
Statements of operations for the three years ended September 30, 2015, 2014 and 2013 F-6
Statements of changes in stockholders’ equity (deficit) for the three years ended September 30, 2015, F-7
2014 and 2013  
Statements of cash flows for the three years ended September 30, 2015, 2014 and 2013 F-8
Notes to financial statements F-9-38

 

F- 3

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

 

 

 

To the Board of Directors and Stockholders of
Blue Sphere Corp.

 

We have audited the accompanying consolidated balance sheets of Blue Sphere Corp. and its subsidiaries as of September 30, 2015 and 2014, the related consolidated statements of operations, stockholders' equity (deficiency), and cash flows for each of the three years in the period ended September 30, 2015. These financial statements are the responsibility of the Company's Board of Directors and management. Our responsibility is to express an opinion on the financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Blue Sphere Corp. and its subsidiaries as of September 30, 2015 and 2014 and the results of their operations and their cash flows for each of the three years in the period ended September 30, 2015, in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1b to the financial statements, the Company has incurred recurring losses from operations that raises substantial doubt about its ability to continue as a going concern. Management's plans concerning these matters are also described in Note lb. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Brightman Almagor Zohar & Co.

Brightman Almagor Zohar & Co.

Certified Public Accountants

A Member Firm of Deloitte Touche Tohmatsu Limited

Tel Aviv, Israel
January 13, 2016

 

F- 4

 

 

BLUE SPHERE CORP.

CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands except share and per share data)

 

    September 30,   September 30,
   

2015

 

2014

Assets                
CURRENT ASSETS:                
Cash and cash equivalents   $ 161     $ 298  
Other current assets     21       265  
          Total current assets     182       563  
                 
PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation     31       —    
                 
INVESTMENTS IN JOINT VENTURES (note 1b)     4,952       469  
          Total assets   $ 5,165     $ 1,032  
                 
Liabilities and Stockholders’ Equity (Deficiency)                
CURRENT LIABILITIES:                
Current maturities of long term loan   $ 32     $ 32  
Accounts payables     58       12  
Other accounts payable     681       343  
Debentures, notes and loans     519       231  
Deferred revenues from joint ventures     6,434       —    
Total current liabilities     7,724       618  
                 
LONG TERM BANK LOAN     135       104  
                 
STOCKHOLDERS’ EQUITY (DEFICIENCY) :                
Common shares of $0.001 par value each:
Authorized: 1,750,000,000 shares at September 30, 2015 and 2014, respectively. Issued and outstanding: 167,952,595 shares and 50,109,036 shares at September 30, 2015 and September 30, 2014, respectively
    1,244       1,126  
Proceeds on account of shares     20       20  
Treasury shares     (28 )        
Additional paid-in capital     39,474       35,106  
Accumulated deficit     (43,404 )     (35,942 )
Total Stockholders’ Equity (Deficiency)     (2,694 )     310  
Total liabilities and Stockholders’ Equity (Deficiency)   $ 5,165     $ 1,032  

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F- 5

 

 

BLUE SPHERE CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(U.S. dollars in thousands except share and per share data)

 

    Year ended
    September 30
    2015   2014   2013
             
OPERATING EXPENSES -                        
General and administrative expenses   $ 5,331     $ 7,120     $ 1,831  
                         
Other losses (incomes)     (14 )     —         20  
                         
Financial expenses , net     2,145       256       119  
                      
NET LOSS FOR THE YEAR   $ 7,462     $ 7,376     $ 1,970  
                         
Net loss per common share - basic and diluted   $ (0.088 )   $ (0.334 )   $ (0.345 )
                         
Weighted average number of common shares outstanding during the period - basic and diluted     85,135,631       22,077,519       5,705,471  

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F- 6

 

 

BLUE SPHERE CORP.

STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIENCY)

(U.S. dollars in thousands, except share and per share data)

 

   

Common Stock,
$0.001 Par Value

  Proceeds on account of  

 

Treasury

  Additional paid-in   Accumulated deficit   Total
Stockholders’ Equity
   

Shares

 

Amount

 

shares

 

Shares

 

Capital

 

stage

 

(deficiency)

                             
BALANCE AT OCTOBER 1, 2012     1,634,478     $ 184     $ —       $ —       $ 25,744     $ (26,596 )   $ (668 )
CHANGES DURING THE YEAR ENDED SEPTEMBER 30, 2013 :                                                        
Share based compensation     —         —         —         —         203       —         203  
Issuance of common stock, net of issuance expenses     3,593,579       406       —         —         485       —         891  
Issuance of common stock in respect of issuance of convertible notes     2,558,224       289       —         —         15       —         304  
Issuance of shares for services     1,834,929       207       —         —         551       —         758  
Net loss for the period     —         —         —         —         —         (1,970 )     (1,970 )
BALANCE AT SEPTEMBER 30, 2013     9,621,210     $ 1,086     $ —       $ —       $ 26,998     $ (28,566 )   $ (482 )
CHANGES DURING THE YEAR ENDED SEPTEMBER 30, 2014 :                                                        
Share based compensation     —         —         —         —         1,711       —         1,711  
Issuance of common stock, net of issuance expenses     9,054,967       9       —         —         891       —         900  
Issuance of common stock in respect of issuance of convertible notes     13,946,727       14       —         —         1,262       —         1,276  
Issuance of shares for services     17,486,132       17       —         —         3,203       —         3,220  
Issuance of convertible debentures containing a beneficial conversion feature     —         —         —         —         1,041       —         1,041  
Proceeds on account of shares     —         —         20       —         —         —         20  
Net loss for the period     —         —         —         —         —         (7,376 )     (7,376 )
BALANCE AT SEPTEMBER 30, 2014     50,109,036     $ 1,126     $ 20     $ —       $ 35,106     $ (35,942 )   $ 310  
CHANGES DURING THE YEAR ENDED SEPTEMBER 30, 2015 :                                                        
Share based compensation     —         —         —         —         558       —         558  
Issuance of common stock, net of issuance expenses     9,338,682       9       —         —         338       —         347  
Issuance of common stock in respect of issuance of convertible notes     75,532,381       76       —         —         1,449       —         1,525  
Issuance of shares for services     33,116,550       33       —         —         1,541       —         1,574  
Issuance of convertible debentures containing a beneficial conversion feature     —         —         —         —         482       —         482  
Treasury shares     (144,054 )     —       —         (28 )     —         —         (28 )
Net loss for the period     —         —         —         —         —         (7,462 )     (7,462 )
BALANCE AT SEPTEMBER 30, 2015     167,952,595     $ 1,244     $ 20       (28 )   $ 39,474     $ (43,404 )   $ (2,694 )

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F- 7

 

 

BLUE SPHERE CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands)

 

    Year ended
    September 30
    2015   2014   2013
CASH FLOWS FROM OPERATING ACTIVITIES:                        
Profit (Net loss) for the period   $ (7,462 )   $ (7,376 )   $ (1,970 )
Adjustments required to reconcile net loss                        
to net cash used in operating activities:                        
Share based compensation expenses     558       1,711       203  
Depreciation     6       3       3  
Expenses in respect of Convertible notes and loans     1,949       684       99  
Issuance of shares for services     1,574       3,220       758  
Amortization of projects costs     469       —         —    
Impairment of investment     (22 )                
                         
Increase (decrease) in other current assets     244       39       (78 )
Increase in deferred revenues     1,482       —         —    
Increase in accounts payables     46       20       5  
Increase (decrease) in other account payables     338       (103 )     (62 )
Net cash used in operating activities     (818 )     (1,802 )     (1,042 )
CASH FLOWS FROM INVESTING ACTIVITIES:                        
Payments on account of project     —         (198 )     (271 )
Short term investments     —         —         (7 )
Purchase of property and equipment     (37 )     —         —    
Net cash used in investing activities     (61 )     (198 )     (278 )
CASH FLOWS FROM FINANCING ACTIVITIES:                        
Proceeds from options exercise     —         20       —    
Loan origination fee     —         —         (178 )
Proceeds from issuance of convertible debenture     625       1,041       —    
Loans received     859       764       666  
Payment of loans and convertible debentures     (1,081 )     (473 )     (183 )
Issuance of shares, net     315       900       1,039  
Net cash provided by financing activities     718       2,252       1,344  
                         
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS     (137 )     252       24  
                         
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD     298       46       22  
                         
CASH AND CASH EQUIVALENTS AT END OF PERIOD   $ 161     $ 298     $ 46  
                         
NON-CASH TRANSACTION:                        
 Deferred revenues against joint ventures investments   4,952     —       —    
Supplemental disclosure of cash flow information:                        
Cash paid during the period for:                           
Interest   172     34     48  
Income taxes   —       —       —    

 

The accompanying notes are an integral part of the consolidated financial statement

 

F- 8

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – GENERAL

 

a.                General

 

Blue Sphere Corp. (“the Company”), together with its wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern”), Binosphere Inc (“Binosphere”), Johnstonsphere LLC (“Johnstonsphere”), and Sustainable Energy Ltd. (“SEL”), is focused on project integration in the clean energy production and waste to energy markets.

As of September 30, 2015, Tipping LLC and Charlottesphere LLC, two former subsidiaries of the Company, had been dissolved and Johnstonsphere had not commenced operations.

On May 12, 2015 the Company formed Bluesphere Pavia (formerly called Bluesphere Italy S.r.l.), a subsidiary of Eastern in order to acquire certain biogas plants located in Italy (see note 2 below).

 

The Company was incorporated in the state of Nevada on July 17, 2007 and was originally in the business of developing and promoting automotive internet sites. On February 17, 2010, the Company conducted a reverse merger, name change and forward split of its common stock, and in March 2010 current management took over operations, at which point the Company changed its business focus to become a project integrator in the clean energy production and waste to energy markets.

 

On October 2, 2014, the Company, together with certain third parties, established Permanent Energy Ltd (“Permanent Energy”) in Israel. Permanent Energy was focused on Build-Own-Operate projects and project integration in the clean energy production and waste to energy markets, primarily in Israel. The Company held a 50% interest in Permanent Energy. Permanent Energy ceased its operations in February 2015 and is in the process of dissolution.

 

The Company is currently focusing on (i) 10 projects related to the construction, acquisition or development of biogas facilities and (ii) a recently licensed fast charging battery technology.

 

On November 26, 2013, the Company amended and restated its Articles of Incorporation to authorize the issuance of 500,000,000 shares of preferred stock, $0.001 par value, in one or more series and with such rights, preferences and privileges as its Board of Directors may determine and to effect a 1 for 113 reverse stock split of the Company’s outstanding common stock. In addition, the Amended and Restated Articles of Incorporation provide, among other things, for indemnification and limitations to the liability of the Company’s officers and directors.

 

As a result of the reverse stock split, which became effective on December 4, 2013, every 113 shares of the Company’s outstanding common stock prior to the effect of that amendment was combined and reclassified into one share of the Company’s common stock, and the number of outstanding shares of the Company’s common stock was reduced from 1,292,103,309 to 11,434,611 shares.

 

All share, stock option and per share information in these consolidated financial statements have been adjusted to reflect the stock split on a retroactive basis.

  

F- 9

 

  

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – GENERAL (continue)

 

b.                Going concern consideration

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of September 30, 2015, the Company had approximately $161 thousand in cash, a negative working capital of approximately $7,542 thousand, a stockholders’ deficiency of approximately $2,694 thousand and an accumulated deficit of approximately $43,404 thousand. Management anticipates their business will require substantial additional investments that have not yet been secured. The Company anticipates that the existing cash will not be sufficient to continue its operations through the next 12 months. Management is continuing in the process of fund raising in the private equity markets as the Company will need to finance future activities and general and administrative expenses. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Company’s ability to continue as a going concern is dependent upon raising capital from financing transactions and revenue from operations.

 

These financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent on its ability to obtain additional financing as may be required and ultimately to attain profitability.

 

NOTE 2 – INVESTMENTS IN JOINT VENTURES

 

On October 19, 2012, the Company signed definitive project agreements in respect of both the North Carolina and Rhode Island sites with Orbit Energy, Inc. (“Orbit”), pursuant to which the Company would be entitled to full ownership of each of the entities that owns the rights to implement the respective projects (Orbit Energy Charlotte, LLC in the case of the North Carolina project (“OEC”) and Orbit Energy Rhode Island, LLC in the case of the Rhode Island project (“OERI”)), subject to the satisfaction of certain conditions.

 

North Carolina Project

 

On November 19, 2014, The Company signed an amended and restated purchase agreement with Orbit for the North Carolina project (the “Amended OEC Purchase Agreement”). Subject to the terms of the Amended OEC Purchase Agreement, Orbit transferred ownership of OEC to the Company in exchange for a development fee of $900,000, reimbursement of $17,764 and an amount equal to 30% of the distributable cash flow from the North Carolina project after the project achieves a post-recoupment 30% internal rate of return computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature. The Company also agreed to use high solid anaerobic digester units designed by Orbit (the “HSAD Units”) and to retain Orbit to implement and operate the HSAD Units for an annual management fee of $187,500 (the “OEC Management Fee”), subject to certain conditions. The Amended OEC Purchase Agreement provided that the Company had until December 15, 2014 to pay Orbit the development fee and reimbursement amount, which was extended to January 15, 2015 upon payment of $75,000. The Company did not pay Orbit the development fee and reimbursement amount and, pursuant to the terms of the Amended OEC Purchase Agreement, ownership of OEC reverted back to Orbit on January 15, 2015.

 

F- 10

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – INVESTMENTS IN JOINT VENTURES (continue)

 

On January 30, 2015, The Company entered into the Orbit Energy Charlotte, LLC Membership Interest Purchase Agreement by and among the Company, Orbit, Concord Energy Partners, LLC, a Delaware limited liability company (“Concord”), and OEC (the “New OEC Purchase Agreement”), pursuant to which (i) Concord purchased all of Orbit’s right, title and interest in and to the membership interests of OEC (the “OEC Interests”), (ii) Orbit abandoned all economic and ownership interest in the OEC Interests in favor of Concord, (iii) Orbit ceased to be a member of OEC and (iv) Concord was admitted as the sole member of OEC.

 

Subject to the satisfaction of certain conditions by Orbit, The Company agreed to be responsible for all costs of evaluating and incorporating into the North Carolina project (i) Orbit’s high solids anaerobic digestion technology, consisting of a proprietary process that uses an anaerobic digester design developed by the U.S. Department of Energy and subsequently modified by Orbit in combination with the proprietary bacteria supplied by Orbit (the “Orbit Technology”), and (ii) two HSAD Units designed by Orbit with up to a total maximum capacity of 100 tons per day. The Company are responsible for both direct and indirect costs, all payments to be made to Orbit and all increased costs, expenses and any damages incurred in connection with the design, installation, integration, operation and maintenance of the Orbit Technology incorporated into the project. The Company also agreed to enter into an operations agreement with Orbit in respect of the HSAD Units to be integrated into the North Carolina project and to pay Orbit the OEC Management Fee.

 

In a letter agreement executed in connection with the New OEC Purchase Agreement, The Company agreed to pay Orbit an amount equal to thirty percent (30%) of the North Carolina project’s distributable cash flow after The Company and the other equity investors in the North Carolina project fully recoup their respective investments in the North Carolina project (such investments to be calculated solely as amounts expended in and for the construction of the North Carolina project) and the North Carolina project achieves a thirty percent (30%) internal rate of return. The calculation of the project’s internal rate of return would take into account and be computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature, as well as the OEC Management Fee.

 

On the same date as the New OEC Purchase Agreement, (i) the Company, Concord and York Renewable Energy Partners LLC (“York”) entered into a development and indemnification agreement (the “Concord Development and Indemnification Agreement”), pursuant to which Concord paid the Company $1,250,000, issued the Company 250 Series B units of Concord (“Concord Series B Units”) and issued 750 Series A units of Concord (“Concord Series A Units”) to York, and (ii) The Company and York entered into an amended and restated limited liability company operating agreement (the “Concord LLC Agreement”) to establish the Concord Series A Units and Concord Series B Units and admit the Company and York as 25% and 75% members of Concord, respectively. Pursuant to the foregoing agreements, York also agreed to pay the Company two equal installments of $587,500 upon (a) mechanical completion of the North Carolina project and (b) commercial operation of the North Carolina project Company’s rights to receive distributions from Concord are subject to certain priorities in favor of York.

 

F- 11

 

  

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – INVESTMENTS IN JOINT VENTURES (continue)

 

In connection with the foregoing, on January 30 2015, the Company terminated its amended and restated construction finance agreement, dated June 6, 2014, with Caterpillar Financial Services Corporation. In February 2015, The Company received $1,586,000 for development fees and reimbursements in connection with the North Carolina project.

 

If commercial operations are not commenced within 60 days of December 31, 2015, OEC will be required to pay $500,000 of liquidated damages to Duke Energy pursuant to the Duke PPA. If applicable, York will be responsible for contributing these funds to OEC. Although no assurances can be given, the Company expects the North Carolina project to commence commercial operations in the first quarter of 2016.

 

Based on the investments made by York as of September 30, 2015, the Company’s portion of net equity in Concord amounted to a total of $3,616,978. Such amount was presented as an asset in the balance sheet and as deferred revenues from equity in subsidiaries. Such deferred revenues will be recorded to the profit and loss statement upon completion of the plants and fulfillment of all the Company’s obligation under the above agreements.

 

Rhode Island Project

 

On January 7, 2015, the Company signed an amended and restated purchase agreement with Orbit for the Rhode Island project (the “Amended OERI Purchase Agreement”). Subject to the terms of the Amended OERI Purchase Agreement, Orbit transferred full ownership of OERI to the Company in exchange for a development fee of $300,000, reimbursement of $86,432 and an amount equal to 30% of the distributable cash flow from the Rhode Island project after the project achieves a post-recoupment 30% internal rate of return computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature. The Company also agreed to use HSAD Units designed by Orbit and to retain Orbit to implement and operate the HSAD Units for an annual management fee of $187,500 (the “OERI Management Fee”), subject to certain conditions. The Amended OERI Purchase Agreement provided that the Company had until January 22, 2015 to pay Orbit the development fee and reimbursement amount, which was extended to February 28, 2015 upon payment of $31,000. The Company did not pay the development fee and reimbursement amount and, pursuant to the terms of the Amended OERI Purchase Agreement, ownership of OERI reverted back to Orbit.

 

On April 8, 2015, the Company entered into the Orbit Energy Rhode Island, LLC Membership Interest Purchase Agreement by and among the Company, Orbit, Rhode Island Energy Partners, LLC, a Delaware limited liability company (“Rhode Island”) and OERI (the “New OERI Purchase Agreement”), pursuant to which (i) Rhode Island purchased all of Orbit’s right, title and interest in and to the membership interests of OERI (the “OERI Interests”), (ii) Orbit abandoned all economic and ownership interest in the OERI Interests in favor of Rhode Island, (iii) Orbit ceased to me a member of OERI and (iv) Rhode Island was admitted as the sole member of OERI.

 

Subject to the satisfaction of certain conditions by Orbit, the Company agreed to be responsible for all costs of evaluating and incorporating into the Rhode Island project (i) the Orbit Technology and (ii) two HSAD Units designed by Orbit with up to a total maximum capacity of 75 tons per day. The Company are responsible for both direct and indirect costs, all payments to be made to Orbit and all increased costs, expenses and any damages incurred in connection with the design, installation, integration, operation and maintenance of the Orbit Technology incorporated into the project. The Company also agreed to enter into an operations agreement with Orbit in respect of the HSAD Units to be integrated into the Rhode Island project and to pay Orbit the OERI Management Fee.

 

F- 12

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – INVESTMENTS IN JOINT VENTURES (continue)

 

The Company also acknowledged in the New OERI Purchase Agreement its continuing responsibility to pay Orbit an amount equal to thirty percent (30%) of the Rhode Island project’s distributable cash flow after the Company and the other equity investors in the Rhode Island project fully recoup Company’s respective investments in the Rhode Island project (such investments to be calculated solely as amounts expended in and for the construction of the Rhode Island project) and the Rhode Island project achieves a thirty percent (30%) internal rate of return. The calculation of the project’s internal rate of return would take into account and be computed on the basis of any and all benefits from tax credits, depreciation and other incentives of any nature, as well as the OERI Management Fee.

 

On the same date as the New OERI Purchase Agreement, (i) the Company, Rhode Island and York entered into a development and indemnification agreement (the “Rhode Island Development and Indemnification Agreement”), pursuant to which Rhode Island agreed to pay the Company $1,481,900, issue the Company 2,275 Series B units of Rhode Island (“Rhode Island Series B Units), and issue 7,725 Series A units of Rhode Island (“Rhode Island Series A Units”) to York, and (ii) the Company and York entered into an amended and restated limited liability company operating agreement (the “Rhode Island LLC Agreement”) to establish the Rhode Island Series A Units and Rhode Island Series B Units and admit the Company and York as 22.75% and 77.25% members of Rhode Island, respectively. Pursuant to the foregoing agreements, York also agreed to pay the Company three equal installments of $562,500 upon (a) signing of the Rhode Island Development and Indemnification Agreement, (b) the later of (i) the date of mechanical completion of the Rhode Island project and (ii) the date on which an executed interconnection agreement between OERI and National Grid, including receipt of any regulatory approvals from the Rhode Island Public Utility Commission, is delivered by OERI, and (c) commercial operation of the Rhode Island project.

 

Based on the investments made by York as of September 30, 2015, the Company’s portion of net equity in Rhode Island amounted to a total of $1,335,377. Such amount was presented as an asset in the balance sheet and as deferred revenues from equity in subsidiaries. Such deferred revenues will be recorded to the profit and loss statement upon completion of the plants and fulfillment of all the Company’s obligation under the above agreements.

 

F- 13

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES

 

a.      

Functional currency

 

The currency of the primary economic environment in which the operations of the Company are conducted is the U.S dollar (“$” or “dollar”).

 

Most of the Company’s expenses are incurred in dollars. Most of the Company’s external financing is in dollars. The Company holds most of its cash and cash equivalents in dollars. Thus, the functional currency of the Company is the dollar.

 

Since the dollar is the primary currency in the economic environment in which the Company operates, monetary accounts maintained in currencies other than the dollar are re-measured using the representative foreign exchange rate at the balance sheet date. Operational accounts and non-monetary balance sheet accounts are measured and recorded at the rate in effect at the date of transaction. The effects of foreign currency re-measurement are reported in current operations (as “financial expenses - net) and have not been material to date.

 

b.      

Principles of consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.

 

Inter-company balances and transactions have been eliminated upon consolidation.

 

c.       

Cash equivalents

 

Cash equivalents are short-term highly liquid investments which include short term bank deposit (up to three months from date of deposit), that are not restricted as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired.

 

d.      

Property, plant and equipment

 

Property, plant and equipment are stated at cost, less accumulated depreciation. Assets are depreciated using the straight-line method over their estimated useful lives.

 

Computers, software and electronic equipment are depreciated over three years. Tools and equipment are depreciated over five years. Furniture is depreciated over fourteen years.

 

F- 14

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES (continue) 

 

e.       

Investment in affiliated companies

 

Investments in affiliated companies that are not controlled but over which the Company can exercise significant influence (generally, entities in which the Company holds approximately between 20% to 50% of the voting rights of the investee) are presented using the equity method of accounting. Profits on intercompany sales, not realized outside the Company, are eliminated. The Company discontinues applying the equity method when its investment (including advances and loans) is reduced to zero and the Company has not guaranteed obligations of the affiliate or otherwise committed to provide further financial support to the affiliate.

 

Investments in preferred shares, which are not in substance common stock, are recorded on a cost basis according to ASC 323-10-15-13, “Investments - Equity Method and Joint Ventures - In-substance Common Stock” and ASC 323-10-40-1, "Investment -Equity Method and Joint Ventures - Investee Capital Transactions".

 

A change in the Company’s proportionate share of an investee’s equity, resulting from issuance of common or in-substance common shares by the investee to third parties, is recorded as a gain or loss in the consolidated income statements in accordance with ASC 323-10-40-1.

 

Investments in non-marketable equity securities of entities in which the Company does not have control or the ability to exercise significant influence over their operation and financial policies, are recorded at cost (generally when the Company holds less than 20% of the voting rights).

 

Management evaluates investments in affiliated companies, partnerships and other non-marketable equity securities for evidence of other-than-temporary declines in value. Such evaluation is dependent on the specific facts and circumstances. Accordingly, in determining whether other-than-temporary declines exist, management evaluates various indicators for other-than-temporary declines and evaluates financial information (e.g. budgets, business plans, financial statements, etc.). During 2015 and 2014, no material impairment was recognized.

 

f.       

Use of estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results may differ from those estimates

 

F- 15

 

   

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES (continue)

 

g.        

Share-base payments

 

Share-based payments to employees are measured at the fair value of the options issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of the goods or services received or the fair value of the equity instruments issued if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The amount recognized as an expense is adjusted to reflect the number of awards expected to vest. The offset to the recorded cost is to share-based payments reserve. Consideration received on the exercise of stock options is recorded as capital stock and the related share-based payments reserve is transferred to share capital.

 

h.      

Loss per share

 

Net loss per share, basic and diluted, is computed on the basis of the net loss for the period divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share is based upon the weighted average number of common shares and of common shares equivalents outstanding when dilutive. Common share equivalents include: (i) outstanding stock options under the Company’s share incentive plan and warrants which are included under the treasury share method when dilutive, and (ii) common shares to be issued under the assumed conversion of the Company’s outstanding convertible notes, which are included under the if-converted method when dilutive. The computation of diluted net loss per share for the years ended September 30, 2015, 2014, and 2013, does not include common share equivalents, since such inclusion would be anti-dilutive.

 

i.      

Deferred income taxes

 

Deferred taxes are determined utilizing the asset and liability method based on the estimated future tax effects of differences between the financial accounting and tax bases of assets and liabilities under the applicable tax laws. Deferred tax balances are computed using the tax rates expected to be in effect when those differences reverse. A valuation allowance in respect of deferred tax assets is provided if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has provided a full valuation allowance with respect to its deferred tax assets.

 

j.        

Comprehensive loss

 

The Company has no component of comprehensive income loss other than net loss.

 

k.        

Revenue recognition

 

The Company recognizes revenues from services rendered in accordance with ASC Topic 605-20 Revenue Recognition from Services. The Company records services to be supplied under contractual agreements as deferred revenue until such related services are provided.

 

 

F- 16

 

  

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES (continue)

 

l.       

Newly issued accounting pronouncements

 

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (“ASC”) 605, Revenue Recognition. The new revenue recognition standard requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. In August 2015, the FASB issued Accounting Standards Update No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, or ASU 2015-14. This amendment defers the effective date of the previously issued Accounting Standards Update ASU 2014-09, until the interim and annual reporting periods beginning after December 15, 2017. Earlier application is permitted for interim and annual reporting periods beginning after December 15, 2016. If the Company begins generating revenue prior to the effective date of ASU 2015-14, the Company will evaluate the effect that ASU 2014-09 will have on the results of operations and financial position.

 

In August 2015, the FASB has issued Accounting Standards Update (ASU) No. 2015-15, Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements - Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting . This ASU adds SEC paragraphs pursuant to the SEC Staff Announcement at the June 18, 2015, Emerging Issues Task Force meeting about the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03 for debt issuance costs related to line-of-credit arrangements, the SEC staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not expect this update will have a material impact on the presentation of the Company’s consolidated financial position, results of operations and cash flows.

 

In September 2015, the FASB issued ASU 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments, which eliminates the requirement to retrospectively account for changes to provisional amounts initially recorded in a business acquisition opening balance sheet. Prior to the issuance of ASU 2015-16, an acquirer was required to restate prior period financial statements as of the acquisition date for adjustments to provisional amounts. This guidance is effective for fiscal years beginning after December 15, 2015, including interim periods within fiscal years. The Company is evaluating the effect, if any, this update will have on the Company’s consolidated financial position, results of operations and cash flows.

 

In November 2015, the FASB has issued Accounting Standards Update (ASU) No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes, which changes how deferred taxes are classified on organizations’ balance sheets. The ASU eliminates the current requirement for organizations to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. Instead, organizations will be required to classify all deferred tax assets and liabilities as noncurrent. The amendments apply to all organizations that present a classified balance sheet. For public companies, the amendments are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not expect this update will have a material impact on the presentation of the Company’s consolidated financial position, results of operations and cash flows.

 

F- 17

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – DEBENTURES, NOTES AND LOANS  

 

Convertible Promissory Notes

 

Between August 4, 2014 and September 30, 2014, the Company issued convertible promissory notes (the “Notes”) to accredited investors in an aggregate principal amount of $1,408,150 for an aggregate purchase price of $1,201,414, net of expenses incurred in connection of such notes.

 

Between October 1, 2014 and January 20, 2015, the Company issued convertible promissory notes (the “Notes”) to accredited investors in an aggregate principal amount of $504,250 for an aggregate purchase price of $464,970, net of expenses incurred in connection of such notes.

 

The Notes were generally mature one-year from the date of issuance and accrue interest at rates ranging from 8% to 18% per annum and in an event of default, the Notes bear interest at rates ranging from 12% to 24% per annum. The Notes may generally be converted into shares of the Company’s common stock at conversion prices ranging from 37% to 45% discounts to lowest trade or closing prices during periods in proximity to the time of conversion subject to further discounts in the case of certain events of default.

 

In accordance with ASC 470-20, the Company allocated to additional paid-in capital a portion of the proceeds of the notes equal to the intrinsic value of the beneficial conversion feature embedded in the debentures and recorded a corresponding discount on such debentures. The amounts allocated to additional paid-in capital were $1,040,919 and $482,485 as of September 30, 2014 and September 30, 2015, respectively. As of September 30, 2015 the notes were converted or repaid in full. During the year ended September 30, 2015, the Company recorded amortization expenses in the amounts of $1,523,404, in respect of the discounts recorded on the debentures.

 

From February through September 2015, convertible promissory notes holders representing an aggregate principal amount of $1,480,716 converted their notes into 75,060,414 shares of the Company’s common stock.

 

F- 18

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – DEBENTURES, NOTES AND LOANS (continue)

 

The Notes include customary default provisions related to payment of principal and interest and bankruptcy or creditor assignment.  In addition, it shall constitute an event of default under certain of the Notes if the Company is delinquent in its filings with the Securities and Exchange Commission, ceases to be quoted on the OTCQB, its common stock is not DWAC eligible or if it has to restate its financial statements in any material respect. In the event of an event of default the Notes may become immediately due and payable at premiums to the outstanding principal. The Notes also provide that if shares issuable upon conversion of the Notes are not timely delivered in accordance with the terms of the Notes then the Company shall be subject to certain cash or share penalties that increase proportionally to the duration of the delinquency up to certain maximums.

 

The Company paid aggregate commissions of $7,500 to MD Global Partners, LLC and $46,000 to Carter Terry & Company (“Carter Terry”), registered broker-dealers, in connection with the issuance of some of Notes in the aggregate principal of up to $480,000. In addition, Carter Terry is entitled to receive 100,000 shares of the Company’s common stock and a further amount of shares of the Company’s common stock equal to 4% of capital raised by them divided by the closing price of the Company common stock on the date of close. On December 8, 2014 the Company issued 209,041 shares of the Company’s common stock, see note 6 below.

 

Loans

On March 7, 2012, the Company entered into a loan agreement with Eli Weinberg, pursuant to which Mr. Weinberg loaned the Company $135,000. The full principal amount of the loan remains outstanding. Mr. Weinberg has the option to convert any or all of the principal amount of the loan to common stock of the Company.

 

On March 15, 2015, the Company entered into a loan agreement with Ori Ackerman (the “Ackerman Loan Agreement”), pursuant to which the Company agreed to borrow $220,000 and issue 3,000,000 shares to Ori Ackerman. The Company received $200,000 under the Ackerman Loan Agreement, as $20,000 was deducted from the original amount of the loan and considered payment of interest in advance. The loan bears no additional interest, and is payable in full within three business days of the date the Company receives revenue from any of its Charlotte, Rhode Island or Italian projects. The Company’s obligations under the loan are personally guaranteed by Shlomi Palas, the Company’s Chief Executive Officer.

 

On March 25, 2015, the Company entered into a loan agreement with Valter Team, Ltd. (the “Valter Team Loan Agreement”), pursuant to which the Company agreed to borrow $68,750 and issue 250,000 shares to Valter Team Ltd. The Company received $62,500 under the Valter Team Loan Agreement, as $6,250 was deducted from the original amount of the loan. This loan bears no interest and is payable in full on the earlier of the date the Company receives cash proceeds from any of its Charlotte, Rhode Island or Italian projects and December 25, 2015. The Company’s obligations under the loan are personally guaranteed by Shlomi Palas, the Company’s Chief Executive Officer. As of September 30, 2015, the Company repaid the loan in full and issued the 250,000 shares.

 

F- 19

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

On July 25, 2011, the Company, JLS and Roy Amitzur entered into a Management Services Agreement according to which JLS, and Mr. Amitzur are engaged to provide management services to the Company devoting at least 75% of this time to the Company, with Mr. Amitzur serving as Executive Vice President. The term of the agreement was originally for two years and in July 2013, was extended for a further eight months. Since the agreement expired in May 2014, Mr. Amitzur’s agreement was further extended on the same terms on an oral basis. For services rendered under the agreement, JLS is entitled to a monthly fee of US$10,000 + VAT subject to the Company raising an aggregate amount of at least $450,000.  Subsequently, such fee increases to a monthly fee of $15,000 + VAT after the Company raises an aggregate equity investment of $2,000,000. Notwithstanding the raise of more than an aggregate of $2,000,000, payment of Mr. Amitzur monthly fee of US $10,000 + VAT has continued to-date. In addition, the Company issued to JLS 110,620 shares of common stock vesting in equal amounts quarterly over 24 months, all of which have fully vested.  JLS and Mr. Amitzur are entitled to participate on similar terms as the other executives of the Company in bonus plans or incentive compensation plans for its employees. 

 

On February 29, 2012, the Company entered into an employment agreement with Mr. Palas to serve as the Company’s Chief Executive Officer for an indefinite term. This agreement was intended to extend the term of a previously entered into employment agreement with Mr. Palas whose term was expiring. Under the agreement, Mr. Palas receives monthly remuneration at a gross rate of USD$15,000 + VAT. Mr. Palas will be entitled to participate in any bonus plan or incentive compensation plan for its employees adopted by the Company.

 

On November 5, 2012, the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company.

 

On March 18, 2013, the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive Officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company.

 

F- 20

 

  

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – RELATED PARTY TRANSACTIONS (continue)

 

On April 30, 2013, the Board of Directors of the Company approved the issuance of 230,089 shares of the Company and options to purchase 230,089 shares of common stock to its Chief Executive Officer, 203,540 shares and options to purchase 203,540 shares of common stock to the Chairman of the Board, 168,142 shares and options to purchase 168,142 shares of common stock to the Executive Vice-President and 88,496 shares and options to purchase 88,496 shares of common stock to both the Chief Carbon Officer and general counsel of the Company and for the CTO of Company. The shares and options will vest over a two year period with 1/8 of the total amount of the shares and options vesting at the end of each quarter from the date of the grant.

 

On June 19, 2013 the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company.

 

On January 26, 2014, the Company signed a subscription agreement with Talya Levy-Tytiun (“Talya”) pursuant to which Talya agreed to invest an aggregate of $400,000 into the Company for the sale of 1,739,130 shares of common stock. The Company was obligated to issue Talya additional shares of the Company, if, six months from the date of the agreement her ownership in the Company would be reduced below 12.3%. In addition, the Company guaranteed that if on the first anniversary of the agreement, the share price of the Company common stock was 0.23$ per share or less, the Company shall transfer Talya such amount necessary to make Talya whole and reimburse her for any loss due to her investment. On September 17, 2014 the Company issued Talya 2,866,194, shares of common stock as a reimbursement under the above agreement.

 

On December 13, 2013 the Board of Directors of the Company approved the issuance of 424,779 shares of the Company to its Chief Executive Officer, 353,982 shares to the Chairman of the Board, 353,982 shares to the Executive Vice-President and 283,186 shares to the Chief Carbon Officer and general counsel of the Company. Such shares were issued at January 9, 2014.

 

On March 10, 2014 the Board of Directors of the Company approved the issuance of 250,000 shares of the Company to its Chief Executive Officer, 220,000 shares to the Chairman of the Board, 200,000 shares to the Executive Vice-President and 180,000 shares to the Chief Carbon Officer and general counsel of the Company.

 

On May 27, 2014 the Company appointed Mr. Yigal Brosh as a member of the Board of Directors of the Company. Mr. Brosh was granted 200,000 options to purchase shares of common stock of the Company at an exercise price of $0.01 per share. The Options vets over a period of two years with a pro-rata portion vesting each three month period.

 

On February 24, 2015, the Board of Directors approved a grant of up to 1,450,000 shares of common stock to certain of its directors under the 2010 Plan. In addition, on February 24, 2015 the Company granted under its 2014 Option Plan 7,450,000 shares of common stock and to 1,775,000 options to purchase shares of common stock to certain of its directors. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.

 

F- 21

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – COMMON SHARES

 

On October 25, 2012 the Company entered into a Subscription Agreement with a non-US investor for the sale of 88,496 shares of common stock for an aggregated amount of $20,000.

 

On October 25, 2012 the Company entered into an agreement with a non-US investor to sell 380,531 shares of common stock for an aggregated amount of $50,000.

 

On November 5, 2012 the Company entered into an agreement with a non-US investor to sell 265,487 shares of common stock at December 25, 2012 for an aggregated amount of $70,000.

 

On November 5, 2012 the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company.

 

On November 20, 2012, the Company agreed to issue 331,859 shares of the Company. Such shares have been issued on January 11, 2013 and were valued based on the share price of the Company to be $101 thousands.

 

On December 20 2012, the Company entered into an agreement with a non-US investor to sell 309,735 shares of common stock at a price of $0.32286 per share for $100,000 and to purchase another 154,868 shares of common stock for $50,000 in January 2013 and another 154,868 shares of common stock for $50,000 in February 2013. Additionally, the Company was (i) obligated to issue such investor 88,496 shares of common stock in February 2013 at no additional cost and (ii) issue to such investor an option to purchase 66,372 shares of common stock for one year for 2.26 per share and to purchase 66,372 shares of common stock for two years at a price per share of $4.52.

 

The Company has estimated the aggregate fair value of such options granted using the Black-Scholes option pricing to be approximately $76,000.

 

On January 3, 2013, the Company signed a consulting agreement with Emerging Market Consulting, LLC (the “EMC”). According to the agreement, EMC would assist the Company with the design, development and dissemination of corporate information for a period of three month with an option to extend the agreement for an additional nine months. The Company paid EMC $11,000 and issued 39,824 restricted shares of the Company common stock, for the first period. The Company evaluated the cost of such issuance based on the share price of the Company to be $11 thousand. The Company elected not to renew the agreement and the agreement expired on April 3, 2013.

F- 22

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – COMMON SHARES (continue)

 

On February 2, 2013 the Company issued 451,328 shares of common stock to an investor for an aggregate amount of $50,000.

 

On February 19, 2013, the Company signed a subscription agreement with a non-US investor pursuant to which such investor agreed to invest an aggregate of $75,000 into the Company in three installments: (i) $25,000 on March 10, 2013, (ii) $25,000 on April 10, 2013 and (iii) $25,000 on May 10, 2013. For each $25,000 invested, the Company was obligated to issue 88,496 shares of common stock to the investor. As of September 30, 2013 the investor transferred to the Company all three installments and the Company issued to the investor 265,487 shares. In addition, the non-US investor invested an additional $25,000 for an additional 88,496 shares of common stock of the Company.

 

On February 20, 2013, the Company signed a subscription agreement with a non-US investor pursuant to which such investor agreed to invest an aggregate of $50,000 into the Company in three installments: (i) $16,600 on March 10, 2013, (ii) $16,600 on April 10, 2013 and (iii) $16,700 on May 10, 2013. Upon receipt of each installment, the Company was obligated to issue 146,903 shares of common stock to the investor. As of September 30, 2013, the Company received all three installments totaling $50,000 and issued 440,708 shares. Additionally, on May 23, 2013 the Company issued 35,399 shares of the Company for $4,000 to the non-US investor under the same terms of the agreement above.

 

On March 18, 2013 the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive Officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company.

 

On April 30, 2013 the Board of Directors of the Company approved the issuance of 230,089 shares of the Company and 203,089 options to its Chief Executive officer, 203,540 shares and 203,540 options to the Chairman of the Board, 168,142 shares and 168,142 options to the Executive Vice-President and 88,496 shares and 88,496 options to both the Chief Carbon Officer and general counsel of the Company and for the CTO of Company. The shares and options will vest over a two year period with 1/8 of the total amount of the shares and options vesting at the end of each quarter from the date of the grant.

 

In May and July 2013, the Company issued 495,576 shares of common stock to an investor for an aggregate amount of $49,315.

 

On June 19, 2013 the Board of Directors of the Company approved the issuance of 53,098 shares of the Company to its Chief Executive officer, 44,248 shares to the Chairman of the Board, 44,248 shares to the Executive Vice-President and 35,399 shares to the Chief Carbon Officer and general counsel of the Company.

 

On June 19, 2013 the Company entered into an agreement with a third party. In exchange for his services the Company issued the third party 176,992 shares of common stock of the Company. On June 23, 2013, the Company signed an additional agreement with the third party according to which the Company issued additional 156,611 shares of common stock of the Company.

F- 23

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – COMMON SHARES (continue)

 

On June 19, 2013 the Company entered into an agreement with a non-US investor to sell 132,744 shares of common stock for an aggregate amount of $50,000.

 

On June 19, 2013 the Company entered into an agreement with a non-US investor to sell 53,634 shares of common stock for an aggregate amount of $20,000.

 

On June 26, 2013 the Company entered into an agreement with a non-US investor to sell 53,098 shares of common stock for an aggregate amount of $20,000.

 

On June 26, 2013 the Company signed a Capital Markets Advisory Consulting Agreement with Incline Partners, LLC (“Incline”). According to the agreement, Incline agreed to provide the Company with capital market advisory and monthly distribution of articles and media for a period between June 15, 2013 through August 15, 2013. In consideration for the above services, the Company paid Incline a cash payment of $28,000 and issued 88,496 restricted shares of the Company common stock.

 

On July 22, 2013 the Company entered into an agreement with a non-US investor to sell 268,169 shares of common stock for an aggregate amount of $100,000.

 

On September 3, 2013 the Company entered into an agreement with a non-US investor to sell 268,169 shares of common stock for an aggregate amount of $100,000.

 

On October 13, 2013 a non-US investor converted $87,000 principal loan for 384,956 shares of the Company’s common stock.

 

On October 13, 2013, a non-US investor converted $37,000 principal loan for 163,717 shares of the Company’s common stock.

 

During October 2013, holders of $47,878 of principal amount of Asher convertible notes converted their notes into 402,276 shares of the Company’s common stock.

 

On October 8, 2013, the Company issued 88,496 shares of common stock for consulting services.

 

On November 5, 2013, the Company’s subsidiary, Eastern Sphere, Ltd., entered into an agreement with an investor providing for the issuance of 491,642 shares of the Company’s common stock in consideration for $100,000.

 

On November 14, 2013, the Company’s subsidiary, Eastern Sphere, Ltd., entered into an agreement with an investor providing for the issuance of 146,016 shares of the Company’s common stock in consideration for $29,107.

 

F- 24

 

  

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – COMMON SHARES (continue)

 

On December 4, 2013, the Company entered into an agreement with an investor that agreed to provide collateral in the amount of $480,000 (€353,200) to enable the Company to receive a letter of credit in respect of the Company’s North Carolina project. In consideration for providing the collateral, the investor shall be entitled to a 4% ownership stake in the North Carolina project companies and was issued 44,248 shares of the Company’s common stock. Mr. Shlomi Palas personally guaranteed the Company’s obligations under the agreement with the investor. In addition, in accordance with the agreement, the Company issued to the investor a convertible note due on March 4, 2014 in the principal amount of $480,000 (€353,200) bearing interest at 1% per month, payable on a monthly basis. On or after March 4, 2014, any outstanding and unpaid principal under the convertible note is convertible into the Company’s shares of common stock based on the then applicable market price of the Company’s shares. The Company and the investor have verbally agreed to extend the maturity of such convertible note indefinitely and, in the meantime, the Company continues to make 1% interest payments on a monthly basis.

 

On December 13, 2013 the Board of Directors of the Company approved the issuance of 424,779 shares of the Company to its Chief Executive Officer, 353,982 shares to the Chairman of the Board, 353,982 shares to the Executive Vice-President and 283,186 shares to the Chief Carbon Officer and general counsel of the Company. Such shares were issued at January 9, 2014.

 

On December 15, 2013, the Company agreed to issue 600,000 shares of common stock to a consultant providing investor relation services. The shares are to be issued in three tranches of 200,000 each, the first within 10 days of entering into the agreement, the second on the four month anniversary of the agreement and the final on the eight month anniversary of the agreement. The first tranche of 200,000 shares was issued on January 9, 2014. During October 2014, the Company terminated the investor relation service agreement.

 

On January 9, 2014, the Company issued 265,486 shares of common stock to an investor for $25,000 in cash.

 

On January 9, 2014, the Company issued 345,132 shares of common stock for consulting services. The Company has estimated the fair value of such shares and recorded an expense of $89,734.

 

On January 9, 2014, the Company issued 17,700 shares of common stock for consulting services. The Company has estimated the fair value of such shares and recorded an expense of $4,602.

 

On January 26, 2014, the Company signed a subscription agreement with Talya Levy-Tytiun (“Talya”) pursuant to which Talya agreed to invest an aggregate of $400,000 into the Company for the sale of 1,739,130 shares of common stock. The Company was obligated to issue Talya additional shares of the Company, if, six months from the date of the agreement her ownership in the Company would be reduced below 12.3%. In addition, the Company guaranteed that if on the first anniversary of the agreement, the share price of the Company common stock was 0.23$ per share or less, the Company shall transfer Talya such amount necessary to make Talya whole and reimburse her for any loss due to her investment. On September 17, 2014 the Company issued Talya 2,866,194, shares of common stock as a reimbursement under the above agreement.

 

On February 7, 2014, the Company issued an aggregate of 1,200,000 shares of its common stock to CTW – Changing the World Technologies, Ltd. (“CTW”) in exchange for (i) an investment of $77,000 (for which CTW received 385,000 shares of common stock) and (ii) the provision of financial engineering services (for which CTW received 815,000 shares of common stock).

 

F- 25

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – COMMON SHARES (continue)

 

On March 5, 2014 Eastern Institutional Funding, LLC purchased $68,750 of the Company’s 20% notes due one year from such date that are convertible into shares of the Company’s common stock at a discount of 50% from the lowest trade price over the last 20 days from the date of conversion. On March 21, 2014, Capitoline Ventures II, LLC purchased $68,750 of the Company’s 20% notes due one year from such date that are convertible into shares of the Company’s common stock at a discount of 50% from the lowest trade price over the last 20 days from the date of conversion. As of June 30, 2014, the Company issued 5,114,073 shares of common stock in respect of the above notes and the remaining 1,320,000 shares were issued on July 2014.

 

On March 10, 2014 the Board of Directors of the Company approved the issuance of 250,000 shares of the Company to its Chief Executive Officer, 220,000 shares to the Chairman of the Board, 200,000 shares to the Executive Vice-President and 180,000 shares to the Chief Carbon Officer and general counsel of the Company.

 

On April 22, 2014 the Company signed a Consulting Services Agreement with a non-US person pursuant to which, the Company agreed to issue 4,000,000 shares of its common stock in exchange for consulting services to include, but not be limited to, advice on investor relations, public relations, transaction structuring, ongoing introductions to investors and strategic initiatives. The agreement is effective for one year commencing September 1, 2013. During the third quarter of 2014, the Company issued 3,350,000 shares of common stock in the Company. The Company has estimated the fair value of such shares and recorded an expense of $612,700.

 

During the third quarter of 2014, the Company signed several investment agreements according to which the Company issued 880,000 shares of common stock the Company for total consideration of $109,721 in cash. In addition, the investors received options to purchase 822,500 shares of common stock of the Company for an exercise price of 0.10 cent per share.

 

During the third quarter of 2014, the Company signed several investment agreements according to which the Company issued 759,041 shares of common stock the Company for total consideration of $77,127 in cash. In addition, the investors received options to purchase 759,041 shares of common stock of the Company for an exercise price of 0.10 cent per share and 759,041 shares of common stock of the Company for an exercise price of 0.13 cent per share.

 

During the third quarter of 2014, the Company signed several investment agreements according to which the Company issued 352,805 shares of common stock the Company for total consideration of $98,784 in cash. In addition, the investors received options to purchase 352,805 shares of common stock of the Company for an exercise price of 0.60 cent per share.

 

F- 26

 

   

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – COMMON SHARES (continue)

 

On May 1, 2014, the Company signed a consulting agreement with an investor according to which the company shall issue 2,819,000 shares of common stock of the Company and warrants to purchase 1,193,000 shares of common stock of the Company at an exercise price of $0.10 for one year commencing May 1, 2014. On September 22, 2014 the Company issued the consultant, 2,484,000 shares of common stock of the Company under the above agreement. In addition, on September 22, 2014 the Company issued 963,000 shares of common stock the Company to the consultant, for total cash consideration of $52,708. In addition, on May 1, 2014 the Company signed an agreement with the consultant according to which the consultant would provide investor relations services for a period of 12 months. Based on the agreement the Company issued the consultant 300,000 shares of the Company and 1,500,000 options to purchase shares of the Company at an exercise price of 0.10 cent per share. The options expire after 5 years. In addition, the Company agreed to issue 500,000 additional shares upon fulfillment of other conditions set in the agreement. The Company evaluated the fair value of the 300,000 shares and 1,500,000 options issued at $90,000 and $151,434, respectively.

 

On May 2, 2014 the Company signed an agreement with a consultant according to which the consultant would provide investor relations services for a period of 12 months. Based on the agreement the Company issued the consultant 211,084 shares of the Company. The Company evaluated the fair value of the 211,084 shares and recorded an expense of $41,518.

 

On May 25, 2014 the Company signed an agreement with a consultant according to which the consultant would provide investor relations services for a period of 6 months. Based on the agreement the Company issued the consultant 350,000 shares of the Company and 350,000 warrants to purchase shares of the Company at an exercise price of 0.20 cent per share. The options expire after 6 month. In addition, the Company agreed to issue 150,000 additional shares after 6 month from the date of the agreement and additional 150,000 shares for $0.20 per share, and pay the consultant NIS 18,000 per month during the agreement term. The Company evaluated the fair value of the 300,000 shares at $54,600. In addition the company recorded an expense related to the warrants issued of $28,310.

 

On June 1, 2014 the Company signed an investment agreement with a third party according to which the Company issued 179,856 shares of common stock the Company for total consideration of $28,874 in cash. In addition, the investor received options to purchase 179,856 shares of common stock of the Company for an exercise price of 0.25 cent per share.

 

During the third quarter of 2014, the Company signed several investment agreements according to which the Company issued 199,039 shares of common stock the Company for total consideration of $19,904 in cash. In addition, the investors received options to purchase 199,039 shares of common stock of the Company for an exercise price of 0.13 cent per share and 199,039 shares of common stock of the Company for an exercise price of 0.16 cent per share.

 

F- 27

 

  

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – COMMON SHARES (continue)

 

On June 18, 2014 the Company signed an advisory board agreement with an accredited investor according to which the investor will serve on the Company’s advisory board for a period of one year from the date of the agreement unless otherwise extended by the parties. For his services, the advisor is entitled to 150,000 shares of the Company’s common stock of which75,000 vest on the date of the agreement and the remaining amount in three quarterly 25,000 shares, beginning 90 days from the date of the agreement. In addition the advisor is entitled to receive 150,000 warrants of the Company’s common stock. The warrants vest in 4 equal amounts over a period of twelve (12) months, the initial amount vesting on the agreement date. The warrants will allow the director to purchase the common stock of the Company for a period of 3 years from the agreement date. The warrants shall be exercisable in the following amounts: 1/3 at $0.30 a share, 1/3 at $0.40 a share, and 1/3 at $0.50 a share. In the event the advisor ceases to be a member of Board at any time during the vesting period for any reason, then any unvested warrants or unvested shares shall be irrefutably forfeited. On July 10, 2014 the Company issued 75,000 shares on account of such agreement. The Company evaluated the fair value of the shares and warrants and recorded an expense of $52,800.

 

At April and June 2014 the Company signed three agreements with a non-US investor who provided the Company with several loans amounted to $78,400, according to which the investor converted his balance of loans into 800,892 shares of common stock of the Company. In addition, the Company issued the non-US investor invested 380,435 shares of common stock of the Company for total cash consideration of $69,000.

 

On July 3, 2014 the Company issued 1,250,000 shares of common stock the Company to an investor for total cash consideration of $75,000.

 

On July 29, 2014 the Company issued 144,054 shares of common stock the Company to an investor for total cash consideration of $34,522. In addition, the investor received options to purchase 144,054 shares of common stock of the Company for an exercise price of 0.10 cent per share. During April 2015 the investor exercised his option and the Company issued additional 144,054 shares.

 

During April 2015, a non-US investor exercised his warrants to purchase shares of common stock of the Company for total consideration of $48,549.

 

On May 27, 2015 the Company issued consultant 180,000 shares of common stock of the Company in respect of his 2014 consulting agreement with the Company. The Company has estimated the fair value of such shares and recorded an expense of $7,560.

 

During July 2014, the Company issued a non-US investor 190,000 shares of common stock pursuant to a convertible loan agreement dated June 2013.

 

During July and August 2014, the Company issued a non-US investor 3,969,133 shares of common stock of the Company, of which 650,000 were issued pursuant to the April 22, 2014 Consulting Services Agreement signed with the non-US person and the remaining were issued pursuant to the August 21, 2014 consulting agreement. The Company has estimated the fair value of such shares and recorded an expense of $970,573.

 

On July 10, 2014 a loan in the amount of $24 thousand amount was converted into 115,000 shares of the Company. In addition, the Company granted the investor additional 75,000 shares for granting the loan.

 

 

F- 28

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – COMMON SHARES (continue)

 

During July through September, 2014 the Company issued a consultant, 2,177,000 shares of common stock of the Company under his September 10, 2013 and April 22, 2014 consulting agreements. The Company has estimated the fair value of such shares and recorded an expense of $481,810.

 

On September 21, 2014, the Company issued 280,592 shares of common stock of the Company for total cash consideration of $59,000.

 

On September 21, 2014 the Company issued 48,183 shares of common stock the Company for total cash consideration of $11,557. In addition, the investor received options to purchase 48,183 shares of common stock of the Company for an exercise price of 0.32 cent per share.

 

On October 28, 2014 the Company issued 335,000 shares of the Company’s common stock, in connection with the May 1, 2014 service agreement.

 

During October, 2014, Asher converted $42,500 principal amount out of the April 11, 2014 notes for 471,967 shares of the Company’s common stock.

 

On December 8, 2014 the Company issued 209,041 shares of the Company’s common stock to Carter Terry, in connection with the issuance of as detailed in note 4 above.

 

On October 3, 2014 the Company signed a consulting agreement with a non-US citizen according to which the consultant would provide investor relation and public relations services for a period of one year. The Company agreed to grant the consultant 2,000,000 shares of the Company and additional 500,000 options to purchase Company’s shares at an exercise price of $0.001 per shares. Such shares were issued on March 19, 2015. In addition, on the same date the Company issued the consultant 500,000 shares of the Company for the exercised of the options granted. The Company has estimated the fair value of such shares and options, and recorded an expense of $216,828.

 

On January 5, 2015 the Company signed a consulting agreement with Dr. Borenstein Ltd according to which the company issued the consultant 1,000,000 options to purchase 1,000,000 shares of common stock of the Company at an exercise price of $0.001 for one year commencing the date of the agreement. The Consultant exercised such options at May 27, 2015. The Company has estimated the fair value of such options, and recorded an expense of $158,024.

 

On February 28, 2015 and March 19, 2015 the Company issued 6,114,867 shares of the Company the consultant in respect of his September 2014 consulting investor relation and public relations services agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $738,353.

 

On March 12, 2015 the Company issued 109,039 shares of the Company for an investor pursuant to the exercise of his options granted at May 2014. The Company has estimated the fair value of such shares, and recorded an expense of $14,103.

 

In May and June 2015, the Company issued 3,765,000 shares of the Company to a consultant in respect of his investor relations and public relations services pursuant to a consulting agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $150,118.

 

 

F- 29

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – COMMON SHARES (continue)

 

In May 2015, the Company issued 3,250,000 shares of the Company to a consultant in respect of his investor relations and public relations services pursuant to a consulting agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $136,500.

 

On June 15, 2015 the Company issued consultant 1,500,000 shares of common stock of the Company in mutual agreement for termination of his June 2014 consulting agreement. The Company has estimated the fair value of such shares, and recorded an expense of $34,500.

 

From July through September 2015, the Company issued 8,035,000 shares of common stock to a consultant in respect of his investor relations and public relations services consulting agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $198,614.

 

In August 2015, the Company issued 3,474,405 shares of the Company to Maxim Group LLC in respect of its financial advisor and investment banker agreement with the Company. The shares have been valued at $34,397.

 

In August 2015, the Company issued 1,128,237 shares of the Company to a non-U.S. person in respect of its financial advisor and investment banker settlement agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $13,088.

 

On April 13, 2015, the Company entered into a subscription agreement with a non-U.S. person pursuant to which the Company issued 416,667 shares of common stock in exchange for $25,000.

On April 15, 2015, the Company entered into a Subscription Agreement with Dr. Borenstein Ltd. (the “April Borenstein Subscription Agreement”) pursuant to which the Company agreed to sell 1,630,000 shares of common stock of the Company for the aggregate purchase price of $48,000. Such shares have been issued after the balance sheet date.

On June 12, 2015, the Company entered into a Subscription Agreement with Dr. Borenstein Ltd. (the “June Borenstein Subscription Agreement”) pursuant to which the Company agreed to sell 8,484,848 shares of common stock of the Company for the aggregate purchase price of $140,000. Such shares have been issued after the balance sheet date.

On July 1, 2015, the Company entered into a subscription agreement with a non-U.S. person pursuant to which the Company issued 2,000,000 shares of common stock in exchange for $32,000.

On July 6, 2015, the Company entered into a subscription agreement with several non-U.S. entity pursuant to which the Company issued 2,428,571 shares of common stock in exchange for $51,000.

On July 17, 2015, the Company entered into a subscription agreement with several non-U.S. personnel pursuant to which the Company issued 2,318,183 shares of common stock in exchange for $39,394.

From February through August 2015, convertible promissory notes holders representing an aggregate principal amount of $1,480,716 converted their notes into 75,060,414 shares of the Company’s common stock.

F- 30

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – COMMON SHARES (continue)

Share Repurchase Program

 

On June 17, 2015, the Company’s Board of Directors approved a share repurchase program (the “Share Repurchase Program”). Under the Share Repurchase Program, the Company is authorized to repurchase up to $500,000 worth of its common stock, which, based on the value of the Company’s common stock on September 30, 2015, equates to approximately 16,666,667 shares of common stock. However, the total number of shares could differ based on the ultimate price per share paid by the Company. Further, the Company’s shares of common stock may be purchased on the open market or through privately negotiated transactions from time-to-time and in accordance with applicable laws, rules and regulations. The Company is not obligated to make any purchases, including at any specific time or in any particular situation. The program may be limited or terminated at any time without prior notice. As of September 30, 2015, the Company had not repurchased any shares under the Share Repurchase Program. On June 23, 2015, the Company repurchased 144,054 shares from a shareholder for $28,328 as part of a settlement with such shareholder. This repurchase was not pursuant to the Share Repurchase Program.

Reverse stock split

 

On November 26, 2013, the Company amended and restated its Articles of Incorporation to authorize the issuance of 500,000,000 shares of preferred stock, $0.001 par value, in one or more series and with such rights, preferences and privileges as its Board of Directors may determine and to effect a 1 for 113 reverse stock split of the Company’s outstanding common stock. In addition, the Amended and Restated Articles of Incorporation provide, among other things, for indemnification and limitations to the liability of the Company’s officers and directors.

 

As a result of the reverse stock split, which became effective on December 4, 2013, every 113 shares of the Company’s outstanding common stock prior to the effect of that amendment was combined and reclassified into one share of the Company’s common stock, and the number of outstanding shares of the Company’s common stock was reduced from 1,292,103,309 to 11,434,611 shares.

 

All share, stock option and per share information in these consolidated financial statements have been adjusted to reflect the stock split on a retroactive basis.

 

NOTE 7 – STOCK OPTIONS

 

The 2010 share option plan was established on March 3, 2010.

 

On February 24, 2015, the Company’s Board of Directors approved and adopted the Global Share and Options Incentive Enhancement Plan (2014) (the “2014 Plan”), pursuant to which the Company may award shares of its common stock, options to purchase shares of its common stock and other equity-based awards to eligible participants. The 2014 Plan replaced the Company’s Global Share Incentive Plan (2010) (the “2010 Plan”). Subject to the terms and conditions of the 2014 Plan, the Board of Directors has full authority in its discretion, from time to time and at any time, to determine (i) eligible participants in the 2014 Plan, (ii) the number of options or shares to be covered by an award, (iii) the time or times at which an award shall be granted, (iv) the vesting schedule and other terms and conditions of an award, (v) the form(s) of written agreements applicable to an award, and (vi) any other matter which is necessary or desirable for, or incidental to, the administration of the 2014 Plan and the granting of awards thereunder.

 

 

F- 31

 

  

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 7 – STOCK OPTIONS (continue)

 

The 2014 Plan permits the grant of up to 13,100,000 shares of common stock and up to 3,175,000 options to purchase shares of common stock to certain of its managers, directors and key employees. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share.

 

Prior to approving the 2014 Plan, on February 24, 2015, the Board of Directors approved a grant of up to 2,575,000 shares of common stock to certain of its managers, directors and key employees under the 2010 Plan, of which 1,875,000 shares were issued as of September 30, 2015.

 

The following table presents the Company’s stock option activity for employees and directors of the Company for the years ended September 30, 2013 through 2015:

 

   

Number of
Options

 

Weighted Average Exercise Price

Outstanding at September 30, 2012     778,761       0.5763  
Granted     —         —    
Exercised     —         —    
Forfeited or expired     —         —    
Outstanding at September 30, 2013     778,761       0.5763  
Granted     350,000       0.1770  
Exercised     —         —    
Forfeited or expired     —         —    
Outstanding at September 30,2014     1,128,761       0.4530  
Granted     3,175,000       0.1400  
Exercised     —         —    
Forfeited or expired     —         —    
Outstanding at September 30,2015     4,303,761       0.2220  
Number of options exercisable at September 30, 2015     1,847,511       0.3362  
Number of options exercisable at  September 30, 2014     684,071       0.5363  

  

The fair value of the stock options granted in 2013 was estimated using the Black-Scholes option valuation model that used the following assumptions:

 

   

%

Dividend yield     0  
Risk-free interest rate     0.32 %
Expected term (years)     5  
Volatility     390  %

 

The fair value of the options granted above using the Black-Scholes model is $0.565 per option.

 

 

F- 32

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 7 – STOCK OPTIONS (continue)

 

The fair value of the stock options granted in 2014 was estimated using the Black-Scholes option valuation model that used the following assumptions:

 

   

%

Dividend yield     0  
Risk-free interest rate     0.88 %
Expected term (years)     3  
Volatility     123%-157  %

 

The fair value of the options granted above using the Black-Scholes model is between $0.190 to $0.214 per option.

 

The fair value of the stock options granted in 2015 was estimated using the Black-Scholes option valuation model that used the following assumptions:

 

   

%

Dividend yield     0  
Risk-free interest rate     1.47 %
Expected term (years)     5  
Volatility     147 %

 

The fair value of the options granted above using the Black-Scholes model is $0.111 per option.

 

Costs incurred in respect of stock based compensation for employees and directors, for the year ended September 30, 2015, 2014 and 2013 were $231, $1,711 and $203 thousands respectively.

 

The following table summarizes information about options and warrants to employees, officers and directors outstanding at September 30, 2015 under the plans:

 

    Options and Warrants Outstanding     Vested and Exercisable

 

Exercise Price

 

Number of Option

 

Weighted Average Remaining Contractual Life (Years)

 

Number of Option

 

weighted Average Exercise Price

  0.01       200,000       1.65       125,000       0.01  
  0.14       3,175,000       4.41       793,750       0.14  
  0.3       50,000       1.72       50,000       0.30  
  0.4       50,000       1.72       50,000       0.40  
  0.5       50,000       1.72       50,000       0.50  
  0.5763       778,761       2.58       778,761       0.5763  
          4,303,761       3.78       1,847,511       0.3362  

 

As of September 30, 2015 the aggregated intrinsic value for the options vested and exercisable was $2.5 thousands with a weighted average remaining contractual life of 1.65 years.

 

The unrecognized compensation expense calculated under the fair value method for the stock options expected to vest as of September 30, 2015 is $249,962 and is expected to be recognized over a weighted average period of 1.5 years.

 

The weighted average grant date fair value of the options granted in 2015, 2014 and 2013 was $0.111, $0.192, $0.565 respectively.

 

F- 33

 

  

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 8 – INCOME TAXES

 

US resident companies are taxed on their worldwide income for corporate income tax purposes at a statutory rate of 35%. No further taxes are payable on this profit unless that profit is distributed. If certain conditions are met, income derived from foreign subsidiaries is tax exempt in the US under applicable tax treaties to avoid double taxation.

 

Taxable income of Israeli companies is subject to tax at the rate of 25% in 2013, 26.5% in the year 2014 and 25% in the year 2015 and onwards.

 

The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are adjusted by a valuation allowance, if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

Deferred income taxes reflect the net effects of temporary differences between the amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The breakdown of the deferred tax asset as of September 30 2015, 2014 and 2013 is as follows:

 

   

2015

 

2014

 

2013

   

U.S. dollars in thousands

      Deferred tax assets:                        
      Net operating loss carry-forward   $ 6,331     $ 3,267     $ 2,502  
   Valuation allowance     (6,331 )     (3,267 )     (2,502 )
    $ 0     $ 0     $ 0  

 

 

A valuation allowance is provided when it is more likely than not that some portion of the deferred tax asset will not be realized. Management has determined, based on its recurring net losses, lack of a commercially viable product and limitations under current tax rules, that a full valuation allowance is appropriate.

 

   

U.S. dollars

in thousands

  Valuation allowance, September 30, 2014     $ 3,267  
  Increase       3,064  
  Valuation allowance, September 30, 2015     $ 6,331  

 

Carry forward losses of the Company are approximately $14,130 thousand at September 30, 2015 and available throughout 2035.

 

Carry forward losses of the Israeli subsidiary are approximately $3,138 thousand at September 30, 2015 and have no expiration date.

 

F- 34

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 8 – INCOME TAXES (continue)

 

Reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company and the actual tax expense as reported in the Statement of Operations, is as follows:

 

    Year ended December 31,
    2015   2014   2013
Loss before taxes, as reported in the                        
    consolidated statements of operations   $ 7,462     $ 7,376     $ 1,970  
                         
Federal statutory rate     35 %     35 %     35 %
                         
Theoretical tax benefit on the above                        
    amount at federal statutory tax rate     2,612       2,582       690  
                         
Losses and other items for which a valuation allowance                        
    Was provided or benefit from loss carry forward     (2,612 )     (2,582 )     (690 )
                         
Actual tax expense     —         —         —    

 

NOTE 9 – NET LOSS PER SHARE DATA

 

The shares issuable upon the exercise of options, and conversion of convertible notes and warrants, which have been excluded from the diluted per share amounts because their effect would have been anti-dilutive, include the following:

 

   

September 30, 2015

 

September 30, 2014

 

September 30, 2013

  Options:                          
  weighted average number       1,847,511       684,071       194,690  
  weighted average exercise price     $ 0.3362     $ 0.5363     $ 0.5763  

 

NOTE 10 – OTHER LOSS (INCOMES)

 

On January 31, 2012, the Company lent an Israeli company, CTG Clean Technology Group Limited (the “Borrower”), U.S. $30,000 at an annual rate of interest of eight percent (8%). The purpose of this loan was to provide the borrower capital to continue its operations while the Company considered acquiring such company. On February 8, 2012, the Company received the cash to make such loan to the borrower from a Cyprus company (JLS Investment Holding). As of December 30, 2012 such loan had been written-off in whole. In May 2015, CTG had repaid the loan in full and the company recorded incomes in the amount of $38 thousands.

 

F- 35

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 11 – SUBSEQUENT EVENTS

 

On October 21, 2015 the Company issued 1,630,000 and 8,484,848 shares of common stock of the Company in respect of the April Borenstein Subscription Agreement and June Borenstein Subscription Agreement, respectively.

Italy Projects

 

In September 2014, the Company entered into a letter of intent to acquire Kinexia S.p.A.’s right, interest and title in, to and under four biogas projects in the Vigevano area in Italy. The letter of intent also provides for the purchase of three additional biogas projects in the Emillia-Romagna and Lazio regions upon the same principals set forth in the letter of intent and subject to definitive agreements.

 

After balance sheet date, on December 14, 2015, and pursuant to a Share Purchase Agreement, dated May 14, 2015 ( the “Share Purchase Agreement”), by and among the Company’s indirect wholly-owned subsidiary, Bluesphere Pavia (formerly called Bluesphere Italy S.r.l.) (“Bluesphere Pavia”), and Volteo Energie S.p.A., Agriholding S.r.l., and Overland S.r.l. (collectively, the “Sellers”), Bluesphere Pavia completed the acquisitions of one hundred percent (100%) of the share capital of Agricerere S.r.l., Agrielektra S.r.l., Agrisorse S.r.l. and Gefa S.r.l . (each, an “SPV” and collectively, the “SPVs”) from the Sellers. Each SPV owns and operates an anaerobic digestion biogas plant in Italy for the production and sale of electricity to Gestore del Servizi Energetici GSE, S.p.A., a state-owned company, pursuant to a power purchase agreement. Pursuant to the Italy Projects Agreement, the Company also issued a corporate guarantee to the Sellers, whereby the Company will secure the obligations of Bluesphere Pavia under the Italy Projects Agreement.

 

Pursuant to the Share Purchase Agreement, the Company paid an aggregate purchase price of $5,837,308 (€5,200,000) (the “Purchase Price”), subject to certain post-closing adjustments, to acquire the share capital of the SPVs. Fifty percent (50%) of the Purchase Price, adjusted for certain closing costs, was paid at closing, and the balance is due to the Sellers on the third anniversary of the closing date. The portion of the Purchase Price paid at closing was primarily financed by a loan of $3,255,422 (€2,900,000) pursuant to a Long Term Mezzanine Loan Agreement, dated August 18, 2015 (the “Loan Agreement”), by and among the Company, its wholly-owned subsidiary, Eastern Sphere Ltd. (“Eastern Sphere”), Eastern Sphere’s wholly-owned subsidiary, Bluesphere Italy, and Helios Italy Bio-Gas 1 L.P.

 

On August 18, 2015, the Company and two of its wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern Sphere”) and BlueSphere Italy, entered into a Long Term Mezzanine Loan Agreement (the “Helios Loan Agreement”) with Helios Italy Bio-Gas 1 L.P. (“Helios”). Under the Helios Loan Agreement, Helios will make up to $5,612,796 (€5,000,000) available to Bluesphere Pavia (the “Helios Loan”) to finance (a) ninety percent (90%) of the total required investment of the first four SVPs acquired, (b) eighty percent (80%) of the total required investment of up to three SVPs subsequently acquired, (c) certain broker fees incurred in connection with the acquisitions, and (d) any taxes associated with registration of an equity pledge agreement (as described below). Each financing of an SVP acquisition will be subject to specified conditions precedent and will constitute a separate loan under the Helios Loan Agreement. Helios may, within 90 days of a closing, require repayment of ten percent (10%) of the relevant loan and broker fees. If no such repayment is required, Helios may reduce the amount of its commitment to finance the acquisitions of the three additional SVPs to seventy to eighty percent (70-80%) of the total required investment. Helios’s commitment to provide any loan under the Helios Loan Agreement that is not utilized by June 30, 2016 will automatically cancel, unless extended in writing by Helios.

 

F- 36

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 11 – SUBSEQUENT EVENTS (continue)

 

Subject to specified terms, representations and warranties, the Helios Loan Agreement provides that each loan thereunder will accrue interest at a rate of 14.5% per annum, paid quarterly. Helios will also be entitled to an annual operation fee, paid quarterly. The final payment for each loan will become due no later than the earlier of (a) thirteen and one half years from the date such loan was made available to Bluesphere Italy, and (b) the date that the Feed in Tariff license granted to the relevant SVP expires. Pursuant to the Helios Loan Agreement and an equity pledge agreement, Eastern Sphere pledged all its shares in Bluesphere Pavia to secure all loan amounts utilized under the Helios Loan Agreement.

 

The Company also entered into a no-interest bearing promissory note, dated December 8, 2015 (the “Palas Promissory Note”), with R.S. Palas Management Ltd. to finance a small portion of the Purchase Price. The Palas Promissory Note is for an amount of $132,462 (€118,000) and is due and payable, without interest or premium, on December 31, 2015. The payee under the Palas Promissory Note, R.S. Palas Management Ltd., is an entity owned and controlled by Shlomi Palas, the Company’s President and Chief Executive Officer and a member of its Board of Directors.

 

In accordance with a Framework EBITDA Guarantee Agreement, dated July 17, 2015 (the “EBITDA Agreement”), between the Company and Austep S.p.A. (“Austep”), Austep will operate, maintain and supervise each biogas plant owned by the SPVs. In addition, Austep will guarantee a monthly aggregate EBITDA of $211,041 (€188,000) from the four SPVs for the initial six months following the acquisition, and thereafter Austep will guarantee an annual aggregate EBITDA of $4,220,823 (€3,760,000) from the four SPVs. Pursuant to the terms of the agreements with Austep, the Company will receive the guaranteed levels of EBITDA and Austep will receive any revenue in excess of these levels.

 

Senior Debentures offering

 

Beginning in November 2015, the Company conducted an offering (the “Offering”) of up to $3,000,000 of the Company's Senior Debentures (the “Debentures”) and Warrants (the “Warrants”, together with the “Debentures”, the “Securities”) to purchase up to 8,000,000 shares of common stock of the Company, par value $0.001 per share, in proportion pro rata to each Subscriber’s subscription amount relative to the total Offering amount, with 50% of the shares exercisable at a price per share of $0.05 and the other 50% of the shares exercisable at price per share of $0.075.

 

The Debentures will bear interest at 11%, paid quarterly, and will mature in two years. The Debentures are secured by a pledge agreement between the Company and each investor, whereby the Company pledged as collateral up to 49% of its shares of common stock in Eastern Sphere, Ltd., our wholly-owned subsidiary (the “Pledge Agreement”). The Pledge Agreement further provides that the Company's obligations under the Debentures rank senior to all other indebtedness of Blue Sphere Corporation, but are subordinate to all indebtedness and liabilities of its subsidiaries and project-level operating entities. The Warrants are exercisable for 5 years from the date of issuance, with 50% exercisable at $0.05 per share and 50% exercisable at $0.075 per share

 

The Securities are being offered pursuant to subscription agreements with each investor (the “Subscription Agreement”). Pursuant to the Subscription Agreements, the investors in the Offering shall have the right to collectively designate one observer or member to the Company’s Board of Directors.

 

 

F- 37

 

 

BLUE SPHERE CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 11 – SUBSEQUENT EVENTS (continue)

 

On December 23, 2015, the Company completed the only closing of the Offering and entered into Subscription Agreements with investors representing aggregate gross proceeds to the Company of $3,000,000.

 

The Company engaged Maxim Group LLC (“Maxim”) to assist in the Offering. Pursuant to the terms of an engagement letter between Maxim and the Company, Maxim received commissions equal to 7% of the gross proceeds raised by Maxim in the Offering, as well as common stock purchase warrants for a number of securities equal to 8% of the total amount of securities sold in the Offering, at a price per share equal to 110% of the price of the securities paid by investors in the Offering.

 

 

F- 38

 

Blue Sphere Corporation 10-K

Exhibit 10.13

SERVICE AGREEMENT

THIS SERVICE AGREEMENT (“ Agreement ”) is made and entered into as of the 15th, day of October 2015 by and between Blue Sphere Corp, a Nevada corporation (hereinafter called the “ Company ”), and Shlomo Palas (hereinafter called the “ Executive ”).

RECITALS

WHEREAS , the Company is in the business of Build Own and Operate Anaerobic Digester facilities generating electricity; and

WHEREAS , the Company acknowledges that the Executive has been serving as the Company’s Chief Executive Officer since February 2010, and has been compensated only partially for the services he has provided prior to the date of this Agreement; and

WHEREAS , the Company desires to maintain the service of the Executive as the Chief Executive Officer of the Company, and the Executive is willing to continue such service; and

WHEREAS , as a condition precedent to and as an incentive to the Company to maintain the services of the Executive as the Chief Executive Officer of the Company, the Company and the Executive desire to record the arrangements for such services, in the manner provided for herein and upon the terms and conditions set forth herein.

AGREEMENT

NOW, THEREFORE , in consideration of the promises and mutual covenants herein contained, and other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the parties agree as follows:

1. Term and Services:

1.1 Term. The Company hereby agrees to engage Executive and the Executive hereby agrees to serve the Company, on the terms and conditions set forth herein, for the period commencing on the date hereof and expiring on October 15, 2020 (the “ Initial Term ”) unless sooner terminated as hereinafter set forth. This Agreement shall be extended for an additional five (5) year term (the “ Renewal Term, ” and collectively with the Initial Term, the “ Term ”) upon prior written mutual agreement between the Company and the Executive of at least ninety (90) days prior to the expiration of the Initial Term.

1.2 Services of Executive. The Executive shall serve as the Chief Executive Officer of the Company. The Executive will be responsible for setting the overall corporate direction for the Company, including establishing and maintaining budgets for the Company and ensuring that the Company has adequate capital for its operations, marketing and general corporate activities, all subject to any applicable law and to instructions provided by the Board of Directors of the Company from time to time. The Executive will plan and direct the organization’s activities to achieve stated/agreed targets and standards for financial and trading performance, quality, culture and legislative adherence. He will recruit, select and develop executive team members and direct functions and performance via the executive team. The Executive will play a leading role in fundraising activities The Executive shall have powers and authority superior to any other officer or employee of the Company or of any subsidiary of the Company, including, without limitation, the duties and responsibilities customarily associated with a chief executive (e.g., control of day-to-day operations, signing checks, hiring and firing, etc.). The Executive shall be required to report solely to, and shall be subject solely to the supervision and direction of the Board of Directors and no other person or group shall be given authority to supervise or direct Executive in the performance of his duties. The Executive shall render such services as provided in this Section 1.2 to the best of his ability, and use his reasonable best efforts to promote the interests of the Company. The Executive is permitted to pursue other business activities so long as the same do not conflict or compete with the business of the Company or the Executive’s ability to provide the services as provided in this Section 1.2 to the Company and so long as such activities do not significantly interfere with the performance of the Executive’s responsibilities as a service provider to the Company in accordance with this Agreement. The Executive’s obligations hereunder shall run only to the Company and its subsidiaries, and not to the Company’s other affiliates, if any.

 
 

2. Compensation.

2.1(a) Base Compensation . Commencing on the effective date of this Agreement, the Executive shall receive an annual base compensation (the “ Base Compensation ”) of $204,000 but not less than 816,000 New Israeli Shekels during the first year of the Initial Term, with an annual increase review per year thereafter during the Term of this Agreement. Such Base Compensation review shall be on or about January 1st of a given contract year. The Base Compensation shall be payable in 12 equal installments consistent with the Company’s normal payroll schedule, subject to applicable withholding and other taxes, and shall not be decreased for any reason. The Base Compensation will be paid, at Executive discretion in NIS translated pursuant to the official representative rate of exchange of the US$ as published by the Bank of Israel on the payment date. Should VAT be imposed on Base Compensation, Such VAT will be added to the Base Compensation and paid by the Company. Any deductions required to be made by the Company and submitted to relevant tax or other authorities will be deducted at source. Payments may be made through an Israeli Subsidiary.

2.1(b) Taxes . The Executive shall be solely responsible for, and will make proper and timely payment of, any and all withholding, taxes, duties, fees and/or other impositions that may be levied pursuant to applicable law upon the Executive in connection with the provision of the services provided in this Agreement. In the event that pursuant to any law or regulation, tax is required to be withheld at source from any payment made to the Executive, the Company shall withhold said tax at the rate set forth in the certification issued by the appropriate taxing authority or at the rate determined by said law or regulation.

2.2 Incentive Compensation. The Executive shall be entitled to receive such bonus payments or incentive compensation as may be determined at any time or from time to time by the Board of Directors of the Company (or any authorized committee thereof) in its discretion. Such potential bonus payments and/or incentive compensation shall be considered at least annually by the Board or committee and shall relate to the following:

2
 

1. A share price incentive bonus associated with the share price of the Company’s Common Stock, as reported, quoted or traded, as the case may, as more fully described on Annex 1 to this Agreement.

2. A cash incentive bonus for each project the Company achieves a full financial close. Full financial close is defined as follows.

(a) For acquisition of projects. When the Company buys the project assets and gets the project shares.

(b) For a new project, when the Company has a definitive signed agreement for the full funding required for the project and starts execution of the project.

(c) Cash incentive bonus amount will be decided from case to case by the Company’s Board of Directors. The bonus amount shall not exceed 3% of the project total value.

3. Any shares issued to Executive pursuant to this Section 2.2 shall be valued at $ 0.001 per share of Common Stock and shall be deemed restricted stock of the Company unless and until a registration statement covering the shares is declared effective or the Executive is able to rely on Rule 144 for any resales.

2.3 Shares and Stock Options.

(a) The Executive shall be entitled to participate in all shares and stock option plans of the Company (the “ Plans ”) in effect during the Term of this Agreement.

(b) Upon execution of this Agreement, the Company will issue Executive stock options, pursuant to a stock option agreement to be entered into between the Company and the Executive (the “ Options ”), to purchase at the end of each anniversary of this Agreement 950,000 shares of the Company’s common stock, $0.001 par value per share (“ Common Stock ”) at an exercise price of 1, (one) US cent.

(c) Milestone Bonus Options . The Executive shall also be entitled to receive shares and options for special events as may be determined by the Board of Directors, from time to time.

(d) All Options issued to the Executive in accordance with this Agreement shall become immediately exercisable as to 100% of the shares of Common Stock not otherwise vested upon any termination of Executive’s Service Agreement pursuant to Sections 3.8 or 3.9 or 3.10 or 3.11 hereof, it being agreed that the Company shall vest the unvested portion of the Executive’s Option shares and cooperate in good faith to afford the Executive the right to accelerate the exercise of the Options in full immediately prior to any Change in Control (as hereinafter defined). In the event that Executive terminates or is terminated pursuant to Sections 3.7 or 3.8 or 3.9 or 3.10 or 3.11 hereof, Executive shall have the greater of (i) Five years after termination, or (ii) the remaining term of the Options, in order to exercise his Options.

3
 

(e) The Company shall take all action reasonably requested by the Executive to permit any “cashless” exercise of the Options that is permitted under Agreement.

(f) Upon proper exercise of an Option, the Executive shall be deemed for all purposes the owner of the shares of Common Stock that are purchasable upon such exercise.

(g) The provisions of the Plan and/or Agreement shall not be adversely modified as to the Executive without the Executive’s prior written consent.

(h) All Option and shares under Agreement shall be fully adjusted for events such as splits.

(i) All shares under Executive possession at a specific point in time will not exceed 10% of the Company then allocated shares.

2.4 Compensation for Past Services. As compensation for the services provided by the Executive to the Company from 2010 through the date of this Agreement, the Executive shall be entitled to receive either in cash or shares the compensation due to him based on the Company CFO reporting to the Board of Directors of the Company.

3. Expense Reimbursement and Other Benefits.

3.1 Expense Reimbursement. During the Term of Executive’s Agreement hereunder, the Company, upon the submission of reasonable supporting documentation by the Executive, shall reimburse the Executive for all reasonable expenses actually paid or incurred by the Executive in the course of and pursuant to the business of the Company, including expenses for travel, lodging and entertainment. The Company may elect to provide Executive with a debit card or credit card in order to facilitate such expenses.

3.2 Incentive, Savings and Retirement Plans. During the Term of this Agreement, the Executive shall participate in any savings and retirement plans, practices, policies and programs established, or to be established and executed by the Company or the Executive may substitute the above with a yearly lump sum representing 10% of the Executive Yearly Base Compensation payable to Executive monthly or quarterly.

3.3 Welfare Benefit Plans. During the Term of Executive’s Agreement, the Executive and/or the Executive’s family, as the case may be, shall be eligible for participation in and shall receive all benefits under welfare benefit plans, practices, policies and programs provided by the Company and its subsidiaries (including, without limitation, medical, prescription, dental, disability, remuneration continuance, employee life, group life, accidental death and travel accident insurance plans and programs), at least as favorable as the most favorable of such plans, practices, policies and programs. The Executive may substitute the above with a yearly lump sum representing 8% of Executive Base Compensation to be paid in advance quarterly.

3.4 Vacation. During the Term of Executive’s Agreement, the Executive shall be entitled to be paid vacation in accordance with the most favorable plans, policies, programs and practices of the Company and its subsidiaries as in effect at any time hereafter with respect to other key executives of the Company and its subsidiaries; provided, however, that in no event shall Executive be entitled to fewer than 30 business days paid vacation per year, as well as pay for all holidays observed by the Company.

4
 

3.5 Directors and Officers Insurance. The Company will insure the Executive (including his heirs, executors and administrators) with coverage under an appropriate directors’ and officers’ liability insurance policy at the Company’s expense with a run-off period of seven (7) years following termination of this Agreement and will provide the Executive with a customary officer indemnification agreement.

3.6 Car. The Company will provide Executive with the use of a car in the 7th category of the Israeli Income Authority (similar to Passat-cc, Chrysler 300c). The Company shall compensate Executive monthly to the extent that the use of the car results in imputation of income to the Executive under the income tax laws of Israel. All car expenses shall be borne by the company. Executive, at his sole discretion may elect to use his personal car and be compensated in cash by the Company. The compensation amount will be based on section 3.6 subject to the Company discretion.

4. Termination.

4.1 Termination for Cause. Notwithstanding anything contained to the contrary in this Agreement, this Agreement may be terminated by the Company for Cause. As used in this Agreement, “ Cause ” shall only mean:

(a) an act or acts of personal dishonesty taken by the Executive and intended to result in substantial personal enrichment of the Executive at the expense of the Company;

(b) subject to the following sentences, repeated violation by the Executive of the Executive’s material obligations under this Agreement which are demonstrably willful, persistent and deliberate on the Executive’s part and which are not remedied in a reasonable period of time after receipt of written notice from the Company’s Board of Directors; or

(c) the conviction of the Executive for any crime involving dishonesty, or fraud and moral turpitude.

Upon any reasonable and good faith determination by the Company’s Board of Directors that Cause exists under clause (a) of the preceding sentence and clause (b) of the preceding sentence (to the extent the violation under said clause (b) has not been cured by the Executive), the Company shall cause a special meeting of the Board to be called and held at a time mutually convenient to the Board and Executive, but in no event later than ten (10) business days after Executive’s receipt of the notice contemplated by clauses (a) and (b). Executive shall have the right to appear before such special meeting of the Board with legal counsel of his choosing to refute any determination of Cause specified in such notice, and any termination of Executive’s service by reason of such Cause determination shall not be effective until Executive is afforded such opportunity to appear. Any termination for Cause pursuant to clause (a) or (b) of the first sentence of this Section 3.7 shall be made in writing to Executive, which notice shall set forth in detail all acts or omissions upon which the Company is relying for such termination. Upon any termination pursuant to this Section 3.7, the Executive shall be entitled to be paid six months of his Base Compensation from the date of the termination or the remaining unexpired term, of this Agreement, whichever shall be shorter. The Executive shall be entitled to enjoy all benefits given under this Service Agreement, including but without limiting the generality thereof, those referred to in clauses 2 and 3 and sub-clauses thereof. Thereafter the Company shall have no further liability hereunder (other than for reimbursement for reasonable business expenses incurred prior to the date of termination).

5
 

4.2 Disability. Notwithstanding anything contained in this Agreement to the contrary, the Company, by written notice to the Executive, shall at all times have the right to terminate this Agreement, and the Executive’s service hereunder, if the Executive shall, as the result of mental or physical incapacity, illness or disability, fail to perform his duties and responsibilities provided for herein for a period of more than two hundred (200) consecutive days in any 12-month period. Upon any termination pursuant to this Section 3.8, the Executive shall be entitled to be paid his Base Compensation and benefits for the remaining term of the Agreement. In the event that the Agreement has less than twelve months remaining at such time, Executive shall be entitled to a payment equal to twelve months of his Base Compensation and benefits. In addition, Executive shall be entitled to reimbursement for all business expenses incurred prior to his disability.

4.3 Death. In the event of the death of the Executive during the Term of this Agreement hereunder, the Company shall pay to the estate of the deceased Executive the compensation, bonuses and benefits as detailed in section 3.11 “Termination without Cause” below.

4.4 Optional Termination. Notwithstanding anything contained in this Agreement to the contrary, the Executive, by giving thirty (30) days prior written notice to the Company, shall one year after the date of this Agreement, have the right to terminate this Agreement at his sole discretion. Upon any termination pursuant to this Section 3.10, the Executive shall be entitled to be paid his Base Compensation and the benefits referred to hereinbefore for a period of 12 months from the date of termination and the immediate vesting of Options as described in Section 2.3(d),and the Company shall have no further liability hereunder thereafter (other than for reimbursement for reasonable business expenses incurred prior to the date of termination) unless the Executive and the Company agree to a different arrangement.

4.5 Termination without Cause. At any time, the Company shall have the right to terminate Executive’s employment hereunder by written notice to Executive; provided, however, that the Company shall:

(a) pay to Executive any all unpaid Base Compensation and allow the Executive to enjoy all the benefits given hereunder, for the remaining period of this Service Agreement, and will further allow to receive all bonuses, incentives, option and shares under Plan and this Agreement that would be payable had Executive completed an additional full two years of service under this Agreement;

6
 

(b) pay to the Executive in a lump sum, in cash within 30 days after the date of termination, an amount equal to the greater of (i) 100% of his annual Base Compensation then in effect, or (ii) the balance of the Executive’s Base Compensation from the effective date of termination through the expiration of the Initial Term or Renewal Term then in effect; and

(c) continue to pay the Executive’s health and disability insurance for the longer of a period of twenty-four (24) months or the remaining term of this Agreement.

(d) The Company shall be deemed to have terminated the Executive’s Agreement pursuant to this Section 3.11 if such service is terminated by the Company without Cause, by the Executive voluntarily for Good Reason, or as a result of a Charge in Control.

(i) For purposes of this Agreement, “ Good Reason ” means:
1) the assignment to the Executive of any duties inconsistent in any respect with the Executive’s position (including status, offices, titles and reporting requirements), authority, duties or responsibilities as contemplated by Section 1.2 of this Agreement, or any other action by the Company which results in a diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Executive;
2) any failure by the Company to comply with any of the provisions of Section 2 or Section 3 of this Agreement, other than an isolated, insubstantial and inadvertent failure not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Executive;
3) the Company’s requiring the Executive to be based at any office or location more than fifty (50) miles from its current executive offices, except for travel reasonably required in the performance of the Executive’s responsibilities;
4) any change in the designation of the particular executive that the Executive is obligated to report to under Section 1.2 hereof;
5) any purported termination by the Company of the Executive’s Service otherwise than as expressly permitted by this Agreement; or
6) any termination by the Executive for any reason during the twelve-month period following the effective date of any Change in Control.

7
 

 

(ii) For purposes of this Agreement, a “ Change in Control ” shall mean:
1) The acquisition (other than by or from the Company), at any time after the date hereof, by any person, entity or “group,” within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 50% or more of either the then outstanding shares of common stock or the combined voting power of the Company’s then outstanding voting securities entitled to vote generally in the election of directors;
2) All or any of the five (5) individuals who, as of the date hereof, constitute the Board (as of the date hereof the “ Incumbent Board ”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (other than an election or nomination of an individual whose initial assumption of office is in connection with an actual or threatened election contest relating to the election of the directors of the Company, as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) shall be, for purposes of this Agreement, considered as though such person were a member of the Incumbent Board;
3) Approval by the shareholders of the Company of (A) a reorganization, merger or consolidation with respect to which persons who were the shareholders of the Company immediately prior to such reorganization, merger or consolidation do not, immediately thereafter, own more than 75% of the combined voting power entitled to vote generally in the election of directors of the reorganized, merged or consolidated company’s then outstanding voting securities, (B) a liquidation or dissolution of the Company, or (C) the sale of all or substantially all of the assets of the Company, unless the approved reorganization, merger, consolidation, liquidation, dissolution or sale is subsequently abandoned.

8
 

 

4) The approval by the Board of the sale, distribution and/or other transfer or action (and/or series of sales, distributions and/or other transfers or actions from time to time or over a period of time), that results in the Company’s ownership of less than 50% of the Company’s current assets.

5. Restrictive Covenants.

5.1(a) Nondisclosure . During his Service and for twelve (12) months thereafter, Executive shall not divulge, communicate, use to the detriment of the Company or for the benefit of any other person or persons, or misuse in any way, any Confidential Information (as hereinafter defined) pertaining to the business of the Company, unless required to do so by a governmental agency or court of law. Any Confidential Information or data now or hereafter acquired by the Executive with respect to the business of the Company shall be deemed a valuable, special and unique asset of the Company that is received by the Executive in confidence and as a fiduciary, and Executive shall remain a fiduciary to the Company with respect to all of such information. For purposes of this Agreement, “ Confidential Information ” means all material information about the Company’s business disclosed to the Executive or known by the Executive as a consequence of or through his service to the Company (including information conceived, originated, discovered or developed by the Executive) after the date hereof, and not generally known.

5.1(b) Exceptions . The general prohibition contained in Section 5.1(a) against the unauthorized disclosure, use or dissemination of the Company’s Confidential Information will not apply in respect of any Company Confidential Information that:

(i) is available to the public generally;
(ii) becomes part of the public domain through no fault of the Executive;
(iii) is already in the lawful possession of the Executive at the time of receipt of the Company’s Confidential Information; or
(iv) is compelled by applicable law to be disclosed, provided that the Executive gives the Company prompt written notice of such requirement prior to such disclosure and provides assistance at the request at the expense of the Company, in obtaining an order protecting the Company’s Confidential Information from public disclosure.

9
 

5.2 No solicitation of Employees. While employed by the Company and for a period of twelve (12) months thereafter, Executive shall not directly or indirectly, for himself or for any other person, firm, corporation, partnership, association or other entity, attempt to employ or enter into any contractual arrangement with any employee or former employee of the Company, unless such employee or former employee has not been employed by the Company for a period in excess of six months. Notwithstanding the foregoing, the Executive shall not be restricted in hiring any person who responds to any general solicitation for employees or public advertising of employment opportunities (including through the use of employment agencies) not specifically directed at any such person.

5.3 Covenant Not to Compete. Executive will not, at any time, during the Term of this Agreement, and for a period of twelve (12) months thereafter, either directly or indirectly, engage in, with or for any enterprise, institution, whether or not for profit, business, or company, competitive with the business (as identified herein) of the Company as such business may be conducted on the date thereof, as a creditor, guarantor, or financial backer, stockholder, director, officer, consultant, advisor, employee, member, or otherwise of or through any corporation, partnership, association, sole proprietorship or other entity; provided, that an investment by Executive, his spouse or his children is permitted if such investment is not more than four percent (4%) of the total debt or equity capital of any such competitive enterprise or business. As used in this Agreement, the business of Employer shall be deemed to include any business which directly competes with the Company in the Build Own and Operate Anaerobic Digester electricity production industry. The covenant not to compete for twelve (12) months after termination shall only be effective if the Executive has received all compensation due to him pursuant to this Agreement. The Company shall have the right in its sole discretion to waive this non-compete provision.

5.4 Injunction. It is recognized and hereby acknowledged by the parties hereto that a breach by the Executive of any of the covenants contained in Sections 4.1, 4.2 or 4.3 of this Agreement will cause irreparable harm and damage to the Company, the monetary amount of which may be virtually impossible to ascertain. As a result, the Executive recognizes and hereby acknowledges that the Company shall be entitled to an injunction from any court of competent jurisdiction enjoining and restraining any violation of any or all of the covenants contained in this Section 4 by the Executive or any of his affiliates, associates, partners or agents, either directly or indirectly, and that such right to injunction shall be cumulative and in addition to whatever other remedies the Company may possess.

6. Re-negotiate. This contract may be re-negotiated by the Executive should the circumstances and the economic situation of the company shows improvement beyond the Company’s forecast.

7. Entire Agreement. This instrument contains the entire agreement of the parties, and supersedes any prior or contemporaneous statements or understandings by or between the parties. This Agreement may be changed only by an agreement in writing signed by the party against whom enforcement of any waiver, change, modification, extension or discharge is sought, and any such modification on behalf of the Company must be approved by the Board.

10
 

8. Governing Law/Jurisdiction. This Agreement shall be governed by the laws of Israel. The competent courts of the city of Tel Aviv, shall have exclusive jurisdiction over any matter in connection with this Agreement.

9. Notices. Any notice required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given (a) when delivered by hand, (b) when deposited by registered or certified mail, return receipt requested, postage prepaid, or via overnight courier, (c) one day after electronically mailed either in the text of an email message or attached in a commonly readable format, and the sender has received no generated notice that the email message has not been successfully delivered, or (d) upon receipt of proof of sending thereof when sent by facsimile, addressed as follows:

If to the Company:

 

       with a copy to: Thompson Hine LLP

335 Madison Avenue, 12th Floor

New York, NY 10017

Attention: Peter J. Gennuso, Esq.

Fax: 212-344-6101

Email: peter.gennuso@thompsonhine.com

 

               If to the Executive: Shlomo Palas

17 Etrog St.

Rosh HaAvin

ISRAEL

 

or to such other addresses as either party hereto may from time to time give notice of to the other in the aforesaid manner.

10. Successors.

(a) This Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Executive’s legal representatives.

(b) This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.

(c) The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets which assumes and agrees to perform this Agreement by operation of law or otherwise.

11
 

11. Severability. The invalidity of any one or more of the words, phrases, sentences, clauses or sections contained in this Agreement shall not affect the enforceability of the remaining portions of this Agreement or any part thereof, all of which are inserted conditionally on their being valid in law, and, in the event that any one or more of the words, phrases, sentences, clauses or sections contained in this Agreement shall be declared invalid, this Agreement shall be construed as if such invalid word or words, phrase or phrases, sentence or sentences, clause or clauses, or section or sections had not been inserted. If such invalidity is caused by length of time or size of area, or both, the otherwise invalid provision will be considered to be reduced to a period or area which would cure such invalidity.

12. Waivers. The waiver by either party hereto of a breach or violation of any term or provision of this Agreement shall not operate nor be construed as a waiver of any subsequent breach or violation.

13. Damages. Nothing contained herein shall be construed to prevent the Company or the Executive from seeking and recovering from the other damages sustained by either or both of them as a result of its or his breach of any term or provision of this Agreement.

14. No Third Party Beneficiary. Nothing expressed or implied in this Agreement is intended, or shall be construed, to confer upon or give any person (other than the parties hereto and, in the case of Executive, his heirs, personal representative(s) and/or legal representative) any rights or remedies under or by reason of this Agreement.

15. Full Settlement. The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Executive or others. In no event shall the Executive be obligated to seek other service or employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement. The Company agrees to pay, to the full extent permitted by law, all legal fees and expenses which the Executive may reasonably incur as a result of any contest (regardless of the outcome thereof) by the Company or others of the validity or enforceability of, or liability under, any provision of this Agreement or any guarantee of performance thereof, plus in each case interest at the applicable Federal rate provided for in Section 7872(f)(2) of the Internal Revenue Code of 1986, as amended.

16. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

17. Executive’s Recognition of Agreement. Executive acknowledges that Executive has read and understood this Agreement, and agrees that its terms are necessary for the reasonable and proper protection of the Company’s business. Executive acknowledges that Executive has been advised by the Company that Executive is entitled to have this Agreement reviewed by an attorney of Executive’s selection, at Executive’s expense, prior to signing, and that Executive has either done so or elected to forgo that right.

[Remainder of page left intentionally blank.]

12
 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.

  COMPANY:
     
   
  By:
     
  EXECUTIVE:
     
   

 

13
 

  

Exhibit 10.13

ANNEX 1

Share price in US cents Shares to be allocated (in thousands)
   
1 0
2 200
3 200
4 200
5 200
6 200
7 200
8 200
9 200
10 200
11 250
12 250
13 250
14 250
15 250
16 250
17 250
18 250
19 250
20 250
21 300
22 and further on 300

  


 

 

Blue Sphere Corporation 10-K

E xhibit 10.14

SERVICE AGREEMENT

THIS SERVICE AGREEMENT (“ Agreement ”) is made and entered into as of the 15th, day of October 2015 by and between Blue Sphere Corp, a Nevada corporation (hereinafter called the “ Company ”), and JLS Advanced Investment holdings Limited (hereinafter called “ JLS AIHL ”) and Roy Amitzur (hereinafter called “ Roy ”). JLS AIHL and Roy jointly and separately hereinafter “ Executive ”).

RECITALS

WHEREAS , the Company is in the business of Build Own and Operate Anaerobic Digester facilities generating electricity; and

WHEREAS , the Company acknowledges that the Executive has been serving as the Company’s Executive Vice President since July 25, 2011, and has been compensated only partially for the services he has provided prior to the date of this Agreement; and

WHEREAS , the Company desires to maintain the service of the Executive as Executive Vice President of the Company, and the Executive is willing to continue such service; and

WHEREAS , as a condition precedent to and as an incentive to the Company to maintain the services of the Executive as Executive Vice President of the Company, the Company and the Executive desire to record the arrangements for such services, in the manner provided for herein and upon the terms and conditions set forth herein.

AGREEMENT 

NOW, THEREFORE , in consideration of the promises and mutual covenants herein contained, and other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the parties agree as follows:

1. Term and Services:

1.1 Term . The Company hereby agrees to engage Executive and the Executive hereby agrees to serve the Company, on the terms and conditions set forth herein, for the period commencing on the date hereof and expiring on October 14, 2020 (the “ Initial Term ”) unless sooner terminated as hereinafter set forth. This Agreement shall be extended for an additional five (5) year term (the “ Renewal Term, ” and collectively with the Initial Term, the “ Term ”) upon prior written mutual agreement between the Company and the Executive of at least ninety (90) days prior to the expiration of the Initial Term.

1.2 Services of Executive . The Executive shall serve as Executive Vice President of the Company. The Executive will be responsible for business activities delegated to him from time to time, sourcing debt and equity for the Company and its projects, developing and managing projects, developing and acquiring new technologies targets. He will contribute to recruit, select and develop executive team members.

 
 

The Executive shall render such services as provided in this Section 1.2 to the best of his ability, and use his reasonable best efforts to promote the interests of the Company. The Executive is permitted to pursue other business activities so long as the same do not conflict or compete with the business of the Company or the Executive’s ability to provide the services as provided in this Section 1.2 to the Company and so long as such activities do not significantly interfere with the performance of the Executive’s responsibilities as a service provider to the Company in accordance with this Agreement. The Executive’s obligations hereunder shall run only to the Company and its subsidiaries, and not to the Company’s other affiliates, if any.

2. Compensation .

2.1(a) Base Compensation . Commencing on the effective date of this Agreement, the Executive shall receive an annual base compensation (the “Base Compensation”) of $ 180,000 but not less than 720,000 New Israeli Shekels during the first year of the Initial Term, with an annual increase review per year thereafter during the Term of this Agreement. Such Base Compensation review shall be on or about January 1st of a given contract year. The Base Compensation shall be payable in 12 equal installments consistent with the Company’s normal payroll schedule, subject to applicable withholding and other taxes, and shall not be decreased for any reason. The Base Compensation will be paid, at Executive discretion in NIS translated pursuant to the official representative rate of exchange of the US$ as published by the Bank of Israel on the payment date. Should VAT be imposed on Base Compensation, Such VAT will be added to the Base Compensation and paid by the Company. Any deductions required to be made by the Company and submitted to relevant tax or other authorities will be deducted at source. Payments may be made through an Israeli Subsidiary.

2.1(b) Taxes . The Executive shall be solely responsible for, and will make proper and timely payment of, any and all withholding, taxes, duties, fees and/or other impositions that may be levied pursuant to applicable law upon the Executive in connection with the provision of the services provided in this Agreement. In the event that pursuant to any law or regulation, tax is required to be withheld at source from any payment made to the Executive, the Company shall withhold said tax at the rate set forth in the certification issued by the appropriate taxing authority or at the rate determined by said law or regulation.

2.2 Incentive Compensation . The Executive shall be entitled to receive such bonus payments or incentive compensation as may be determined at any time or from time to time by the Board of Directors of the Company (or any authorized committee thereof) in its discretion. Such potential bonus payments and/or incentive compensation shall be considered at least annually by the Board or committee and shall relate to the following:

1. A share price incentive bonus associated with the share price of the Company’s Common Stock, as reported, quoted or traded, as the case may, as more fully described on Annex 1 to this Agreement.

2. A cash incentive bonus for each project the Company achieves a full financial close. Full financial close is defined as follows.

2
 

(a) For acquisition of projects. When the Company buys the project assets and gets the project shares.

(b) For a new project, when the Company has a definitive signed agreement for the full funding required for the project and starts execution of the project.

(c) Cash incentive bonus amount will be decided from case to case by the Company’s Board of Directors. The bonus amount shall not exceed 3% of the project total value.

3. Any shares issued to Executive pursuant to this Section 2.2 shall be valued at $ 0.001 per share of Common Stock and shall be deemed restricted stock of the Company unless and until a registration statement covering the shares is declared effective or the Executive is able to rely on Rule 144 for any resales.

2.3 Shares and Stock Options .

(a) The Executive shall be entitled to participate in all shares and stock option plans of the Company (the “ Plans ”) in effect during the Term of this Agreement.

(b) Upon execution of this Agreement, the Company will issue Executive stock options, pursuant to a stock option agreement to be entered into between the Company and the Executive (the “ Options ”), to purchase at the end of each anniversary of this Agreement 850,000 shares of the Company’s common stock, $0.001 par value per share (“ Common Stock ”) at an exercise price of 1, (one) US cent.

(c) Milestone Bonus Options. The Executive shall also be entitled to receive shares and options for special events as may be determined by the Board of Directors, from time to time.

(d) All Options issued to the Executive in accordance with this Agreement shall become immediately exercisable as to 100% of the shares of Common Stock not otherwise vested upon any termination of Executive’s Service Agreement pursuant to Sections 3.8 or 3.9 or 3.10 or 3.11 hereof, it being agreed that the Company shall vest the unvested portion of the Executive’s Option shares and cooperate in good faith to afford the Executive the right to accelerate the exercise of the Options in full immediately prior to any Change in Control (as hereinafter defined). In the event that Executive terminates or is terminated pursuant to Sections 3.7 or 3.8 or 3.9 or 3.10 or 3.11 hereof, Executive shall have the greater of (i) Five years after termination, or (ii) the remaining term of the Options, in order to exercise his Options.

(e) The Company shall take all action reasonably requested by the Executive to permit any “cashless” exercise of the Options that is permitted under Agreement. 

(f) Upon proper exercise of an Option, the Executive shall be deemed for all purposes the owner of the shares of Common Stock that are purchasable upon such exercise.

3
 

(g) The provisions of the Plan and/or Agreement shall not be adversely modified as to the Executive without the Executive’s prior written consent.

(h) All Option and shares under Agreement shall be fully adjusted for events such as splits.

(i) All shares under Executive possession at a specific point in time will not exceed 10% of the Company then allocated shares.

2.4 Compensation for Past Services . As compensation for the services provided by the Executive to the Company from 2011 through the date of this Agreement, the Executive is entitled to receive $60,000.

3. Expense Reimbursement and Other Benefits .

3.1 Expense Reimbursement . During the Term of Executive’s Agreement hereunder, the Company, upon the submission of reasonable supporting documentation by the Executive, shall reimburse the Executive for all reasonable expenses actually paid or incurred by the Executive in the course of and pursuant to the business of the Company, including expenses for travel, lodging and entertainment. The Company may elect to provide Executive with a debit card or credit card in order to facilitate such expenses.

3.2 Incentive, Savings and Retirement Plans . During the Term of this Agreement, the Executive shall participate in any savings and retirement plans, practices, policies and programs established, or to be established and executed by the Company or the Executive may substitute the above with a yearly lump sum representing 10% of the Executive Yearly Base Compensation payable to Executive monthly or quarterly.

3.3 Welfare Benefit Plans . During the Term of Executive’s Agreement, the Executive and/or the Executive’s family, as the case may be, shall be eligible for participation in and shall receive all benefits under welfare benefit plans, practices, policies and programs provided by the Company and its subsidiaries (including, without limitation, medical, prescription, dental, disability, remuneration continuance, employee life, group life, accidental death and travel accident insurance plans and programs), at least as favorable as the most favorable of such plans, practices, policies and programs. The Executive may substitute the above with a yearly lump sum representing 8% of Executive Base Compensation to be paid in advance quarterly.

3.4 Vacation . During the Term of Executive’s Agreement, the Executive shall be entitled to be paid vacation in accordance with the most favorable plans, policies, programs and practices of the Company and its subsidiaries as in effect at any time hereafter with respect to other key Executives of the Company and its subsidiaries; provided, however, that in no event shall Executive be entitled to fewer than 25 business days paid vacation per year, as well as pay for all holidays observed by the Company.

4
 

3.5 Directors and Officers Insurance . The Company will insure the Executive (including his heirs, executors and administrators) with coverage under an appropriate directors’ and officers’ liability insurance policy at the Company’s expense with a run-off period of seven (7) years following termination of this Agreement and will provide the Executive with a customary officer indemnification agreement. 

3.6 Car . The Company will provide Executive with the use of a car in the 6th category of the Israeli Income Authority (similar to Nissan Maxima or Chevrolet Impala). The Company shall compensate Executive monthly to the extent that the use of the car results in imputation of income to the Executive under the income tax laws of Israel. All car expenses shall be borne by the company. Executive, at his sole discretion may elect to use his personal car and be compensated in cash by the Company. The compensation amount will be based on section 3.6 subject to the Company discretion.

4. Termination .

4.1 Termination for Cause . Notwithstanding anything contained to the contrary in this Agreement, this Agreement may be terminated by the Company for Cause. As used in this Agreement, “ Cause ” shall only mean:

(a) an act or acts of personal dishonesty taken by the Executive and intended to result in substantial personal enrichment of the Executive at the expense of the Company;

(b) subject to the following sentences, repeated violation by the Executive of the Executive’s material obligations under this Agreement which are demonstrably willful, persistent and deliberate on the Executive’s part and which are not remedied in a reasonable period of time after receipt of written notice from the Company’s Board of Directors; or

(c) the conviction of the Executive for any crime involving dishonesty, or fraud and moral turpitude.

Upon any reasonable and good faith determination by the Company’s Board of Directors that Cause exists under clause (a) of the preceding sentence and clause (b) of the preceding sentence (to the extent the violation under said clause (b) has not been cured by the Executive), the Company shall cause a special meeting of the Board to be called and held at a time mutually convenient to the Board and Executive, but in no event later than ten (10) business days after Executive’s receipt of the notice contemplated by clauses (a) and (b). Executive shall have the right to appear before such special meeting of the Board with legal counsel of his choosing to refute any determination of Cause specified in such notice, and any termination of Executive’s service by reason of such Cause determination shall not be effective until Executive is afforded such opportunity to appear. Any termination for Cause pursuant to clause (a) or (b) of the first sentence of this Section 3.7 shall be made in writing to Executive, which notice shall set forth in detail all acts or omissions upon which the Company is relying for such termination. Upon any termination pursuant to this Section 3.7, the Executive shall be entitled to be paid six months of his Base Compensation from the date of the termination or the remaining unexpired term, of this Agreement, whichever shall be shorter. The Executive shall be entitled to enjoy all benefits given under this Service Agreement, including but without limiting the generality thereof, those referred to in clauses 2 and 3 and sub-clauses thereof. Thereafter the Company shall have no further liability hereunder (other than for reimbursement for reasonable business expenses incurred prior to the date of termination).

5
 

4.2 Disability . Notwithstanding anything contained in this Agreement to the contrary, the Company, by written notice to the Executive, shall at all times have the right to terminate this Agreement, and the Executive’s service hereunder, if the Executive shall, as the result of mental or physical incapacity, illness or disability, fail to perform his duties and responsibilities provided for herein for a period of more than two hundred (200) consecutive days in any 12-month period. Upon any termination pursuant to this Section 3.8, the Executive shall be entitled to be paid his Base Compensation and benefits for the remaining term of the Agreement. In the event that the Agreement has less than twelve months remaining at such time, Executive shall be entitled to a payment equal to twelve months of his Base Compensation and benefits. In addition, Executive shall be entitled to reimbursement for all business expenses incurred prior to his disability.

4.3 Death . In the event of the death of the Executive during the Term of this Agreement hereunder, the Company shall pay to the estate of the deceased Executive the compensation, bonuses and benefits as detailed in section 3.11 “Termination without Cause” below. 

4.4 Optional Termination . Notwithstanding anything contained in this Agreement to the contrary, the Executive, by giving thirty (30) days prior written notice to the Company, shall one year after the date of this Agreement, have the right to terminate this Agreement at his sole discretion. Upon any termination pursuant to this Section 3.10, the Executive shall be entitled to be paid his Base Compensation and the benefits referred to hereinbefore for a period of 12 months from the date of termination and the immediate vesting of Options as described in Section 2.3(d),and the Company shall have no further liability hereunder thereafter (other than for reimbursement for reasonable business expenses incurred prior to the date of termination) unless the Executive and the Company agree to a different arrangement.

4.5 Termination without Cause . At any time, the Company shall have the right to terminate Executive’s employment hereunder by written notice to Executive; provided, however, that the Company shall:

(a) pay to Executive any all unpaid Base Compensation and allow the Executive to enjoy all the benefits given hereunder, for the remaining period of this Service Agreement, and will further allow to receive all bonuses, incentives, option and shares under Plan and this Agreement that would be payable had Executive completed an additional full two years of service under this Agreement;

(b) pay to the Executive in a lump sum, in cash within 30 days after the date of termination, an amount equal to the greater of (i) 100% of his annual Base Compensation then in effect, or (ii) the balance of the Executive’s Base Compensation from the effective date of termination through the expiration of the Initial Term or Renewal Term then in effect; and

6
 

(c) continue to pay the Executive’s health and disability insurance for the longer of a period of twenty-four (24) months or the remaining term of this Agreement.

(d) The Company shall be deemed to have terminated the Executive’s Agreement pursuant to this Section 3.11 if such service is terminated by the Company without Cause, by the Executive voluntarily for Good Reason, or as a result of a Charge in Control. 

(i) For purposes of this Agreement, “ Good Reason ” means:

1) the assignment to the Executive of any duties inconsistent in any respect with the Executive’s position (including status, offices, titles and reporting requirements), authority, duties or responsibilities as contemplated by Section 1.2 of this Agreement, or any other action by the Company which results in a diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Executive;

2) any failure by the Company to comply with any of the provisions of Section 2 or Section 3 of this Agreement, other than an isolated, insubstantial and inadvertent failure not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Executive;

3) the Company’s requiring the Executive to be based at any office or location more than fifty (50) miles from its current executive offices, except for travel reasonably required in the performance of the Executive’s responsibilities;

4) any change in the designation of the particular executive that the Executive is obligated to report to under Section 1.2 hereof;

5) any purported termination by the Company of the Executive’s Service otherwise than as expressly permitted by this Agreement; or

6) any termination by the Executive for any reason during the twelve-month period following the effective date of any Change in Control.

7
 

 

(ii) For purposes of this Agreement, a “ Change in Control ” shall mean:

1) The acquisition (other than by or from the Company), at any time after the date hereof, by any person, entity or “group,” within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 50% or more of either the then outstanding shares of common stock or the combined voting power of the Company’s then outstanding voting securities entitled to vote generally in the election of directors;

2) All or any of the five (5) individuals who, as of the date hereof, constitute the Board (as of the date hereof the “ Incumbent Board ”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (other than an election or nomination of an individual whose initial assumption of office is in connection with an actual or threatened election contest relating to the election of the directors of the Company, as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) shall be, for purposes of this Agreement, considered as though such person were a member of the Incumbent Board;

3) Approval by the shareholders of the Company of (A) a reorganization, merger or consolidation with respect to which persons who were the shareholders of the Company immediately prior to such reorganization, merger or consolidation do not, immediately thereafter, own more than 75% of the combined voting power entitled to vote generally in the election of directors of the reorganized, merged or consolidated company’s then outstanding voting securities, (B) a liquidation or dissolution of the Company, or (C) the sale of all or substantially all of the assets of the Company, unless the approved reorganization, merger, consolidation, liquidation, dissolution or sale is subsequently abandoned.

4) The approval by the Board of the sale, distribution and/or other transfer or action (and/or series of sales, distributions and/or other transfers or actions from time to time or over a period of time), that results in the Company’s ownership of less than 50% of the Company’s current assets.

8
 

5. Restrictive Covenants .

5.1(a) Nondisclosure . During his Service and for twelve (12) months thereafter, Executive shall not divulge, communicate, use to the detriment of the Company or for the benefit of any other person or persons, or misuse in any way, any Confidential Information (as hereinafter defined) pertaining to the business of the Company, unless required to do so by a governmental agency or court of law. Any Confidential Information or data now or hereafter acquired by the Executive with respect to the business of the Company shall be deemed a valuable, special and unique asset of the Company that is received by the Executive in confidence and as a fiduciary, and Executive shall remain a fiduciary to the Company with respect to all of such information. For purposes of this Agreement, “ Confidential Information ” means all material information about the Company’s business disclosed to the Executive or known by the Executive as a consequence of or through his service to the Company (including information conceived, originated, discovered or developed by the Executive) after the date hereof, and not generally known. 

5.1(b) Exceptions . The general prohibition contained in Section 5.1(a) against the unauthorized disclosure, use or dissemination of the Company’s Confidential Information will not apply in respect of any Company Confidential Information that:

(i) is available to the public generally;

(ii) becomes part of the public domain through no fault of the Executive;

(iii) is already in the lawful possession of the Executive at the time of receipt of the Company’s Confidential Information; or

(iv) is compelled by applicable law to be disclosed, provided that the Executive gives the Company prompt written notice of such requirement prior to such disclosure and provides assistance at the request at the expense of the Company, in obtaining an order protecting the Company’s Confidential Information from public disclosure.

9
 

5.2 No solicitation of Employees . While employed by the Company and for a period of twelve (12) months thereafter, Executive shall not directly or indirectly, for himself or for any other person, firm, corporation, partnership, association or other entity, attempt to employ or enter into any contractual arrangement with any employee or former employee of the Company, unless such employee or former employee has not been employed by the Company for a period in excess of six months. Notwithstanding the foregoing, the Executive shall not be restricted in hiring any person who responds to any general solicitation for employees or public advertising of employment opportunities (including through the use of employment agencies) not specifically directed at any such person.

5.3 Covenant Not to Compete . Executive will not, at any time, during the Term of this Agreement, and for a period of twelve (12) months thereafter, either directly or indirectly, engage in, with or for any enterprise, institution, whether or not for profit, business, or company, competitive with the business (as identified herein) of the Company as such business may be conducted on the date thereof, as a creditor, guarantor, or financial backer, stockholder, director, officer, consultant, advisor, employee, member, or otherwise of or through any corporation, partnership, association, sole proprietorship or other entity; provided, that an investment by Executive, his spouse or his children is permitted if such investment is not more than four percent (4%) of the total debt or equity capital of any such competitive enterprise or business. As used in this Agreement, the business of Employer shall be deemed to include any business which directly competes with the Company in the Build Own and Operate Anaerobic Digester electricity production industry. The covenant not to compete for twelve (12) months after termination shall only be effective if the Executive has received all compensation due to him pursuant to this Agreement. The Company shall have the right in its sole discretion to waive this non-compete provision.

5.4 Injunction . It is recognized and hereby acknowledged by the parties hereto that a breach by the Executive of any of the covenants contained in Sections 4.1, 4.2 or 4.3 of this Agreement will cause irreparable harm and damage to the Company, the monetary amount of which may be virtually impossible to ascertain. As a result, the Executive recognizes and hereby acknowledges that the Company shall be entitled to an injunction from any court of competent jurisdiction enjoining and restraining any violation of any or all of the covenants contained in this Section 4 by the Executive or any of his affiliates, associates, partners or agents, either directly or indirectly, and that such right to injunction shall be cumulative and in addition to whatever other remedies the Company may possess.

6. Re-negotiate . This contract may be re-negotiated by the Executive should the circumstances and the economic situation of the company shows improvement beyond the Company’s forecast.

7.  Entire Agreement . This instrument contains the entire agreement of the parties, and supersedes any prior or contemporaneous statements or understandings by or between the parties. This Agreement may be changed only by an agreement in writing signed by the party against whom enforcement of any waiver, change, modification, extension or discharge is sought, and any such modification on behalf of the Company must be approved by the Board.

10
 

8. Governing Law/Jurisdiction . This Agreement shall be governed by the laws of Israel. The competent courts of the city of Tel Aviv, shall have exclusive jurisdiction over any matter in connection with this Agreement.

9. Notices . Any notice required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given (a) when delivered by hand, (b) when deposited by registered or certified mail, return receipt requested, postage prepaid, or via overnight courier, (c) one day after electronically mailed either in the text of an email message or attached in a commonly readable format, and the sender has received no generated notice that the email message has not been successfully delivered, or (d) upon receipt of proof of sending thereof when sent by facsimile, addressed as follows:

If to the Company:

 

  with a copy to:   Thompson Hine LLP  
    335 Madison Avenue, 12th Floor  
    New York, NY 10017  
    Attention: Peter J. Gennuso, Esq.  
    Fax: 212-344-6101  
    Email: peter.gennuso@thompsonhine.com  
       
  If to the Executive: NEED TO COMPLETE  

   

or to such other addresses as either party hereto may from time to time give notice of to the other in the aforesaid manner. 

10. Successors .  

(a) This Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Executive’s legal representatives.

(b) This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. 

(c) The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets which assumes and agrees to perform this Agreement by operation of law or otherwise.

11
 

11. Severability . The invalidity of any one or more of the words, phrases, sentences, clauses or sections contained in this Agreement shall not affect the enforceability of the remaining portions of this Agreement or any part thereof, all of which are inserted conditionally on their being valid in law, and, in the event that any one or more of the words, phrases, sentences, clauses or sections contained in this Agreement shall be declared invalid, this Agreement shall be construed as if such invalid word or words, phrase or phrases, sentence or sentences, clause or clauses, or section or sections had not been inserted. If such invalidity is caused by length of time or size of area, or both, the otherwise invalid provision will be considered to be reduced to a period or area which would cure such invalidity.

12. Waivers . The waiver by either party hereto of a breach or violation of any term or provision of this Agreement shall not operate nor be construed as a waiver of any subsequent breach or violation.

13. Damages . Nothing contained herein shall be construed to prevent the Company or the Executive from seeking and recovering from the other damages sustained by either or both of them as a result of its or his breach of any term or provision of this Agreement. 

14. No Third Party Beneficiary . Nothing expressed or implied in this Agreement is intended, or shall be construed, to confer upon or give any person (other than the parties hereto and, in the case of Executive, his heirs, personal representative(s) and/or legal representative) any rights or remedies under or by reason of this Agreement.

15. Full Settlement . The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Executive or others. In no event shall the Executive be obligated to seek other service or employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement. The Company agrees to pay, to the full extent permitted by law, all legal fees and expenses which the Executive may reasonably incur as a result of any contest (regardless of the outcome thereof) by the Company or others of the validity or enforceability of, or liability under, any provision of this Agreement or any guarantee of performance thereof, plus in each case interest at the applicable Federal rate provided for in Section 7872(f)(2) of the Internal Revenue Code of 1986, as amended.

16. Counterparts . This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

17. Executive’s Recognition of Agreement . Executive acknowledges that Executive has read and understood this Agreement, and agrees that its terms are necessary for the reasonable and proper protection of the Company’s business. Executive acknowledges that Executive has been advised by the Company that Executive is entitled to have this Agreement reviewed by an attorney of Executive’s selection, at Executive’s expense, prior to signing, and that Executive has either done so or elected to forgo that right. 

[Remainder of page left intentionally blank.]

12
 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.

  COMPANY:
     
   
  By: Shlomi Palas Chief Executive Officer
     
  EXECUTIVE:
     
  JLS Advanced Investment Holdings Limited
   
   
  Roy Amitzur
   

  

13
 

 

ANNEX 1  

Share price in US cents Shares to be allocated in thousands
   
1 0
2 150
3 150
4 150
5 150
6 150
7 150
8 150
9 150
10 150
11 200
12 200
13 200
14 200
15 200
16 200
17 200
18 200
19 200
20 200
21 250
22 and further on 250

  


 

Blue Sphere Corporation 10-K

Exhibit 10.15

ADVISORY AGREEMENT

THIS ADVISORY AGREEMENT (“ Agreement ”) is made and entered into as of the 15th, day of October 2015 by and between Blue Sphere Corp, a Nevada corporation (hereinafter called the “ Company ”), and Joshua Shoham (hereinafter called “ Advisor ”).

RECITALS

WHEREAS , the Company is in the business of Build Own and Operate Anaerobic Digester facilities generating electricity; and

WHEREAS , the Company acknowledges that the Advisor has been serving as Advisor to the Company since July 20, 2012, and has been compensated only partially for the services he has provided prior to the date of this Agreement; and

WHEREAS , the Company desires to maintain the service of the Advisor as Strategic and Business Advisor of the Company while maintaining his role of Chairman of the Board of Director and Director with Eastern Sphere Ltd., an Israeli fully owned subsidiary of the Company and the Advisor is willing to continue such service; and

WHEREAS , as a condition precedent to and as an incentive to the Company to maintain the services of the Advisor to the Company, the Company and the Advisor desire to record the arrangements for such services, in the manner provided for herein and upon the terms and conditions set forth herein.

AGREEMENT

NOW, THEREFORE , in consideration of the promises and mutual covenants herein contained, and other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the parties agree as follows:

1. Term and Services:

1.1 Term. The Company hereby agrees to engage Advisor and the Advisor hereby agrees to serve the Company, on the terms and conditions set forth herein, for the period commencing on the date hereof and expiring on October 14, 2020 (the “ Initial Term ”) unless sooner terminated as hereinafter set forth. This Agreement shall be extended for an additional five (5) year term (the “ Renewal Term, ” and collectively with the Initial Term, the “ Term ”) upon prior written mutual agreement between the Company and the Advisor of at least ninety (90) days prior to the expiration of the Initial Term.

1.2 Services of Advisor. The Advisor shall serve as Strategic and Business Advisor. The Advisor shall render such services as provided in this Section 1.2 to the best of his ability, and use his reasonable best efforts to promote the interests of the Company. The Advisor is permitted to pursue other business activities so long as the same do not conflict or compete with the business of the Company or the Advisor’s ability to provide the services as provided in this Section 1.2 to the Company and so long as such activities do not significantly interfere with the performance of the Advisor’s responsibilities as a service provider to the Company in accordance with this Agreement. The Advisor’s obligations hereunder shall run only to the Company and its subsidiaries, and not to the Company’s other affiliates, if any.

 
 

2. Compensation.

2.1(a) Base Compensation . Commencing on the effective date of this Agreement, the Advisor shall receive an annual base compensation (the “Base Compensation”) of $ 180,000 but not less than 720,000 New Israeli Shekels during the first year of the Initial Term, with an annual increase review per year thereafter during the Term of this Agreement. Such Base Compensation review shall be on or about January 1st of a given contract year. The Base Compensation shall be payable in 12 equal installments consistent with the Company’s normal payroll schedule, subject to applicable withholding and other taxes, and shall not be decreased for any reason. The Base Compensation will be paid, at Advisor discretion in NIS translated pursuant to the official representative rate of exchange of the US$ as published by the Bank of Israel on the payment date. Should VAT be imposed on Base Compensation, Such VAT will be added to the Base Compensation and paid by the Company. Any deductions required to be made by the Company and submitted to relevant tax or other authorities will be deducted at source. Payments may be made through an Israeli Subsidiary.

2.1(b) Taxes . The Advisor shall be solely responsible for, and will make proper and timely payment of, any and all withholding, taxes, duties, fees and/or other impositions that may be levied pursuant to applicable law upon the Advisor in connection with the provision of the services provided in this Agreement. In the event that pursuant to any law or regulation, tax is required to be withheld at source from any payment made to the Advisor, the Company shall withhold said tax at the rate set forth in the certification issued by the appropriate taxing authority or at the rate determined by said law or regulation.

2.2 Incentive Compensation. The Advisor shall be entitled to receive such bonus payments or incentive compensation as may be determined at any time or from time to time by the Board of Directors of the Company (or any authorized committee thereof) in its discretion. Such potential bonus payments and/or incentive compensation shall be considered at least annually by the Board or committee and shall relate to the following:

1. A share price incentive bonus associated with the share price of the Company’s Common Stock, as reported, quoted or traded, as the case may, as more fully described on Annex 1 to this Agreement.

2. A cash incentive bonus for each project the Company achieves a full financial close. Full financial close is defined as follows.

(a) For acquisition of projects. When the Company buys the project assets and gets the project shares.

(b) For a new project, when the Company has a definitive signed agreement for the full funding required for the project and starts execution of the project.

(c) Cash incentive bonus amount will be decided from case to case by the Company’s Board of Directors. The bonus amount shall not exceed 3% of the project total value.

2
 

3. Any shares issued to Advisor pursuant to this Section 2.2 shall be valued at $ 0.001 per share of Common Stock and shall be deemed restricted stock of the Company unless and until a registration statement covering the shares is declared effective or the Advisor is able to rely on Rule 144 for any resales.

2.3 Shares and Stock Options.

(a) The Advisor shall be entitled to participate in all shares and stock option plans of the Company (the “ Plans ”) in effect during the Term of this Agreement.

(b) Upon execution of this Agreement, the Company will issue Advisor stock options, pursuant to a stock option agreement to be entered into between the Company and the Advisor (the “ Options ”), to purchase at the end of each anniversary of this Agreement 850,000 shares of the Company’s common stock, $0.001 par value per share (“ Common Stock ”) at an exercise price of 1, (one) US cent.

(c) Milestone Bonus Options. The Advisor shall also be entitled to receive shares and options for special events as may be determined by the Board of Directors, from time to time.

(d) All Options issued to the Advisor in accordance with this Agreement shall become immediately exercisable as to 100% of the shares of Common Stock not otherwise vested upon any termination of Advisor’s Service Agreement pursuant to Sections 3.8 or 3.9 or 3.10 or 3.11 hereof, it being agreed that the Company shall vest the unvested portion of the Advisor’s Option shares and cooperate in good faith to afford the Advisor the right to accelerate the exercise of the Options in full immediately prior to any Change in Control (as hereinafter defined). In the event that Advisor terminates or is terminated pursuant to Sections 3.7 or 3.8 or 3.9 or 3.10 or 3.11 hereof, Advisor shall have the greater of (i) Five years after termination, or (ii) the remaining term of the Options, in order to exercise his Options.

(e) The Company shall take all action reasonably requested by the Advisor to permit any “cashless” exercise of the Options that is permitted under Agreement.

(f) Upon proper exercise of an Option, the Advisor shall be deemed for all purposes the owner of the shares of Common Stock that are purchasable upon such exercise.

(g) The provisions of the Plans and/or Agreement shall not be adversely modified as to the Advisor without the Advisor’s prior written consent.

(h) All Option and shares under Agreement shall be fully adjusted for events such as splits.

(i) All shares under Advisor possession at a specific point in time will not exceed 10% of the Company then allocated shares.

3
 

2.4 Compensation for Past Services. As compensation for the services provided by the Advisor to the Company from 2012 through the date of this Agreement, the Advisor shall be entitled to receive $60,000.

3. Expense Reimbursement and Other Benefits.

3.1 Expense Reimbursement. During the Term of Advisor’s Agreement here-under, the Company, upon the submission of reasonable supporting documentation by the Advisor, shall reimburse the Advisor for all reasonable expenses actually paid or incurred by the Advisor in the course of and pursuant to the business of the Company, including expenses for travel, lodging and entertainment. The Company may elect to provide Advisor with a debit card or credit card in order to facilitate such expenses.

3.2 Incentive, Savings and Retirement Plans. During the Term of this Agreement, the Advisor shall participate in any savings and retirement plans, practices, policies and programs established, or to be established and executed by the Company or the Advisor may substitute the above with a yearly lump sum representing 10% of the Advisor Yearly Base Compensation payable to Advisor monthly or quarterly.

3.3 Welfare Benefit Plans. During the Term of Advisor’s Agreement, the Advisor and/or the Advisor’s family, as the case may be, shall be eligible for participation in and shall receive all benefits under welfare benefit plans, practices, policies and programs provided by the Company and its subsidiaries (including, without limitation, medical, prescription, dental, disability, remuneration continuance, employee life, group life, accidental death and travel accident insurance plans and programs), at least as favorable as the most favorable of such plans, practices, policies and programs. The Advisor may substitute the above with a yearly lump sum representing 8% of Advisor Base Compensation to be paid in advance quarterly.

3.4 Vacation. During the Term of Advisor’s Agreement, the Advisor shall be entitled to be paid vacation in accordance with the most favorable plans, policies, programs and practices of the Company and its subsidiaries as in effect at any time hereafter with respect to other key Advisors of the Company and its subsidiaries; provided, however, that in no event shall Advisor be entitled to fewer than 25 business days paid vacation per year, as well as pay for all holidays observed by the Company.

3.5 Directors and Officers Insurance. The Company will insure the Advisor (including his heirs, executors and administrators) with coverage under an appropriate directors’ and officers’ liability insurance policy at the Company’s expense with a run-off period of seven (7) years following termination of this Agreement and will provide the Advisor with a customary officer indemnification agreement.

3.6 Car. The Company will provide Advisor with the use of a car in the 6th category of the Israeli Income Authority (similar to Nissan Maxima or Chevrolet Impala). The Company shall compensate Advisor monthly to the extent that the use of the car results in imputation of income to the Advisor under the income tax laws of Israel. All car expenses shall be borne by the company. Advisor, at his sole discretion may elect to use his personal car and be compensated in cash by the Company. The compensation amount will be based on section 3.6 subject to the Company discretion.

4
 

4. Termination.

4.1 Termination for Cause. Notwithstanding anything contained to the contrary in this Agreement, this Agreement may be terminated by the Company for Cause. As used in this Agreement, “ Cause ” shall only mean:

(a) an act or acts of personal dishonesty taken by the Advisor and intended to result in substantial personal enrichment of the Advisor at the expense of the Company;

(b) subject to the following sentences, repeated violation by the Advisor of the Advisor’s material obligations under this Agreement which are demonstrably willful, persistent and deliberate on the Advisor’s part and which are not remedied in a reasonable period of time after receipt of written notice from the Company’s Board of Directors; or

(c) the conviction of the Advisor for any crime involving dishonesty, or fraud and moral turpitude.

Upon any reasonable and good faith determination by the Company’s Board of Directors that Cause exists under clause (a) of the preceding sentence and clause (b) of the preceding sentence (to the extent the violation under said clause (b) has not been cured by the Advisor), the Company shall cause a special meeting of the Board to be called and held at a time mutually convenient to the Board and Advisor, but in no event later than ten (10) business days after Advisor’s receipt of the notice contemplated by clauses (a) and (b). Advisor shall have the right to appear before such special meeting of the Board with legal counsel of his choosing to refute any determination of Cause specified in such notice, and any termination of Advisor’s service by reason of such Cause determination shall not be effective until Advisor is afforded such opportunity to appear. Any termination for Cause pursuant to clause (a) or (b) of the first sentence of this Section 3.7 shall be made in writing to Advisor, which notice shall set forth in detail all acts or omissions upon which the Company is relying for such termination. Upon any termination pursuant to this Section 3.7, the Advisor shall be entitled to be paid six months of his Base Compensation from the date of the termination or the remaining unexpired term, of this Agreement, whichever shall be shorter. The Advisor shall be entitled to enjoy all benefits given under this Service Agreement, including but without limiting the generality thereof, those referred to in clauses 2 and 3 and sub-clauses thereof. Thereafter the Company shall have no further liability hereunder (other than for reimbursement for reasonable business expenses incurred prior to the date of termination).

5
 

4.2 Disability. Notwithstanding anything contained in this Agreement to the contrary, the Company, by written notice to the Advisor, shall at all times have the right to terminate this Agreement, and the Advisor’s service hereunder, if the Advisor shall, as the result of mental or physical incapacity, illness or disability, fail to perform his duties and responsibilities provided for herein for a period of more than two hundred (200) consecutive days in any 12-month period. Upon any termination pursuant to this Section 3.8, the Advisor shall be entitled to be paid his Base Compensation and benefits for the remaining term of the Agreement. In the event that the Agreement has less than twelve months remaining at such time, Advisor shall be entitled to a payment equal to twelve months of his Base Compensation and benefits. In addition, Advisor shall be entitled to reimbursement for all business expenses incurred prior to his disability.

4.3 Death. In the event of the death of the Advisor during the Term of this Agreement hereunder, the Company shall pay to the estate of the deceased Advisor the compensation, bonuses and benefits as detailed in section 3.11 “Termination without Cause” below.

4.4 Optional Termination. Notwithstanding anything contained in this Agreement to the contrary, the Advisor, by giving thirty (30) days prior written notice to the Company, shall one year after the date of this Agreement, have the right to terminate this Agreement at his sole discretion. Upon any termination pursuant to this Section 3.10, the Advisor shall be entitled to be paid his Base Compensation and the benefits referred to hereinbefore for a period of 12 months from the date of termination and the immediate vesting of Options as described in Section 2.3(d),and the Company shall have no further liability hereunder thereafter (other than for reimbursement for reasonable business expenses incurred prior to the date of termination) unless the Advisor and the Company agree to a different arrangement.

4.5 Termination without Cause. At any time, the Company shall have the right to terminate Advisor’s employment hereunder by written notice to Advisor; provided, however, that the Company shall:

(a) pay to Advisor any all unpaid Base Compensation and allow the Advisor to enjoy all the benefits given hereunder, for the remaining period of this Service Agreement, and will further allow to receive all bonuses, incentives, option and shares under Plan and this Agreement that would be payable had Advisor completed an additional full two years of service under this Agreement;

(b) pay to the Advisor in a lump sum, in cash within 30 days after the date of termination, an amount equal to the greater of (i) 100% of his annual Base Compensation then in effect, or (ii) the balance of the Advisor’s Base Compensation from the effective date of termination through the expiration of the Initial Term or Renewal Term then in effect; and

(c) continue to pay the Advisor’s health and disability insurance for the longer of a period of twenty-four (24) months or the remaining term of this Agreement.

(d) The Company shall be deemed to have terminated the Advisor’s Agreement pursuant to this Section 3.11 if such service is terminated by the Company without Cause, by the Advisor voluntarily for Good Reason, or as a result of a Charge in Control.

6
 

(i) For purposes of this Agreement, “ Good Reason ” means:
1) the assignment to the Advisor of any duties inconsistent in any respect with the Advisor’s position (including status, offices, titles and reporting requirements), authority, duties or responsibilities as contemplated by Section 1.2 of this Agreement, or any other action by the Company which results in a diminution in such position, authority, duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Advisor;
2) any failure by the Company to comply with any of the provisions of Section 2 or Section 3 of this Agreement, other than an isolated, insubstantial and inadvertent failure not occurring in bad faith and which is remedied by the Company promptly after receipt of notice thereof given by the Advisor;
3) the Company’s requiring the Advisor to be based at any office or location more than fifty (50) miles from its current Advisor offices, except for travel reasonably required in the performance of the Advisor’s responsibilities;
4) any change in the designation of the particular Advisor that the Advisor is obligated to report to under Section 1.2 hereof;
5) any purported termination by the Company of the Advisor’s Service otherwise than as expressly permitted by this Agreement; or
6) any termination by the Advisor for any reason during the twelve-month period following the effective date of any Change in Control.

7
 

 

(ii) For purposes of this Agreement, a “ Change in Control ” shall mean:
1) The acquisition (other than by or from the Company), at any time after the date hereof, by any person, entity or “group,” within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 50% or more of either the then outstanding shares of common stock or the combined voting power of the Company’s then outstanding voting securities entitled to vote generally in the election of directors;
2) All or any of the five (5) individuals who, as of the date hereof, constitute the Board (as of the date hereof the “ Incumbent Board ”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (other than an election or nomination of an individual whose initial assumption of office is in connection with an actual or threatened election contest relating to the election of the directors of the Company, as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) shall be, for purposes of this Agreement, considered as though such person were a member of the Incumbent Board;
3) Approval by the shareholders of the Company of (A) a reorganization, merger or consolidation with respect to which persons who were the shareholders of the Company immediately prior to such reorganization, merger or consolidation do not, immediately thereafter, own more than 75% of the combined voting power entitled to vote generally in the election of directors of the reorganized, merged or consolidated company’s then out-standing voting securities, (B) a liquidation or dissolution of the Company, or (C) the sale of all or substantially all of the assets of the Company, unless the approved reorganization, merger, consolidation, liquidation, dissolution or sale is subsequently abandoned.
4) The approval by the Board of the sale, distribution and/or other transfer or action (and/or series of sales, distributions and/or other transfers or actions from time to time or over a period of time), that results in the Company’s ownership of less than 50% of the Company’s current assets.

8
 

5. Restrictive Covenants.

5.1(a) Nondisclosure . During his Service and for twelve (12) months thereafter, Advisor shall not divulge, communicate, use to the detriment of the Company or for the benefit of any other person or persons, or misuse in any way, any Confidential Information (as hereinafter defined) pertaining to the business of the Company, unless required to do so by a governmental agency or court of law. Any Confidential Information or data now or hereafter acquired by the Advisor with respect to the business of the Company shall be deemed a valuable, special and unique asset of the Company that is received by the Advisor in confidence and as a fiduciary, and Advisor shall remain a fiduciary to the Company with respect to all of such information. For purposes of this Agreement, “ Confidential Information ” means all material information about the Company’s business disclosed to the Advisor or known by the Advisor as a consequence of or through his service to the Company (including information conceived, originated, discovered or developed by the Advisor) after the date hereof, and not generally known.

5.1(b) Exceptions . The general prohibition contained in Section 5.1(a) against the unauthorized disclosure, use or dissemination of the Company’s Confidential Information will not apply in respect of any Company Confidential Information that:

(i) is available to the public generally;
(ii) becomes part of the public domain through no fault of the Advisor;
(iii) is already in the lawful possession of the Advisor at the time of receipt of the Company’s Confidential Information; or
(iv) is compelled by applicable law to be disclosed, provided that the Advisor gives the Company prompt written notice of such requirement prior to such disclosure and provides assistance at the request at the expense of the Company, in obtaining an order protecting the Company’s Confidential Information from public disclosure.

5.2 No solicitation of Employees. While employed by the Company and for a period of twelve (12) months thereafter, Advisor shall not directly or indirectly, for himself or for any other person, firm, corporation, partnership, association or other entity, attempt to employ or enter into any contractual arrangement with any employee or former employee of the Company, unless such employee or former employee has not been employed by the Company for a period in excess of six months. Notwithstanding the foregoing, the Advisor shall not be restricted in hiring any person who responds to any general solicitation for employees or public advertising of employment opportunities (including through the use of employment agencies) not specifically directed at any such person.

9
 

5.3 Covenant Not to Compete. Advisor will not, at any time, during the Term of this Agreement, and for a period of twelve (12) months thereafter, either directly or indirectly, engage in, with or for any enterprise, institution, whether or not for profit, business, or company, competitive with the business (as identified herein) of the Company as such business may be conducted on the date thereof, as a creditor, guarantor, or financial backer, stockholder, director, officer, consultant, advisor, employee, member, or otherwise of or through any corporation, partnership, association, sole proprietorship or other entity; provided, that an investment by Advisor, his spouse or his children is permitted if such investment is not more than four percent (4%) of the total debt or equity capital of any such competitive enterprise or business. As used in this Agreement, the business of Employer shall be deemed to include any business which directly competes with the Company in the Build Own and Operate Anaerobic Digester electricity production industry. The covenant not to compete for twelve (12) months after termination shall only be effective if the Advisor has received all compensation due to him pursuant to this Agreement. The Company shall have the right in its sole discretion to waive this non-compete provision.

5.4 Injunction. It is recognized and hereby acknowledged by the parties hereto that a breach by the Advisor of any of the covenants contained in Sections 4.1, 4.2 or 4.3 of this Agreement will cause irreparable harm and damage to the Company, the monetary amount of which may be virtually impossible to ascertain. As a result, the Advisor recognizes and hereby acknowledges that the Company shall be entitled to an injunction from any court of competent jurisdiction enjoining and restraining any violation of any or all of the covenants contained in this Section 4 by the Advisor or any of his affiliates, associates, partners or agents, either directly or indirectly, and that such right to injunction shall be cumulative and in addition to whatever other remedies the Company may possess.

6. Re-negotiate. This contract may be re-negotiated by the Advisor should the circumstances and the economic situation of the company shows improvement beyond the Company’s forecast.

7. Entire Agreement. This instrument contains the entire agreement of the parties, and supersedes any prior or contemporaneous statements or understandings by or between the parties. This Agreement may be changed only by an agreement in writing signed by the party against whom enforcement of any waiver, change, modification, extension or discharge is sought, and any such modification on behalf of the Company must be approved by the Board.

8. Governing Law/Jurisdiction. This Agreement shall be governed by the laws of Israel. The competent courts of the city of Tel Aviv, shall have exclusive jurisdiction over any matter in connection with this Agreement.

9. Notices. Any notice required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given (a) when delivered by hand, (b) when deposited by registered or certified mail, return receipt requested, postage prepaid, or via overnight courier, (c) one day after electronically mailed either in the text of an email message or attached in a commonly readable format, and the sender has received no generated notice that the email message has not been successfully delivered, or (d) upon receipt of proof of sending thereof when sent by facsimile, addressed as follows:

10
 

If to the Company:

 

       with a copy to: Thompson Hine LLP

335 Madison Avenue, 12th Floor

New York, NY 10017

Attention: Peter J. Gennuso, Esq.

Fax: 212-344-6101

Email: peter.gennuso@thompsonhine.com

 

                  If to the Advisor: Joshua Shoham

10 Zamir St.

Caesarea 3088900 Israel

Josh.shoham@gmail.com

 

or to such other addresses as either party hereto may from time to time give notice of to the other in the aforesaid manner.

10. Successors.

(a) This Agreement is personal to the Advisor and without the prior written consent of the Company shall not be assignable by the Advisor otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Advisor’s legal representatives.

(b) This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.

(c) The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets which assumes and agrees to perform this Agreement by operation of law or otherwise.

11. Severability. The invalidity of any one or more of the words, phrases, sentences, clauses or sections contained in this Agreement shall not affect the enforceability of the remaining portions of this Agreement or any part thereof, all of which are inserted conditionally on their being valid in law, and, in the event that any one or more of the words, phrases, sentences, clauses or sections contained in this Agreement shall be declared invalid, this Agreement shall be construed as if such invalid word or words, phrase or phrases, sentence or sentences, clause or clauses, or section or sections had not been inserted. If such invalidity is caused by length of time or size of area, or both, the otherwise invalid provision will be considered to be reduced to a period or area which would cure such invalidity.

11
 

12. Waivers. The waiver by either party hereto of a breach or violation of any term or provision of this Agreement shall not operate nor be construed as a waiver of any subsequent breach or violation.

13. Damages. Nothing contained herein shall be construed to prevent the Company or the Advisor from seeking and recovering from the other damages sustained by either or both of them as a result of its or his breach of any term or provision of this Agreement.

14. No Third Party Beneficiary. Nothing expressed or implied in this Agreement is intended, or shall be construed, to confer upon or give any person (other than the parties hereto and, in the case of Advisor, his heirs, personal representative(s) and/or legal representative) any rights or remedies under or by reason of this Agreement.

15. Full Settlement. The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Advisor or others. In no event shall the Advisor be obligated to seek other service or employment or take any other action by way of mitigation of the amounts payable to the Advisor under any of the provisions of this Agreement. The Company agrees to pay, to the full extent permitted by law, all legal fees and expenses which the Advisor may reasonably incur as a result of any contest (regardless of the outcome thereof) by the Company or others of the validity or enforceability of, or liability under, any provision of this Agreement or any guarantee of performance thereof, plus in each case interest at the applicable Federal rate provided for in Section 7872(f)(2) of the Internal Revenue Code of 1986, as amended.

16. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

17. Advisor’s Recognition of Agreement. Advisor acknowledges that Advisor has read and understood this Agreement, and agrees that its terms are necessary for the reasonable and proper protection of the Company’s business. Advisor acknowledges that Advisor has been advised by the Company that Advisor is entitled to have this Agreement reviewed by an attorney of Advisor’s selection, at Advisor’s expense, prior to signing, and that Advisor has either done so or elected to forgo that right.

[Remainder of page left intentionally blank.]

12
 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.

  COMPANY:
     
   
   
  By: Shlomi Palas Chief Executive Officer
     
  ADVISOR:
     
   

  

13
 

 

Exhibit 10.15

ANNEX 1 

Share price in US cents Shares to be allocated in thousands
   
1 0
2 150
3 150
4 150
5 150
6 150
7 150
8 150
9 150
10 150
11 200
12 200
13 200
14 200
15 200
16 200
17 200
18 200
19 200
20 200
21 250
22 and further on 250

 


 

 

 

 

Blue Sphere Corporation 10-K

Exhibit 10.16

 

DATED THIS 30TH DAY OF OCTOBER 2014

 

Between

 

NANYANG TECHNOLOGICAL UNIVERSITY

 

And

 

BLUE SPHERE CORPORATION

 

  

LICENSE AGREEMENT 

 

 

 

 

NTU CONFIDENTIAL

 

THIS AGREEMENT is entered into on 30th day of October 2014 between:

 

(1) NANYANG TECHNOLOGICAL UNIVERSITY , located at 50 Nanyang Avenue, Singapore 639798 (hereinafter referred to as “ NTU ”);

 

And

 

(2) BLUE SPHERE CORPORATION a publicly traded company with registration number NV20071294271 incorporated in the State of Nevada United States of America with a business address at 301 McCullough Drive, 4th Floor, Charlotte, NC 28262, USA (hereinafter referred to as “ Licensee ”).

 

WHEREAS:

 

(A) NTU declares it is the legal owner of the Invention and the Licensed Technology and is entitled to grant the rights under this Agreement to Licensee.

 

(B) Licensee is desirous of obtaining exclusive license rights to the Licensed Technology to develop Licensed Products in the Field and to manufacture, have manufactured, offer for sale, sell, have sold, export, import and otherwise commercialize and exploit the Licensed Products in the Territory in accordance with the terms of this Agreement.

 

NTU and Licensee acknowledge TechBridge Ventures Pte Ltd’s assistance in introducing Licensee for this License and its assistance in reaching this agreement.

 

NOW THEREFORE in consideration of the mutual promises set forth herein and rights obtained thereby, NTU and Licensee agree as follows.

 

1. DEFINITIONS

 

1.1. In this Agreement, unless the context otherwise requires, the following expressions have the following meanings:

 

“Affiliate” -

means any corporation, company or other entity which:  

 

(i)

is Controlled by the relevant Party;  

 

(ii)

Controls the relevant Party; or  

 

(iii)

is under common Control with the relevant Party.  

 

For this purpose, “Control” means (a) more than fifty percent (50%) of the controlled entity’s outstanding shares or ownership interest representing the right to make decision for such entity are owned or controlled, directly or indirectly, by the controlling entity, and/or (b) the controlling entity possesses, directly or indirectly, the power to influence the decision-making process, the direction of management and the policies of the controlled entity.

 

 

1
 

 

NTU CONFIDENTIAL

     
“Arms length transaction” - means any transaction with an entity that is not a Related entity.
     
“Business Day” - means a day other than a Saturday, Sunday or a gazetted public holiday in Singapore and/or Israel.
     
“First Commercial Sale” - means, the first sale of a Licensed Products by Licensee, an Affiliate or a Sub-Licensee.
     
“Confidential Information” -

means:

 

(i)

the Licensed Proprietary Materials; and

 
(ii)

any device, materials, samples, software programmes, documents, data, graphics, specifications, technical information, business information, or any other information, whether oral, written, visual or otherwise, or hard or electronic soft copy, that is disclosed by the Disclosing Party to the Receiving Party for the purposes of this Agreement which:

 

(a)

in the case of a tangible disclosure, is marked by the Disclosing Party as “Confidential” or “Proprietary” or with other words of similar import; or

 
(b)

in the case of an oral or visual disclosure, the Disclosing Party identifies such disclosure as being confidential concurrent with the oral or visual disclosure or delivers to the Receiving Party a written statement within thirty (30) days to the effect that such disclosure is confidential.

 

“Disclosing Party” will refer to the Party which in the context is disclosing the Confidential Information. “Receiving Party” will refer to the Party which in the context is receiving the Confidential Information.

     

  

2
 

 

NTU CONFIDENTIAL

 

“Effective Date”   Means the date of this Agreement as written above.
     
“Field of Application” - means applications in the field of (i) consumer electronics including without limitation, wearable electronics, mobile phones, smart devices and electric batteries, including rechargeable and non-rechargeable batteries; and (ii) electric vehicles.
     
“Invention” - means the invention(s) as described in Schedule 1 .
     
“Licensed Patents” -

means:  

 

(i)

the patents and patent applications in respect of the Invention as listed in Schedule 2 ;  

 

(ii)

all divisional, continuation or reissue applications of any such patent applications;  

 

(iii)

all patents issuing from any of the foregoing applications;  

 

(iv)

all reissues, re-examinations and extensions of any of the foregoing patents; and  

 

(v)

all patents and patent applications anywhere in the Territory that, at any time, claimed priority from or contained the same disclosure as any of the foregoing patent applications.

     
“Licensed Products” -

means:  

 

(i)

any product or service the making, using, selling or import of which is covered by any claim of any patent under the Licensed Patents (treating for this purpose, any pending patents as if they had been issued) (the “ Patented Licensed Products ”); and  

 

(ii)

any product or service, other than Patented Licensed Products, that incorporates or that is or was developed in whole or in part through the use or application of any of the Licensed Proprietary Materials (the “ Other Licensed Products ”).

 

3
 

 

NTU CONFIDENTIAL

     
“Licensed Proprietary Materials” - means unpublished research and development information, technical information, manufacturing techniques, formulae, data, designs and other information in relation to the Invention in the possession of NTU as of the Effective Date and as listed in Schedule 3 to be transferred to Licensee pursuant to this Agreement.
     
“Licensed Technology” - means all Licensed Patents, Licensed Proprietary Materials.
     
“Net Sales” -

means the amount actually received for all sales, leases, or other transfers of Licensed Products by or for Licensee and its Affiliates, less:  

 

(i)

customary trade, quantity or cash discounts and non-affiliated brokers’ or agents’ commissions actually allowed and taken;

 

(ii)

amounts repaid or credited by reason of rejection or return;  

 

(iii)

to the extent separately stated on purchase orders, invoices, or other documents of sale, taxes levied on and/or other governmental charges made as to production, sale, transportation, delivery or use; and  

 

(iv)

reasonable charges for delivery or transportation provided by third parties, if separately stated (to the extent not paid by the third party customer).  

 

Net Sales also includes the fair market value of any non-cash consideration received by Licensee and its Affiliates for the use, sale, lease, or transfer of Licensed Products.  

 

Licensee will make best efforts to collect such payment that is due and payable.

 

4
 

 

NTU CONFIDENTIAL

     
“Parties” - means NTU and Licensee collectively, and a “Party” means any one of them.
     
“Patent Expenses” - means any and all reasonable and actual costs and expenses (including legal and other professional fees, Goods and Services Tax and stamp duties) incurred by NTU in relation to the preparation, filing, prosecution, and maintenance of Licensed Patents.
     
“Related Entity” - means any entity that is connected to the Licensee or any of its Affiliates in the manner as stated in Section 6 of the Singapore Companies Act (Cap 50)
     
“Sub-License Consideration”   Means any payments or other consideration that Licensee or its Affiliates actually receives from a Sub-Licensee including, without limitation, royalties (including royalties calculated on the basis of sales), up-front payments, milestone payments, license fees, and license maintenance fees. In the case of Sub Licenses, where the Licensee or an Affiliate receives non-cash consideration from that Sub-Licensee, the Sub-License Consideration will be calculated based on the fair market value of such consideration or transaction, at the time of the transaction, assuming an arms-length transaction made in the ordinary course of business. Sub-License Consideration will not include (i) any equity investments and/or loans made by a Sub-Licensee in and to Licensee or an Affiliate, provided however that such equity investments and/or loans are not made in consideration for the grant of any Sub-License or any option to obtain such Sub-License, that Licensee actually receives from a Sub- Licensee as a result of the grant of a Sub-License or an option to obtain such Sub-License.

Licensee will make best efforts to collect such payments from its Sub-Licensee.
     
“Sub-Licensee” - means the holder of a license granted by Licensee or its Affiliates to a third party who is not an Affiliate of Licensee to enable the third party to exploit the Licensed Technology for its own account and “Sub- License” will mean the license so granted.
     
“Term” - means the period during which this Agreement continues in force pursuant to Clause 3 .
     
“Territory” - means worldwide.

 

1.2.

In this Agreement, except where the context indicates to the contrary:

   
  (a)      "person" includes any individual, body corporate, joint venture, trust, agency or other body;
     
  (b) words importing the singular will include the plural and vice versa and words denoting a given gender will include each other gender;
     
  (c) headings are inserted for ease of reference only and will not affect the interpretation of this Agreement;
     
  (d) references to clauses or sub-clauses will have reference to clauses or sub- clauses of this Agreement; and
     
  (e) all schedules and attachments to this Agreement form part of this Agreement.

 

5
 

 

NTU CONFIDENTIAL

 

 

2. GRANT OF LICENSE
   
2.1.

NTU hereby grants to Licensee, and Licensee accepts, subject to the terms and conditions hereof, a perpetual, exclusive (even as to NTU), worldwide, royalty- bearing license, with rights to sublicense as set forth herein, under the Licensed Technology to develop, have developed, manufacture, have manufactured, import, export, use, market, offer for sale, sell, have sold and otherwise commercialize and exploit the Licensed Products in the Field of Application in the Territory, and to use the Licensed Technology for such purpose. This license will extend to Affiliates present and future, of Licensee who notify NTU in writing that they accept the terms, including the obligations, of this Agreement respecting such license.

 

2.2. Licensee will further have the right to grant sub-licenses of the Licensed Technology under this Agreement to any person, subject to the following:

 

  (a)

Licensee will be responsible for its Sub-Licensees and will not grant any rights which are inconsistent with the rights granted to and obligations of Licensee hereunder.

     
     
  (b) Any act or omission of a Sub-Licensee which would be a breach of this Agreement if performed by Licensee will be deemed to be a breach by Licensee of this Agreement; provided that (a) if Licensee cures the breach during the applicable curing period and/or (b) if Licensee terminates the Sub-Licensee's Sub-License following the applicable curing period in the event that the breach has not been cured; such cure and/or termination, shall be deemed a cure by Licensee of the breach of this Agreement and shall not constitute a cause for the termination of this Agreement.
     
  (c) Each Sub-License granted by Licensee will include an audit right by NTU of the same scope as provided in Clause 6.1(b) hereof with respect to Licensee.
     
  (d) Licensee will at all times indemnify and keep indemnified NTU against all or any costs, claims, damages or expenses incurred by NTU, or for which NTU may become liable, as a result of the default or negligence of any Sub-Licensee.
     
  (e) Upon the early termination of this Agreement, prior to its expiration, under Clause 13 . 1 , any existing Sub-License will terminate; provided, however , that:
     
    (i)      for each Significant Sub-Licensee (as such term is defined herein), if the Significant Sub-Licensee is not then in breach of such Sub- License agreement with Licensee such that Licensee would have the right to terminate such Sub-License, NTU shall, at the request of such Significant Sub-Licensee, continue to uphold such Sub- License with such Significant Sub-Licensee on substantially the same terms as those contained in such Sub-License agreement; and provided, further , that such terms shall be amended, to the extent required to ensure that such Sub-License agreement does not impair any rights of NTU included in, or arising under, this Agreement or impose any obligations or liabilities on NTU which are not included in this Agreement; and
     
    (ii) for each Sub-Licensee not considered a Significant Sub-Licensee, NTU shall, at the request of such Sub-Licensee, consider the continued upholding of such Sub-License, in accordance with the terms stated in Clause 2.2(e)(i) above, such request not be unreasonably withheld.
     
    For the purpose of this Clause 2.2, the term "Significant Sub-Licensee" shall mean any Sub-Licensee (a) determined in good faith and jointly by Licensee and NTU to be of strategic importance within the Field of Application; or (b) which on the effective date of termination has annual sales of US $ 10 Million or more.
     
  (f) Licensee will within thirty (30) days of the grant of any Sub-License provide NTU with a true copy of it at Licensee's own expense.
     
  (g) The sub-licensing rights under the Licensed Technology granted by Licensee under any Sub-License will not be transferable and will not be further sub-licensed , without NTU’s prior consent .

  

2.3. Licensee acknowledges and agrees that the rights granted to it under this Agreement are limited to the license granted under this Clause 2 . Licensee acknowledges that the grant of those rights are conditioned on its agreement to refrain from using the Licensed Technology outside of the Field of Application and Territory without NTU’s consent and that any such activity by Licensee will be a material breach of this Agreement.
   
2.4. Subject to the confidentiality restrictions, set forth in Clause 10 below, nothing in this Agreement will prejudice NTU’s right to practice the Licensed Technology for the sole purpose of academic research, teaching and other non-commercial educational purposes.
   
2.5. Nothing in this Agreement will be construed as a grant of a license or any right by NTU or any of its Affiliates to Licensee to use any third party intellectual property rights, information or other property rights. Licensee will be solely responsible at its own expense, for obtaining all necessary third party licenses required for its exploitation of the Licensed Technology pursuant to this Agreement, including all necessary third party licenses required for its use, development, manufacture, distribution and sale of any Licensed Product.
   
2.6. NTU shall following the execution of this Agreement and upon Licensee’s written request, deliver to Licensee all the Licensed Proprietary Materials listed in Schedule 3 (in English and without additional charge). Thereafter and following the transfer of such to be accompanied by any clarifications and explanations reasonably requested by Licensee for the first thirty (30) days after the delivery of the Licensed Proprietary Materials. After the expiry of thirty (30) days after the delivery of the Licensed Proprietary Materials, NTU will not be obliged to render any technical assistance, or support, or provide training to Licensee. Without derogating from the above, following the signing of this Agreement, Licensee shall have the option, which is to be exercised by the Licensee within 6 months of the last signatory to this Agreement, to enter into a Research Collaboration Agreement (RCA) with NTU, for the purpose of further developing the Licensed Technology by its inventor, Prof. Chen Xiao Dong and his team, on such terms as will be determined by the Parties. For the avoidance of doubt, any and all foreground intellectual property rights sponsored by Licensee and developed under the RCA, based upon and/or relating to the Licensed Technology, which is jointly developed by Licensee and NTU shall be jointly owned by NTU and Licensee. NTU’s ownership interest in such foreground intellectual property shall be licensed to Licensee under the terms of this Agreement and made an integral part hereof.
   
3. COMMENCEMENT DATE AND ROYALTY PERIOD
   
3.1. This Agreement will come into effect on the Effective Date.

 

6
 

 

NTU CONFIDENTIAL
  

3.2. Licensee’s obligations for payment of royalties pursuant to Clause 4 will terminate, on a country-by-country basis, upon the later of:

 

  (a) the last to expire of any patents under the Licensed Patents as listed in Schedule 2; or

 

(b) the end of a period of fifteen (15) years from the date of the First Commercial Sale of Licensed Product.

 

4. OBLIGATIONS OF LICENSEE

 

4.1. Licensee hereby undertakes and agrees with NTU that it will at all times during the Term observe and perform the terms and conditions set out in this Agreement and in particular will:

 

  (a) use diligent efforts to effect introduction of Licensed Products into the commercial market as soon as practicable, consistent with sound reasonable business practice and judgment;

 

(b) observe all applicable laws and regulations and obtain all necessary licenses, consents and permissions required in respect of the use, manufacture, importation, storage, marketing and sale of Licensed Products (including the sub-licensing of Licensed Products) in the Territory, as applicable;

 

(c) register or record this Agreement with the relevant government agency as may be required by the laws of a country as a prerequisite to enforceability of this Agreement in the courts, and Licensee will be responsible for all costs and legal fees in connection therewith; and

 

(d) deliver to NTU annual audited financial statements during the Term.

 

4.2. Licensee will further exercise best efforts to meet the following performance milestones:

 

(a) Licensee will have a First Commercial Sale a Licensed Product for consumer electronics starting from the fourth (4th) anniversary of the effective date of the license agreement.

 

(b) Licensee will have a First Commercial Sale of a Licensed Product for electric vehicles starting from the fourth (4th) anniversary of the effective date of the license agreement.

 

4.3. In the event that Licensee does not meet a performance milestone, NTU will have the right, upon sixty (60) days notice, to convert the license granted in Clause 2 from exclusive to non-exclusive with respect to the applicable field of use (i.e. consumer electronics and/or electric vehicles). Failure of NTU to give the notice provided in this Clause 4.2 in reference to any performance milestone will not constitute a waiver of the right to give such notice in reference to any subsequent performance milestone.

 

7
 

 

NTU CONFIDENTIAL

 

4.4. Notwithstanding Sections 4.2 and 4.3 above Licensee shall have the option to extend the term for the achievement of the applicable performance milestone set forth in Section 4.2 above, by 12 months at a time (as long as Licensee is pursuing the commercialization of the Licensed Products), by paying NTU an option fee of US $ 25,000 for each 12 months extension period. Licensee is to exercise the option to extend the performance milestones within thirty (30) days of the expiry of the then applicable performance milestones date. Licensee is to make payment of the option fee upon exercising the option.

 

5. FINANCIAL PROVISIONS

 

5.1. Milestone Payments . In consideration for the rights granted under Clause 2 , Licensee will pay to NTU the milestone payments in the sums and upon the occurrence of the milestone event(s) specified below:

 

  (a) Singapore Dollars Ten thousand (S $10,000) to be paid as a downpayment upon signing of this License Agreement; and

 

  (b) Singapore Dollars Fifty Thousand (S $50,000) to be paid upon the finalization of a first advanced non-laboratory scale prototype of the first Licensed Product (where such determination will be made by an independent, neutral industry expert).

 

(c) Singapore Dollars Fifty Thousand (S $50,000) to be paid upon the First Commercial Sale of a Licensed Product.

 

The amounts stated above are exclusive of any applicable Singapore Goods and Services Tax (GST) payable by Licensee. In the event of early termination of this Agreement, any milestone payments made under this Clause 5.2 are non-refundable. NTU will issue an invoice to Licensee for the amount of milestone payment and Licensee will pay such amount to NTU upon receipt of such invoice and in accordance with the instructions for payment stated in such invoice.

 

Licensee will notify NTU upon the occurrence of the milestone event in part (b) above within fourteen (14) days of such occurrence

 

5.2. Royalty Payments . In addition to any milestone payments, Licensee will pay to NTU royalties in respect of all sales, leases or other transfers of Licensed Products during the Term of this Agreement, such amounts to be exclusive of any applicable GST payable by Licensee on such royalties, at the following rates:

 

(a) three and one half percent (3.5%) of Net Sales of Patented Licensed Products; and

 

(b) three and one half percent (3.5%) of Net Sales of Other Licensed Products.

 

5.3. Sub-License Consideration . Licensee will further pay to NTU fifteen percent (15%) of all Sub-License Consideration, such amounts to be exclusive of any applicable GST payable by Licensee on such payments.

 

8
 

 

NTU CONFIDENTIAL

 

Notwithstanding the above, the Sub-License Consideration payable to NTU with respect to Sub-Licenses granted to Related Entities shall be either (a) 15% of the Sublicense Consideration; or (b) royalties on Net Sales as required from Licensee and its Affiliates, whichever is the greater amount.

 

5.4. The royalties and all other sums payable under Clauses 5.2 to 5.3 will be paid as follows:-

 

  (a) within the period of sixty (60) days after the end of each calendar year, Licensee will send to NTU a written statement showing:

 

  (i) complete and accurate details of all safes, leases or other transfers of Licensed Products referred to in Clause 5.3 on a country-by-country basis in that calendar year;

 

(ii) the Net Sales in respect of the transactions referred to in Clause 5.4(a)(i) above;

 

(iii) the amount of the royalties payable under Clause 5.2 in respect of those transactions; and

 

(iv) complete and accurate details of all Sub-License Consideration received by Licensee from each Sub-Licensee and the amount payable to NTU with respect to such Sub-License Consideration referred to in Clause 5.3 .

 

(v) Notwithstanding the royalty obligations set out above, in the event that Licensee or an Affiliate is legally or contractually required to pay, and actually pays during the term of this Agreement, royalty payments to unaffiliated third parties on sales of Licensed Products in a particular country in order to obtain a license to patents owned or controlled by such third party, covering the Licensed Products, and provided such license is required in order to manufacture, use, sell and import and/or export Licensed Products (“ Third Party Licenses ”), then Licensee shall be entitled to offset 50% of such third party royalty payments against the royalty due to NTU on Net Sales in such country during the same period; provided , however , that the final amount due following all deductions shall not be less than 50% of the amount due prior to deductions. Licensee shall include all relevant information regarding such third party licenses and deduction in the reports detailed in this Clause 5.4(a).

 

  (b) NTU will issue an invoice to Licensee for the amount of the royalties and other payments so shown and Licensee will pay such amount to NTU upon receipt of such invoice.

 

5.5. All royalties and all other sums payable under this Agreement will be paid in Singapore Dollars.

 

9
 

 

NTU CONFIDENTIAL

 

  (a) If such royalties or sums payable are calculated in a currency other than Singapore Dollars, they will be converted into Singapore Dollars by reference to the average of the relevant buying and selling closing rates of the OCBC Bank in Singapore (the “ Bank ”) on the last day of the year to which they relate.

 

  (b) If such day will be on a day when the Bank is closed, then the reference date will be the first immediately preceding day on which the Bank was open.

 

5.6. All such royalties and other sums payable under this Agreement will be paid in cleared funds to such bank account or in such other manner as NTU may specify from time to time to Licensee, without any set off, deduction or withholding of taxes, charges and other duties. Licensee will be responsible for any and all bank charges associated with such payment. Licensee agrees to release and indemnify NTU from and against all liability of whatever nature arising out of Licensee’s failure duly and timely to pay and discharge any of the above-mentioned taxes.

 

5.7. If Licensee fails to pay in full to NTU any undisputed royalties or other sums payable under this Agreement on the date due, or within the period specified for payment, the amount outstanding will bear interest, both before and after any judgment, at the rate of three percent (3%) per annum above the prime lending rate of the Bank (or the maximum allowed by law, if less), from such date until the said amount is paid in full to NTU; provided however that NTU shall have first sent written notice to the Licensee of said default in payment.

 

5.8. The Parties agree that timely payment of royalties and other sums payable under this Agreement is of the essence to this Agreement and failure to make any such payment on time will be a material breach.

 

6. ACCOUNTS

 

6.1. Licensee will, and Licensee will make best efforts to procure that its Affiliates will:

 

  (a) keep full, proper and accurate accounts and records in sufficient detail of all sales, leases, or other transfers of Licensed Products to enable the amount of royalties and other sums payable under this Agreement to be determined; and

 

  (b) at the reasonable request of NTU from time to time, but no more than once per calendar year, and upon not less than thirty (30) days prior written notice, allow NTU or its or its appointed independent, Certified “top ten” Public Accountants (CPA) acceptable to the Licensee (or enable NTU or said accountants) at NTU’s expense to inspect its accounts and records bearing upon the amount of royalties and other sums due and to make copies of them.

 

Licensee will preserve and maintain all such accounts and records required for audit for a period of at least five (5) years after the calendar year to which such accounts and records apply.

 

10
 

  

NTU CONFIDENTIAL

 

6.2. If, following any inspection pursuant to Clause 6.1(b) , NTU discovers a discrepancy in the amount of royalties and other sums paid from those payable under this Agreement, Licensee will, within seven (7) days of the date of NTU’s notification thereof, make up any shortfall. Licensee will further reimburse NTU in respect of any professional charges incurred for such inspection, if the discrepancy exceeds five percent (5%) of the total amount of royalties and other sums payable to NTU during the inspected period.

 

6.3. The provisions of this Clause 6 will remain in full force and effect after the termination of this Agreement for any reason until the settlement of all subsisting claims of NTU under this Agreement.

 

7. INTELLECTUAL PROPERTY, PATENT EXPENSES AND MANAGEMENT OF LICENSED PATENTS

 

7.1. Licensee acknowledges that all intellectual property rights in and relating to the Licensed Technology belong to NTU, and to thy extent legally enforceable, Licensee hereby agrees not do anything which might bring into question NTU’s ownership of those rights or their validity. Licensee will mark all Patented Licensed Products sold by it under the license granted herein with the word “Patent” or “Patents” and the number or numbers of the Licensed Patent(s) applicable thereto.
   
7.2. All enhancements, modifications, improvements, and derivatives of and to the Licensed Technology created or developed solely by the Licensee, its employees, staff, servants or agents, without any intellectual input or contribution from NTU, shall be the sole and exclusive property of the Licensee. For the avoidance of doubt, no input and/or contribution shall be deemed to have been made by NTU to Licensee absent of an express supplement written agreement noting NTU’s rights with respect to such input and/or contribution.
   
7.3. Except as otherwise expressly noted in this Agreement, all enhancements, modifications, improvements, and derivatives of and to the Licensed Technology created or developed jointly by NTU and Licensee shall be jointly owned in equal undivided shares by the Parties (“ Joint IP ”). For the avoidance of doubt, no such enhancements and/or modifications and/or improvements and/or derivatives shall be deemed to have been made by NTU to Licensee absent of an express written supplement agreement noting NTU’s rights with respect to the above.
   
7.4. Licensee will reimburse NTU for all documented out-of-pocket Patent Expenses incurred by NTU prior to the Effective Date, up to and not exceeding Singapore Dollars Twenty Thousand ($20,000). Subject to Section 7.5 below, Licensee will also be responsible for all Patent Expenses subsequent to the Effective Date. Licensee will pay for such Patent Expenses upon receipt of the relevant invoice for such Patent Expenses.
   
7.5. Subsequent to the Effective Date, NTU will continue to be responsible for managing the filings, prosecution and maintenance of all Licensed Patents in the Territory. NTU will keep Licensee informed of the status of the Licensed Patents from time to time as well as upon request. The Parties will cooperate to ensure protection of the Licensed Patents and pursue and maintain the Licensed Patents in at least in the following jurisdictions: Singapore, China and the US (the “ Mandatory Jurisdictions ”). The filing and maintenance of patents in any jurisdiction other than the Mandatory Jurisdictions shall be determined by Licensee following consultation with NTU. For the avoidance of doubt, Licensee’s obligations with respect to the Patent Expenses shall apply so long as Licensee holds an exclusive license under the Licensed Patents.

 

11
 

 

NTU CONFIDENTIAL

 

8. INFRINGEMENT OF LICENSED PATENTS
   
8.1. Licensee will notify NTU in writing of any infringement, or suspected or threatened infringement, of any of the Licensed Patents that will at any time come to its knowledge.
   
8.2. While and as long as its license under this Agreement remains exclusive, Licensee will be responsible for, after consultation with NTU, taking appropriate steps as may be necessary to prevent or restrain any infringement by a third party of any of the Licensed Patents in the Field of Application and will be responsible for all costs and fees incurred by Licensee in the taking of any such steps. Licensee is empowered to bring any such legal proceedings in its own name, or if required by law, jointly with NTU. Any award or settlement payment resulting from an action initiated by Licensee will be first used to reimburse all documented out-of-pocket expenses incurred by both Parties in relation to such legal action, and thereafter paid to Licensee and will be deemed Sub-License Consideration received under this Agreement. To dispel all doubt it is hereby clarified that Licensee shall not be obligated to commence legal proceedings against a third party infringer and any such proceedings shall be at Licensee’s sole discretion.

 

8.3. If Licensee decides not to or fails to take appropriate steps to prevent or restrain any infringement by any third party of any of the Licensed Patents (but not otherwise), NTU shall have the right (however not the obligation) to take action to prevent or restrain such infringement. NTU will be entitled to retain any award of damages or other compensation obtained as a result of any such action (including any proceedings) being taken by NTU. Licensee agrees to provide reasonable assistance which NTU may require in any litigation including the execution of all necessary legal documents.
   
8.4. The parties will cooperate fully and make requisite personnel and documents available to assist and to be produced to the other side as necessary with respect to any claims or proceedings contemplated above.
   
9. INFRINGEMENT OF THIRD PARTY RIGHTS
   
9.1. If any proceedings are brought against Licensee on grounds that the use or exploitation by Licensee of any of the Licensed Technology infringes the rights of any third party, Licensee will forthwith notify NTU of the same. Licensee will have the exclusive control of the defense of such proceedings.
   
9.2. NTU will not be liable for any costs or expenses, including consequential loss or damage, loss of profits or other economic loss, suffered by Licensee in respect of such proceedings in Clause 9.1 .

 

12
 

 

NTU CONFIDENTIAL

 

9.3. Licensee will indemnify NTU and keep NTU indemnified against all loss or damage and any costs and expenses suffered by NTU in respect of such proceedings in Clause 9.1 .
   
10. CONFIDENTIALITY
   
10.1. The Receiving Party agrees to use the Confidential Information of the Disclosing Party disclosed under this Agreement solely in connection with the Receiving Party’s rights and obligations under this Agreement.
   
10.2. Licensee and NTU agree that the terms hereof and the nature of the contemplated transaction described herein, as well as the fact that negotiations have commenced between the parties, shall not be disclosed to any third party who is not a director, officer, employee, agent, consultant or affiliate of either of the Parties. Notwithstanding the above, whereas Licensee is a publicly traded company, it is hereby agreed that any disclosure of Confidential Information in accordance with the applicable laws and stock exchange regulations governing Licensee shall not be deemed a breach of the confidentiality terms stated herein.
   
10.3. The Receiving Party agrees to make such Confidential Information received from the Disclosing Party available only to those directors, officers, employees, agents, consultants, Affiliates or Sub-Licensees who require access to it in the performance of their professional responsibilities under this Agreement and to potential and actual investors, business partners, service providers and consultants who have a need to know same whether to consider an investment transaction, collaboration or service arrangement, and who are bound to maintain the confidentiality of such Confidential Information under similar obligations of confidentiality as the Receiving Party under this Agreement.
   
10.4. Other than as provided for under Clause 10.1 above, no Receiving Party will disclose any Confidential Information of the Disclosing Party to any other third party without the prior written consent of the Disclosing Party.
   
10.5. The Receiving Party will exert reasonable efforts, no less than the protection given its own confidential information, to maintain Confidential Information received from the Disclosing Party in confidence.
   
10.6. Each Party agrees that the obligations of confidentiality contained herein will not attach to:

 

  (a) information which is or was already known to the Receiving Party at the time of disclosure to it, as evidenced by written records; or

 

(b) information which, at the time of disclosure to the Receiving Party or thereafter, is published or otherwise generally available to the public through no fault or omission of the Receiving Party of its obligations hereunder; or

 

13
 

 

NTU CONFIDENTIAL

 

  (c) information which can be established by tangible evidence was independently developed by the Receiving Party without the use of or reference to the Disclosing Party’s Confidential Information; or

 

(d) information which is lawfully obtained by the Receiving Party from a third party not under any confidentiality obligation to the Disclosing Party; or

 

(e) information which is required to be disclosed by court rule or governmental law or regulation, provided that the Receiving Party gives the Disclosing Party prompt notice of any such requirement and cooperates with the Disclosing Party in attempting to limit such disclosure.

 

10.7. Title to, and all rights emanating from, the ownership of all Confidential Information disclosed under this Agreement will remain vested in the Disclosing Party. Nothing herein will be construed as granting any license or other right to use the Confidential Information of the Disclosing Party other than as specifically agreed upon by the Parties.
   
10.8. Upon written request of the Disclosing Party given after termination of this Agreement, the Receiving Party will promptly return to the Disclosing Party all written materials and documents, as well as other media, made available or supplied by the Disclosing Party to the Receiving Party that contains Confidential Information, together with any copies thereof, except that the Receiving Party may retain one copy each of such document or other media for archival purposes only, subject to protection and nondisclosure in accordance with the terms of this Agreement.
   
11. LIMITED WARRANTIES / LIABILITIES
   
11.1. Each Party warrants that it has the necessary rights, powers and authority to enter into this Agreement.
   
11.2. NTU warrants in respect of the Licensed Technology that it has the legal power to extend the rights granted to Licensee in this Agreement.
   
11.3. NTU hereby represents and warrants that: (a) it is the sole and exclusive owner of the Licensed Technology; and (b) to the best of its knowledge, as of the date hereof, the Licensed Technology is free from infringement of any patent or other rights of third parties.
   
11.4. Except for the warranties expressed in Clauses 11.1, 11.2, and 11.3 above, NTU makes no other warranties or representations, express or implied, including without limitation:

 

(a) warranties of fitness for a particular purpose or merchantability, satisfactory quality, reliability, accuracy or validity of the Licensed Technology or Licensed Products; or;

 

(b) the patentability of the Licensed Technology or Licensed Products or of the enforceability of any Licensed Patents, if any; or

 

(c) that the Licensed Technology or Licensed Products will be free from infringement of any patent or other rights of third parties.

 

14
 

 

NTU CONFIDENTIAL

 

11.5. Neither NTU, nor any of its faculty members, scientists, researchers, employees, officers, trustees or agents, assume any responsibility for the use of the Licensed Technology by Licensee, its Affiliates or its Sub-Licensees, or any use, manufacture, specifications, sale or other dispositions of Licensed Products by or for Licensee, its Affiliates or its Sub-Licensees.
   
11.6. NTU will not be liable to Licensee for any loss, damages, expenses, costs, damages or any other liability whatsoever which in any way relates to the use of the Licensed Technology by Licensee, its Affiliates or its Sub-Licensees, or any use, manufacture, specifications, sale or other dispositions of Licensed Products by or for Licensee, its Affiliates or its Sub-Licensees.
   
11.7. IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER PARTY FOR LOSS OF PROFITS, LOSS OR INTERRUPTION OF BUSINESS, OR FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY OR PUNITIVE DAMAGES OF ANY KIND. EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES . Notwithstanding anything to the contrary, to the extent permitted under the applicable law each Party’s total and cumulative liability under this Agreement, howsoever arising, will not exceed the total sum of monies paid by Licensee to NTU pursuant to this Agreement.
   
11.8. The express terms of this Agreement are in lieu of all warranties, conditions, terms, undertakings and obligations implied by statute, common law, custom, trade usage, course of dealing or otherwise, all of which are hereby excluded to the fullest extent permitted by law.
   
12. INDEMNITIES AND INSURANCE
   
12.1. Licensee will at all times indemnify, defend and hold harmless NTU against all and any loss, damages, expenses, costs, or damages, incurred by NTU, or for which NTU may become liable arising: (a) out of any use of the Licensed Technology by Licensee, its Affiliates or its Sub-Licensees; or (b) out of any use, manufacture, sale, or other disposition of Licensed Products by or for Licensee, its Affiliates or its Sub-Licensees. Such indemnity and defense obligation will apply to any claims, including without limitation, infringement of third party intellectual property rights, personal injury, and death or property damage, made by employees, subcontractors or agents of Licensee, as well as any member of the general public
   
12.2. Licensee will maintain adequate public liability and product liability insurance coverage and will ensure that NTU’s interest is noted on the policy. Licensee will supply NTU with a copy of such insurance policy on request.

 

15
 

 

NTU CONFIDENTIAL

   
13. TERMINATION
   
13.1. NTU will be entitled forthwith to terminate this Agreement immediately by notice in writing if:

 

(a) Licensee or any of its Affiliates is in breach of any term of this Agreement which is either incapable of rectification or which is not rectified within sixty (60) days of written notice given by NTU;

 

(b) Licensee or any of its Affiliates commences an action in which it challenges the validity or enforceability of any of the Licensed Patents;

 

(c) Licensee ceases or announces its intention to cease to carry on its business;

 

(d) Licensee becomes insolvent or is unable to pay its debts as they fall due or suspends or threatens to suspend making payments with respect to all or any class of its debts or enters into any composition or arrangement with its creditors or makes a general assignment for the benefit of its creditors; where such insolvency proceedings have not been dismissed within sixty (60) days;

 

(e) Licensee goes into liquidation or if an order is made or a resolution is passed for the winding up of Licensee whether voluntarily or compulsorily (except for the purpose of a bona fide reconstruction or amalgamation); where such liquidation or winding-up proceedings have not been dismissed within sixty (60) days; or

 

(f) Licensee has a receiver or receiver and manager or judicial manager appointed over any part of its assets or undertaking; where such receivership proceedings have not been dismissed within sixty (60) days.

 

13.2. Licensee may terminate this Agreement by giving thirty (30) days advance written notice of termination to NTU.
   
13.3. Termination of this Agreement howsoever caused will not prejudice any other right or remedy of the Parties in respect of any antecedent breach. Any termination rights will be in addition to and not in substitution for any other remedies that may be available to the non-breaching Party and will not relieve the breaching Party from liability and damages to the other Party for breach of this Agreement.
   
13.4. In the event of termination of this Agreement in accordance with Clause 13.1 above:

 

(a) Licensee and its Affiliates and Sub-Licensees will be entitled to continue to exercise the rights granted to it under this Agreement to such extent and for such further period, not exceeding six (6) months from the date of termination, reasonably necessary to enable Licensee and its Affiliates to satisfy any orders placed prior to such termination date or scheduled for delivery within such six (6) months prior to the termination date;

 

16
 

 

NTU CONFIDENTIAL

 

(b) subject to Clause 13.4(a) above, Licensee and its Affiliates will forthwith cease to market or use, either directly or indirectly, the Licensed Products or Licensed Technology;

 

(c) Licensee will forthwith return all Confidential Information pursuant to Clause 10.8 ;

 

(d) Licensee will promptly pay all amounts due under this Agreement to NTU and will submit a notice in writing signed by a duly authorised officer that it has complied with such payment obligations, along with a copy of all materials reasonably necessary to support such statement.

 

13.5. Notwithstanding termination or expiry of this Agreement under any of its provision, Clauses 6 (Accounts), 10 (Confidentiality), 11 (Disclaimer of Warranties), 12 (Indemnities and Insurance), 13 (Termination), 18 (Dispute Resolution) and 19 (Governing Law) , and any other Clauses of this Agreement which from their context are intended to survive the termination or expiry of this Agreement, will survive the Term or the termination or expiry of this Agreement and will be deemed to remain in full force and effect.
   
14. ASSIGNMENT
   
14.1. All rights and obligations hereunder are personal to the Parties and each Party shall not assign any such rights and obligations to any third party without the prior consent in writing of the other Party on terms to be agreed by the Parties; provided however that Licensee may assign, with novation, all rights and obligations hereunder to any of its related companies (as defined under section 6 of the Singapore Companies Act (Chapter 50)) or any other companies affiliated with Licensee which shall be identified to NTU in advance, without any prior consent. The Party which is the assignor shall procure that such third party covenants with the other Party to be bound by the terms of this Agreement as if it had been a party hereto in place of the assignor.
   
14.2. The rights and licenses granted by NTU in this Agreement are personal to Licensee and may not be assigned or otherwise transferred to any third party without the prior written consent of NTU, which will not be unreasonably withheld. Where such consent is given by NTU, Licensee will procure that such third party covenants with NTU to be bound by the terms of this Agreement as if it had been a party hereto in place of Licensee.
   
14.3. Notwithstanding the above, (i) NTU may assign or otherwise transfer all or any of its rights and/or obligations under this Agreement to an NTU Affiliate responsible for commercializing and/or managing NTU’s intellectual property rights, (ii) Licensee undertakes to inform NTU prior to, or as soon as is reasonably practicable after assigning its rights and obligations under this Agreement, and (iii) Licensee undertakes that, to its knowledge, none of its assignees are involved in activities that are detrimental to the interests of the Republic of Singapore or to NTU’s position as an Institute of Higher Learning.

 

17
 

 

NTU CONFIDENTIAL

   
15. FORCE MAJEURE
   
15.1. Notwithstanding anything else in this Agreement, no default, delay or failure to perform on the part of either Party will be construed a breach of this Agreement if such default delay or failure to perform is shown to be due entirely to causes beyond the control of the Party charged with a default, delay or failure, including but not limited to, causes such as strikes, lockouts or other labour disputes, riots, civil disturbances, actions or inaction of governmental authorities, epidemics, war, embargoes, severe weather, fire, earthquakes, acts of God or the public enemy and nuclear disasters.
   
15.2. Any non-performance or delay of Licensee subject to Clause 15.1 above that is in excess of one hundred and eighty (180) days will constitute cause for termination by NTU of this Agreement upon written notice to Licensee.
   
16. PUBLICITY
   
16.1. Except to notify that this Agreement is in effect, including the identification of the Parties which information will not be deemed to be confidential, to acknowledge that Licensee has entered into an exclusive license for rights to certain technology developed by NTU and to describe, without divulging any Confidential Information, the nature of this Agreement and the Field of Application, Licensee agrees that it will not use in any way the name of NTU or any logotypes or symbols associated with NTU or the names of any of the scientists or other researchers at NTU in any publicity, promotion, news release or disclosure relating to this Agreement or its subject matter, without the prior written consent of NTU, which consent will not be unreasonably withheld.
   
17. NOTICES
   
17.1. Any notice to be given by a Party to this Agreement will be in writing and will be deemed duly served if delivered personally or sent by electronic mail or sent by facsimile transmission or by prepaid registered post to the addressee at the address or (as the case may be) the facsimile number or e-mail address, respectively, of that Party as set out below or at such other address (or facsimile number) as the Party to be served may have notified the other Party for the purposes of this Agreement:

 

NTU:
Nanyang Technological University
Blk 1, Unit 100, Innovation Centre
16 Nanyang Drive
Singapore 637722
Attn: Director
Facsimile: (+65) 6792 1737
E-mail: CEO-NTUlnnovation@ntu.edu.sg

 

Licensee:
BLUESPHERE CORPORATION
301 McCullough Drive,
4th Floor,
Charlotte, NC 28262,
USA
Attn: CEO
Facsimile: 704-9092701
E-mail: shlomi@bluespherecorporate.com

 

18
 

 

NTU CONFIDENTIAL

 

17.2. Any notice given pursuant to Clause 17.1 will be deemed to have been received:

 

  (a) in the case of delivery by hand, when delivered; or

 

(b) in the case of sending by post:

 

(i) where posted in the country of the addressee, on the third Business Day following the day of posting; and

 

(ii) where posted in any other country, on the seventh Business Day following the day of posting; or

 

(c) in the case of facsimile or electronic mail, on acknowledgement by the recipient facsimile receiving equipment or recipient of the electronic mail, respectively, on a Business Day if the acknowledgement occurs before 1700 hours local time of the recipient, and in any other case on the following Business Day.

 

18. DISPUTE RESOLUTION

 

18.1. In the event of any difference or dispute arising between the Parties relating to the validity, interpretation, construction or performance of this Agreement, the Parties will use their best endeavours to settle amicably such difference or dispute by consultation and negotiation.
   
18.2. If such efforts taken under Clause 18.1 above fail, then the Parties will refer the matter to mediation in accordance with the rules and procedures of the Singapore Mediation Centre.
   
18.3. If, and to the extent that, any dispute has not been settled pursuant to Clauses 18.1 and 18.2 above, then the dispute will be referred to and finally resolved by arbitration in Singapore in accordance with the Arbitration Rules of the Singapore International Arbitration Centre for the time being in force, which rules are deemed to be incorporated by reference to this Clause 18 . The language of the arbitration will be English. Any award made hereunder will be final and binding upon the Parties hereto and judgment on such award may be entered into any court or tribunal having jurisdiction thereof.
   
18.4. The institution of any arbitration hereunder will not prevent NTU from applying for and obtaining from a court a temporary restraining order and/or preliminary injunctive relief pending the outcome of the arbitration.

 

19
 

  

NTU CONFIDENTIAL

 

19. GOVERNING LAW
   
19.1. The construction, validity and performance of this Agreement will be governed in all respects by the Laws of the Republic of Singapore (excluding conflicts of laws), except that questions affecting the construction and effect of any patent will be determined by the law of the country in which such patent has been granted. The Parties hereby submit to the non-exclusive jurisdiction of the courts of the Republic of Singapore.
   
20. GENERAL
   
20.1. Nothing in this Agreement will create or be deemed to create, a partnership, or the relationship of principal and agent, between the Parties. Neither party has any authority of any kind to bind the other Party in any respect whatsoever.
   
20.2. No person will have any right pursuant to the Contracts (Right of Third Parties) Act (CAP.53B) to enforce any of the terms and conditions in this Agreement.
   
20.3. Unless otherwise expressly specified, this Agreement embodies the entire understanding between the Parties in respect of the subject matter hereof and any prior or contemporaneous representations, either oral or written, are hereby superseded. No amendments or changes to this Agreement will be effective unless made in writing and signed by duly authorized representatives of the Parties.
   
20.4. No exercise, or failure to exercise, or delay in exercising any right power or remedy vested in any Party under or pursuant to this Agreement will constitute a waiver by that Party of that or any other right, power or remedy.
   
20.5. In the event that any term, condition or provision of this Agreement is held to be a violation of any applicable law, statute or regulation, the same will be deemed to be deleted from this Agreement and will be of no force and effect, and this Agreement will remain in full force and effect as if such term, condition or provision had not originally been contained in this Agreement. Notwithstanding the above, in the event of any such deletion, the Parties will negotiate in good faith in order to agree on terms of a mutually acceptable and satisfactory alternative provision in place of the provision so deleted such that the objectives contemplated by the Parties when entering into this Agreement may be realised.
   
20.6. The Parties will co-operate with each other and execute and deliver to the other such instruments and documents and take such other action as may be reasonably requested from time to time in order to carry out and confirm the rights and the intended purpose of this Agreement.
   
20.7. Stamp fees, if any, payable in respect of this Agreement will be borne wholly by Licensee.

 

 

20
 

 

NTU CONFIDENTIAL

   
20.8. The Parties may sign this Agreement in one (1) or more counterparts by the duly authorised representatives of the Parties, each of which constitutes an original and all of which taken together will constitute the Agreement. The Parties may sign and deliver this Agreement by facsimile or by emailed portable document format (“PDF”) document (or other mutually agreeable document format), and a reproduction of this Agreement with a Party’s signature made by facsimile or PDF, sent by facsimile or email will have the same effect as and be enforceable as a signed and delivered original version of this Agreement.

 

21
 

 

NTU CONFIDENTIAL

 

IN WITNESS WHEREOF the Parties have caused this Agreement to be executed by its duly authorised officers or representatives on the date first above written.

 

SIGNED by for and on behalf of   SIGNED by for and on behalf of
     
NANYANG TECHNOLOGICAL UNIVERSITY   BLUESPHERE CORPORATION
     
     
     
     
Name: Dr. Lim Jul   Name: Shlomi Palas
Designation: CEO (NTU Innovation)   Designation: CEO
     
     
     
In the presence of:   In the presence of:
     
     
     
     
Name: David Yeow   Name: Roy Amitzur
Designation: Director   Designation: Executive VP

 

22
 

 

NTU CONFIDENTIAL

 

SCHEDULE 1

 

INVENTION

 

[NTU itive R ef : TD/119/13, TD/197/13]

 

TD/119/13 : Synthesis of High Aspect Ratio Titanate Nanotubes and Its Environmental Applications As Free-Standing Multifunctional Membrane

 

TD/197/13 : Correlating Aspect Ratio Of Nanotubular Structures With Electrochemical Performance To Achieve Ultrafast-Charging Lithium-Ion Battery

 

 

23
 

 

NTU CONFIDENTIAL

 

SCHEDULE 2

 

LICENSED PATENTS

 

(a) Patents
Title Country Grant No. Grant Date
N.A.      
 
(b) Patent Applications
Title Country Application No. International Filing Date
Elongated Titanate Nanotube, Its Synthesis Method, And Its Use PCT PCT/SG2014/000435 16/09/2014
Synthesis Of High Aspect Ratio Titanate Nanotubes And Its Environmental Applications As Free-Standing Multifunctional Membrane US PRV 61/878,456 16/09/2013
Correlating Aspect Ratio Of Nanotubular Structures With Electrochemical Performance for High-Rate and Long-Life Lithium-Ion Battery US PRV 61/951,194 11/03/2014

  

24
 

 

NTU CONFIDENTIAL

 

SCHEDULE 3

 

LICENSED PROPRIETARY MATERIALS

 

Laboratory manual, formulations and instructions for preparation of Titanate Nanotube as well as any and all technical information and know-how, including (without limitation) methods, practices, formulae, techniques, procedures, specifications, product samples, drawings, diagrams, charts, blue-prints, designs, computer programs, instructions and the like, in NTU’s custody, care or control, which may be required and/or useful in the commercialisation of the Invention and/or the Licensed Patents.

  

25

 

 

Blue Sphere Corporation 10-K

E xhibit 10.17

FOUNDERS AGREEMENT

Made and entered into this 8 day of January, 2015 (“Effective Date”) By and between

BlueSphere Corporation , a corporation incorporated pursuant to the laws of the State of Nevada, United States of America, having a place of business at 301 McCullough Drive, 4th Floor, Charlotte, NC 28262, United States of America (“ BlueSphere ”)

of the first part; and

Prof. Chen Xiaodong (Singapore NRIC No. S7587208I) of 85A Nanyang View Singapore 639661 (“Chen”)

of the second part;

(BlueSphere and Chen shall be referred to hereinafter as the “ Founders ” or the “ Parties ”)

Whereas pursuant to a license agreement between BlueSphere and Nanyang Technological University (“NTU”) dated 30 October 2014 (“License Agreement”), BlueSphere has obtained a license to use the intellectual property disclosed in NTU’s technology disclosures numbered TD/119/13 and TD/197/13 (“Technology”) in the field of rechargeable batteries powering (i) consumer electronics including without limitation, wearable electronics, mobile phones, smart devices and electric batteries, including rechargeable and non-rechargeable batteries; and (ii) electric vehicles (“Field”);
   
Whereas Chen is one of the inventors of the Technology;
   
Whereas the Founders have caused the Company (defined in Section 2 below) to be incorporated for the purpose of developing and commercializing the Technology; and
   
Whereas the Founders desire to set forth the guidelines for the establishment, management, control and business operations of the Company, as well as their relationship as shareholders of the Company.

  

Now, Therefore, the Parties hereby represent, warrant, undertake and agree as follows: 

1. Preamble and Interpretation

The Preamble to this Agreement forms an integral part hereof.

2. Establishment of the Company

2.1 Prior to the execution of this Agreement, the Founders have caused a company (“ Company ”) to be incorporated in Singapore with following particulars:

 
 

 

  Name of Company: QUICKCHARGE PTE. LTD.
  Company Registration No. 201424899H
  Registered Address 1, Marina Boulevard, #28-00
Singapore 018989 
  No of Shares 200 ordinary shares
  Issued and Paid Up Capital S$200.00

 

2.2 In the event of any inconsistency between the provisions of this Agreement and the memorandum and articles of association (“ M&A ”) of the Company, the former shall prevail and the Founders hereto will, at the request of any one of them, cooperate with a view to taking all necessary action to make any appropriate amendments to the M&A to reflect the provisions of this Agreement.

2.3 The Founders shall, as soon as practicable cause,

2.3.1 100 of the 200 ordinary shares in the capital of the Company to be transferred to each of them;

2.3.2 the Company to execute a deed of adherence agreeing to be bound by the provisions of this Agreement; and

2.3.3 the M&A to be amended by deleting Article 58 and inserting the following in substitution thereof:
If within half an hour from the time appointed for the meeting a quorum is not present, the meeting, it shall stand adjourned to the same day in the next week at the same time and place, or to such other day and at such other time and place as the directors may determine. And if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the meeting, the member or members present in person or by proxy, attorney or representative shall be a quorum..

3. Purposes of the Company

3.1 The Company shall engage in the development and commercialization of the Technology in the Field, and in any other related business as shall be determined by the Company’s Board of Directors (the “ Board ”).

3.2 Following the execution of this Agreement Company shall enter into a Research Collaboration Agreement (“ RCA ”) with NTU in furtherance of the further development of the Technology.

3.3 The RCA will be financed through funds to be made available by

3.3.1 BlueSphere by way of subscription price to be paid for pursuant to Sections 4.1 and 4.2 below; and

3.3.2 Non-Dilutive Financing.

For the purpose of this Agreement, the term “Non-Dilutive Financing” means any source of funds obtained from Singapore governmental agencies or any other third parties which

2
 

(a) either (a) is given to the Company; (b) in any other way funds the activities of the RCA or (c) funds research activities which deliverables and/or deliveries will be licensed pursuant to the License Agreement and/or the RCA to, and without requiring further consideration from, BlueSphere and/or the Company; and.

(b) which neither BlueSphere nor the Company need to repay or to issue any equity (or options in respect of equity) in consideration thereof.

3.4 BlueSphere hereby undertakes to make available to the Company at least (i) US$500,000.00; or (ii) an amount equal to the Non-Dilutive Financing, whichever is lower.

4. Initial Allocation of Share Capital

4.1 The Founders shall subscribe Company issued share capital to be increased to 9,800 ordinary shares which shall be allocated as follows:

4.1.1 BlueSphere - 6,760 ordinary shares to be subscribed for, issued and paid up to the amount of US$0.01 per share (“Initial Subscription Amount”) which constitute 70% of the Company’s issued share capital.

4.1.2 Chen - 2,840 ordinary shares to be subscribed for, issued and paid up to the amount of US$0.01 per share, which constitutes 30% of the Company’s issued share capital.

4.2 BlueSphere shall provide loan financing (“Loan Financing”) to the Company amounting to US$500,000.00, as and when required in order to finance the Company’s R&D efforts less the amount which BlueSphere shall have paid by way of subscription for its shares in the capital of the Company. Notwithstanding the above, BlueSphere’s obligation pursuant to this Section 4.2 is conditional upon either (i) the continuance of the activities or (ii) the delivery of the deliverables, as contemplated under and set forth in the RCA. In the event that the RCA terminates, prior to the delivery of the deliverables contemplated under the RCA, BlueSphere’s Loan Financing undertaking shall terminate.

4.3 On each occasion that the debt on the Loan Financing is to be repaid, the Company shall pay to Chen, by way of dividends (including dividends waived by BlueSphere) or any other arrangement agreed upon between the Founders, an amount calculated as follows:

3
 

  C = BxShC/ShB
       
  Where
   
  C = Amount to be paid to Chen pursuant to this Section 4.3
       
  B = Amount of debt on Loan Financing to be repaid to BlueSphere
       
  ShC = Number of shares held by Chen
       
  ShB = Number of shares held by BlueSphere.

 

4.4 In the event that, upon expiry of three (3) years from the date of this Agreement, the amount of Non-Dilutive Financing is less than US$500,000.00, BlueSphere shall have the option to acquire from Chen a number of ordinary shares on the following terms:

4.4.1 the number of shares in respect of such option shall computed as follows:

  N = (500,000 — F) / 500,000 x 1,960
       
  Where
   
  N = number of shares which may be acquired; and
       
  F = amount of Non-Dilutive Financing converted into United States Dollars (at the conversion rate prevailing as of the date on which BlueSphere had paid the Initial Subscription Amount.

 

4.4.2 The total price to be paid for the Option Shares shall be US$1.00 and the option may be exercise at any time prior to the expiry of 42 months from the date of this Agreement.

4.5 In the event that, upon expiry of three (3) years from the date of this Agreement, the amount of Loan Financing is less than US$500,000.00 and BlueSphere’s Loan Financing undertaking has not terminated (pursuant to Section 4.2 above), Chen, either by himself or through another party (“ Participating Third Party ”)secures non-dilutive financing for the shortfall between US $500,000.00 and the amount of Loan Financing (“ Shortfall ”) Chen (or at Chen’s option, the Participating Third Party or a combination of Chen and such Participating Third Party in such numbers as may be determined by Chen) shall have the option to acquire from BlueSphere a number of ordinary shares on the following terms:

4.5.1 the number of shares in respect of such option shall computed as follows:

  N = (500,000 — BF) / 500,000 x 6,760
       
  Where
   
  N = number of shares which may be acquired; and
       
  B F = amount of Loan Financing actually provided by BlueSphere (in US Dollars)

4
 

4.5.2 The total price to be paid for the Option Shares shall be US$1.00 and the option may be exercise at any time prior to the expiry of 42 months from the date of this Agreement.

4.5.3 Upon exercise of the option described in this Section 4.5, Chen shall assume and take upon himself (including without limitation by utilizing financing received from the Participating Third Party)to provide the loan financing in respect of the Shortfall, to fully release BlueSphere from any related obligation, as a pre-condition to the purchase of the BlueSphere shares.

4.6 The issuance of shares or other securities or rights convertible into shares including, without limitation, options and warrants to future third party investors in the Company or any allocation and/or grant of shares or options to the Company’s employees, consultants etc., as determined by the Company’s Board of Directors, shall dilute the shareholdings of the Founders pari passu on a pro-rata basis.

4.7 BlueSphere shall within 30 days from the execution of this agreement and, at its option, assign the License Agreement to the Company or sublicense the rights under the License to the Company.

5. Drag Along Rights

In the event that Founders holding the majority of the shares held by the Founders (the “ Founders Majority ”) accept (the “ Founders Acceptance ”) or reject (the “ Founders Rejection ”) an offer to sell their shares to a purchaser in a transaction that is conditioned upon the sale of all remaining share capital and securities of the Company to such purchaser, then (i) in case of a Founders Acceptance, all Founders shall agree to sell their shares and other securities in the Company in such transaction, on the same terms as the Founders Majority agreed to, and (ii) in case of a Founders Rejection, all Founders shall decline and not agree to sell their shares in such transaction.

Provided always that

5.1 In the event of a Founders Acceptance and unless the consideration payable to the holders of the share capital and securities of the Company is equal to or exceeds US$10,000,000,

(a) any of the Founders not constituting the Founders Majority (“Founders Minority”) shall be entitled to require that a third party professional valuer (“Valuer”), to be agreed upon by the Founders (or in the absence of such agreement, a valuer to be appointed from among one of the big four international accounting firms to be appointed by the board of directors of the Company) to undertake a valuation of the shares to be acquired; and

(b) in the event that the price at which the Founders Majority intends to dispose of their shares is less than the valuation arrived at by the Valuer, each of members of the Founders Minority shall be entitled to refuse to sell their shares.

5
 

5.2 In the event of a Founders Rejection, Chen shall be still entitled to sell the number of shares set described in the second paragraph of Section 8.1.

6. Board of Directors

6.1 The board of directors of the Company (“ Board ”) shall consist of up to 5 members.

6.2 Each holding of 20% of the issued and outstanding share capital of the Company shall entitled the holder appoint one director to the Board. Provided always that any Founder holding at least 15% of the issued capital of the Company shall be entitled to appoint one director to the Board notwithstanding that he may hold less than 20% of the issued and outstanding share capital.

6.3 Resolutions proposed at any meeting of the Board, shall be deemed adopted if passed by a majority of the members of the Board present at the relevant meeting and entitled to vote thereon. At any meeting of the Board, each member entitled to vote shall have one vote.

7. Positions in the Company

7.1 It is hereby agreed that Chen shall enter into a consulting agreement with the Company (“ Consulting Agreement ”) under which he will provide technical and scientific consultancy services to the Company of the Company.

7.2 The terms of Consulting Agreement shall be concluded between the Company and Chen at a later stage.

7.3 Each Founder hereby warrants and represents that he is not prevented or barred, in any way, from entering into this Founders Agreement and acting in accordance thereto, and the execution hereof or its implementation does not constitute a breach of and/or does not contradict any other agreement, undertaking, commitment or limitation which applies to it/him, including without limitation any confidentiality or non-competition agreements. Each Founder hereby warrants and represents that neither the execution hereof nor the implementation of this Founders Agreement requires the further approvals of any third party.

8. Transfer of Shares

8.1 Unless otherwise determined in the framework of any future round of investment in the Company and save in the event of a Founders Acceptance Chen hereby undertakes not to sell, transfer or make other disposition of his shares in the Company for a period of three (3) years as of the Effective Date (“ No Sale Period ”).

6
 

Notwithstanding the aforesaid and subject to BlueSphere’s right of first refusal, Chen shall be entitled to sell up to 10% of his shares in the Company (calculated on an aggregate basis as of the Effective Date).

8.2 Without derogating from Section 8.1 above, and unless determined otherwise in the framework of any future round of investment in the Company, until the consummation of an IPO, the sale and/or transfer of Company shares by a Founder shall be subject to a right of first refusal, as set forth below:

(a) A Founder (the “ Offering Founder ”) wishing to sell or transfer any of its shares in the Company shall provide the other Founders (herein the “ Offeree ”) with notice detailing the Company shares he/it wishes to sell or transfer (the “ Offered Shares ”) and the price, terms of payment and the name of the buyer (the “ Buyer ”) who wishes to acquire the Offered Shares pursuant to said conditions (aforesaid notice terms shall be referred to as the “ Offer ”).

Should the Offeree wish to acquire the Offered Shares at the price and under the terms detailed in the Offer, the Offeree shall respond to the Offer in writing (the “ Response ”) within 21 days from receipt of Offer. Such Response shall indicate the maximum number of Offered Shares the Offeree is/are willing to purchase, including in the event that any other Offeree refuses to buy his part of the Offered Shares.

(b) Should the Offeree provide notice within the aforementioned period that they wish to acquire all of the Offered Shares (and not less than all of the Offered Shares), such notice shall be considered a notice of acceptance and shall create an agreement to sell and acquire the Offered Shares, at the price and under the terms detailed in the Offer. In such case the Offering Founder shall be obliged to transfer the Offered Shares to the Offeree against payment of the abovementioned price or arrangement to pay the price under the terms detailed in the Offer.

(c) Should the Offeree notify the Offering Founder that they do not intend to acquire all of the Offered Shares, or do not respond to the Offer within the aforementioned 21 day period, the Offering Founder shall be entitled to sell and transfer the Offered Shares to the Buyer, at the price and under the same terms listed in the Offer, within 90 (ninety) days from (1) the end of the 21-day period for notification of the Response or (2) the date on which the Offerees notified the Offering Founder that they do not wish to acquire all of the Offered Shares, the earlier of the two.

(d) If the Offering Founder does not sell the Offered Shares to the Buyer within the aforesaid 90 day period and nevertheless still desires to sell or transfer the Offered Shares, the Offering Founder shall be obliged to re-offer the Offered Shares to the Offeree under the procedure detailed in Sections 8.2(a) and 8.2(b) above.

7
 

(e) The aforesaid in this Section 8.2 shall also apply to the sale and/or transfer of shares by a receiver, liquidator, etc., but shall not apply to the sale and/or transfer of shares to a Founder’s immediate family member (spouse and children only) or its Affiliate (all of the aforementioned people and entities shall be referred to as “ Permitted Transferees ”).
Affiliate ” for the purpose of this Agreement shall mean means, with respect to an entity, any person, organization or entity controlling, controlled by or under common control with, such party. For purposes of this definition only, “control” of another person, organization or entity shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the activities, management or policies of such person, organization or entity, whether through the ownership of voting securities, by contract or otherwise. Without limiting the foregoing, control shall be presumed to exist when a person, organization or entity (a) owns or directly controls fifty percent (50%) or more of the outstanding voting stock or other ownership interest of the other organization or entity or (b) possesses, directly or indirectly, the power to elect or appoint fifty percent (50%) or more of the members of the governing body of the organization or other entity. The parties acknowledge that in the case of certain entities organized under the laws of certain countries, the maximum percentage ownership permitted by law for a foreign investor may be less than fifty percent (50%), and that in such cases such lower percentage shall be substituted in the preceding sentence.

(f) In any event and as a precondition to the transfer of shares by the Offerer, the Buyer or any Founder’s Permitted Transferee shall be obligated to assume, in writing, all of the undertakings of the transferring Founder pursuant to this Agreement.

9. Raisins Capital

It is agreed between the Founders that insofar as the Company decides in the future to raise capital, in any manner, including but not limited to private equity transaction, from the public, by way of the publication of a prospectus, or any other manner, and the provisions of this Agreement will be in contrast to such intentions, the parties shall enter into good faith negotiations in order to adapt such provision by mutual consent.

8
 

10. Confidentiality

Each of the Founders shall hold in strict confidence all documents and information concerning the Company, its business, operations, technology and products, including without limitation, any commercial, financial or technical information, information regarding technologies, know-how, inventions, developments, formulas, processes, methods, specifications, raw materials, trade secrets, marketing, business plans, activities, business opportunities, names of suppliers, customers, strategic partners, sources, costs and/or any other private, confidential and/or proprietary information with regard to the Company, its affiliates, shareholders, officers, employees, etc. (all hereinafter referred to as the “ Confidential Information ”), and shall not: (i) directly or indirectly, in writing or otherwise, disclose, communicate, disseminate, expose, allow access to or make available the Confidential Information, in whole or in part, to any person or entity; or (ii) use the Confidential Information in any way, directly or indirectly, all other than for purposes for the Company and/or for fulfilling such Founder’s obligations and exercising such Founder’s rights under this Agreement.

The obligations hereunder shall not apply to any Confidential Information which is proven by the Founder receiving the information (the “ Receiving Founder ”) to be generally available to the public through no fault of the Receiving Founder.

Disclosure of any Confidential Information pursuant to any compelling judicial or administrative order or proceeding or as required by law, shall not be deemed a breach hereof. Furthermore, Chen hereby acknowledges and confirms he is aware that BlueSphere, as a public traded company and is required to comply with disclosure requirements under applicable securities laws and/or stock exchange regulations and disclosure of any Confidential Information pursuant to any such requirements shall not be deemed a breach hereof.

Notwithstanding the above, to the extent that it is reasonably necessary, each Fonder may disclose information it is otherwise obligated under this Section 9 not to disclose to (i) its employees and consultants on a need-to-know basis and on condition that such employees abide by the obligations set forth in this Section 9; (ii) in confidence, to lawyers, accountants and financial advisors; (iii) to potential inventors which have entered customary non-discloser and non-use agreement for the benefit of the Company.

11. Protective Provisions

Notwithstanding anything to the contrary herein, until an IPO, any action or resolution of the Company’s general meeting, or its Board of Directors (or any committee thereof), as applicable, regarding any of the following issues shall require the consent of each of the Founders holding more than 15% of the outstanding share capital of the Company and voting rights thereof (“ Eligible Founder ”), or each of such Eligible Founders’ representatives in the Board of Directors (provided such Founder has a representative in the Board of Directors), as applicable:

11.1 Alter or change materially or adversely, any of the rights attached to the Ordinary Shares held by the Founders.

11.2 Any material deviation from the business of the Company and/or any material change in the business character of the Company.

11.3 All decisions concerning expanding and/or entering new business territories.

11.4 Any amendment to the M&A.

11.5 A merger, consolidation or the sale, of all or substantially all of the Company’s assets.

11.6 Any process of liquidation, dissolution, winding-up or IPO of the Company.

9
 

12. Non-Competition

Each Founder hereby covenants and undertake that as long as he is active in the business and/or operations of the Company or any affiliate of the Company, and for a period of 24 months thereafter, he shall not: (i) be engaged or involved, directly or indirectly, whether as owner, independent contractor or service provider, shareholder of more than five percent (5%), director, principal, partner, manager, agent, employee, advisor or otherwise, in designing, developing, manufacturing, marketing or otherwise commercializing products in the Field; or (ii) employ, offer to employ or otherwise engage or solicit for employment, any person who is or was, during the 24 month period prior to the time they ceased to be active in the business and/or operations of the Company or any affiliate of the Company, an employee or sales and/or marketing agent of the Company or an exclusive provider of services or contractor to the Company.

No Founder shall pursue, whether directly or indirectly, any activity which intervenes in the relationship between the Company and any of the Company’s employees, contractors or consultants.

Provided always that nothing in this Section 12 shall prohibit Chen from undertaking

(a) his academic and research duties as a faculty member of a university; and

(b) consulting activities for any party to whom a university which employs or has employed Chen has licensed a technology invented by Chen which technology BlueSphere and the Company have prior to such license been offered a right of first refusal to obtain a license to.

13. Governing Law and Forum

This Agreement and the interpretation, validity and breach thereof shall be governed by the laws of Singapore, without regard to its choice of law rules.

Any dispute arising out of or in connection with this contract, including any question regarding its existence, validity or termination, shall be referred to and finally resolved by arbitration in Singapore in accordance with the Arbitration Rules of the Singapore International Arbitration Centre (“SIAC Rules”) for the time being in force, which rules are deemed to be incorporated by reference in this Section 13. The parties agree that any arbitration commenced pursuant to this Section 13 shall be conducted in accordance with the Expedited Procedure set out in Rule 5.2 of the SIAC Rules. The Tribunal shall consist of one arbitrator. The language of the arbitration shall be English.

10
 

14. Miscellaneous

14.1 Further Cooperation

The Parties agree to execute any and all documents necessary in order to consummate, implement and give full force and effect to this Agreement and to all matters and transactions envisaged and contemplated herein, including, but not limited to, filings with governmental or regulatory bodies, powers of attorney, corporate resolutions and such other documentation as may be reasonably necessary from time to time.

14.2 Captions

The captions of Sections in this Agreement are intended solely for convenience, and will have no significance in the interpretation of this Agreement.

14.3 Counterparts

This Agreement may be executed in any number of counterparts, and at one (1) or more times, each of which containing the signature of any of the Parties, shall be deemed an original, but all of which together shall constitute one and the same instrument.

14.4 Non-Assignability

The respective obligations and rights of the Parties hereunder cannot be assigned, transferred or otherwise conveyed, without the prior written consent of the other Parties hereto. Notwithstanding the aforesaid, BlueSphere may assign this Agreement and/or its respective obligations and rights hereunder to any of its affiliates, upon written notice.

14.5 Validity

In the event wherein any provision of this Agreement is held by a competent court to be invalid or unenforceable, for any reason whatsoever, all of the remaining provisions contained herein shall remain in full force and effect and shall be binding on the Parties without any change; furthermore, if all or part of the obligations of the Parties hereinabove shall be held to be invalid or unenforceable by reason of exceeding the extent and/or scope allowed by law, such exceeding obligation(s) shall be reduced to the maximum extent and/or scope allowed by law.

14.6 Waiver and Consent

The failure of any Party at any time or times to require performance of any provision hereof or to enforce any right with respect thereto, shall in no manner affect the right of such Party at a later time to enforce the same and shall in no way be construed to be a waiver of such provision or right.

11
 

14.7 Amendments

No amendment, addition, omission, modification or change to this Agreement shall be valid unless drawn up in writing and signed by a majority of the Parties; provided, however, that in no event shall the obligation or liability of any Founder be increased, except upon the written consent of such Founder.

14.8 Third Party Beneficiary

The provisions of Sections 9 (“ Confidentiality ”) and 10 (“ Non-Competition ”) hereto, shall inure to the benefit of the Company as a third party beneficiary thereto.

14.9 Entire Agreement

This Agreement fully embraces the entire legal relationship between the Founders regarding the subject matter herein, and no previous agreements, memoranda of agreements, letters, negotiations, promises, consents, undertakings, representations, warranties or documents which were applied, exchanged, or signed by or between any of the Parties hereto prior to the signing of this Agreement shall have any force or effect.

14.10 Notices

All notices given by one Party to the other hereunder will be given in writing, and will be deemed to have been delivered to the addressee immediately upon their delivery if delivered by hand, or upon transmission if sent by facsimile and confirmed by a machine printout, or within three (3) business days after being sent by mail, as per the addresses indicated in the preamble hereof, or to such other address or facsimile number as a Party may thereafter give notice in writing, to the other Parties of this Agreement.

In Witness Whereof, the Parties hereto have caused this Agreement to be duly executed on the day and year first above written:

Signed by Shlomi Palas )
for and on behalf of )
BlueSphere Corporation )
in the presence of )

   

12


 

 

Blue Sphere Corporation 10-K  

Exhibit 21.1  

 

LIST OF SUBSIDIARIES

 

Blue Sphere Corporation has the following direct and indirect subsidiaries:

 

Subsidiary Name   Jurisdiction of
Formation
  Percentage of
Ownership
         
Eastern Sphere, Ltd.   Israel     100 %
             
Bluesphere Pavia   Italy     100 %
             
Johnstonsphere LLC   Delaware     100 %
             
Binosphere Inc.   Delaware     100 %
             
Sustainable Energy Ltd.   Israel     100 %
             
Orbit Energy Charlotte, LLC*   North Carolina     25 %
             
Orbit Energy Rhode Island, LLC*   Rhode Island     22.75 %
             
Quickcharge PTE Ltd.   Singapore     70 %

*Blue Sphere Corporation’s interests in these entities is based on its interests in Concord Energy Partners, LLC, a Delaware limited liability company, and Rhode Island Energy Partners, LLC, a Delaware limited liability company, which are the owners of Orbit Energy Charlotte, LLC and Orbit Energy Rhode Island, LLC, respectively.


 

BLUE SPHERE CORPORATION 10-K

Exhibit 31.1

 

CERTIFICATION OF 

CHIEF EXECUTIVE OFFICER 

PURSUANT TO 18 U.S.C. SECTION 1350, 

AS ADOPTED PURSUANT TO SECTION 302 OF 

THE SARBANES-OXLEY ACT OF 2002

 

I, Shlomi Palas, certify that:

 

1. I have reviewed this Form 10-K of Blue Sphere Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;

 

  c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 13, 2016  
   
/s/Shlomi Palas  
Shlomi Palas  
Chief Executive Officer  

 


 

Blue Sphere Corporation 10-K

Exhibit 31.2

 

CERTIFICATION OF 

CHIEF FINANCIAL OFFICER 

PURSUANT TO 18 U.S.C. SECTION 1350, 

AS ADOPTED PURSUANT TO SECTION 302 OF 

THE SARBANES-OXLEY ACT OF 2002 

  

I, Shlomo Zakai, certify that:

 

1. I have reviewed this Form 10-K of Blue Sphere Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;

 

  c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 13, 2016  
   
/s/Shlomo Zakai  
Shlomo Zakai  
Chief Financial Officer  

 


 

Blue Sphere Corporation 10-K

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 

18 U.S.C. SECTION 1350, 

AS ADOPTED PURSUANT TO 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

 

In connection with this Annual Report on Form 10-K of Blue Sphere Corp. (the “Company”) for the year ended September 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Shlomi Palas, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

  

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

  

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

  

 Dated: January 13, 2016 By: /s/Shlomi Palas
    Shlomi Palas
    Chief Executive Officer
       

This certification accompanies each Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

  

A signed original of this written statement required by §906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 


 

 

Blue Sphere Corporation 10-K

Exhibit 32.2

 

CERTIFICATION PURSUANT TO  

18 U.S.C. SECTION 1350, 

AS ADOPTED PURSUANT TO 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

  

In connection with this Annual Report on Form 10-K of Blue Sphere Corp. (the “Company”) for the year ended September 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Shlomo Zakai, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

  

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

  

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

  

Dated: January 13, 2016 By: /s/Shlomo Zakai
    Shlomo Zakai
    Chief Financial Officer
       

This certification accompanies each Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.

  

A signed original of this written statement required by §906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.